<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
<channel>
<title>Academic Journals Inc.</title>
<link>http://academicjournalsinc.com</link>
<description>Academic Journals Inc.</description>
<language>en-us</language>
<copyright>Academic Journals Inc.</copyright>
<pubDate>Fri, 10 Feb 2012 18:11:57 +0200</pubDate>
<lastBuildDate>Fri, 10 Feb 2012 18:14:14 +0200</lastBuildDate>
<generator>RssPublisher 0.2.0 beta</generator>
<image>
<url>http://academicjournalsinc.com/images/logo1.gif</url>
<title>ANSInet</title>
<link>http://academicjournalsinc.com</link>
<height>37</height>
<width>155</width>
<description>Academic Journals Inc.</description>
</image>

<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/ajinc" /><feedburner:info uri="ajinc" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId>ajinc</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><feedburner:browserFriendly></feedburner:browserFriendly><item>
<title><![CDATA[Influenza in Africa Should Not Be Ignored, Researchers Urge]]></title> 
<description><![CDATA[Influenza is circulating in Africa, but virtually no information or attention is evident, says a new essay in PLoS Medicine. Maria Yazdanbakhsh and Peter Kremsner argue that the lack of adequate surveillance means that the burden of influenza in Africa is incorrectly believed to be negligible. But sporadic reports from various regions in Africa indicate that influenza is circulating and may be regularly causing epidemics

 

Whereas in temperate areas influenza activity displays a seasonal pattern with marked peaks in the winter, influenza is present all year round throughout the tropics. The authors say that the well-established surveillance network WHO Flu Net in place in Europe and North America, provides continuous data on influenza burden and the spread of viral types and subtypes. Recent threats of pandemic influenza have prompted similar active monitoring in parts of Southeast Asia and Latin America. But the prevalence and incidence of influenza in most tropical countries especially in Africa are largely unknown, say the authors, and improved surveillance is needed.

 

For example, the authors state, the WHO H1N1 swine flu update of May 2009 contained reports of infected patients in many countries, but none in Africa, whereas two reports in October 2009 confirmed swine flu cases from South Africa and Kenya. This indicates that "that the virus was circulating in Africa, but because of the lack of a rigorous surveillance system, it was not reported as readily." 
<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-04-07</pubDate>
</item>
 
<item>
<title><![CDATA['Land Grabs' For Rice Production Due To Supply Threats]]></title> 
<description><![CDATA[Recent interest in �land grabs� or the international acquisition of land to produce rice is sparked by a looming threat of inadequate rice supplies.

 

To put it simply, there is not enough rice to feed the world,� says Dr. Robert Zeigler, director general of the International Rice Research Institute (IRRI).

 

�To meet the need and keep rice prices around US$300 a ton � which allows poor rice farmers to make some profit yet keeps rice affordable for poor rice consumers � we need to produce an additional 8�10 million tons of rice more than in the previous year for the next twenty years.�

 

Many countries do not have the capacity to grow enough rice on their own land to meet existing or anticipated demand. To meet their needs governments or the private sector import rice and some are exploring ways to invest in rice production or rice-growing land in other countries.

 

IRRI is not involved in any projects on land acquisition for rice production, nor does it provide advice on land acquisition, but it does find ways to help increase the overall rice supply � with a mandate to help poor rice farmers and consumers and improve environmental health.
<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-04-07</pubDate>
</item>
 
<item>
<title><![CDATA[Genetic Link to Heart Failure]]></title> 
<description><![CDATA[A team of researchers, at Washington University School of Medicine, St Louis, has identified a group of 12 genetic variants in the HSPB7 gene that is associated with heart failure in humans.

 

The research is reported in the Journal of Clinical Investigation.

 

The team, led by Gerald Dorn, used an approach they have recently developed that allows ultra-high-throughput targeted DNA sequencing to identify genetic variation in four genes with biological relevance to heart failure. They identified in a large group of Caucasian individuals with heart failure, 129 separate genetic variants in the four genes, including 23 that seemed to be novel.

 

Further analysis of 1117 Caucasian individuals with heart failure and 625 nonaffected Caucasians indicated that a block of 12 genetic variants in the HSPB7 gene was associated with heart failure. Confirmation of this association was provided by analysis of an independent group of individuals.

 

The authors hope to use the same approach to identify further genetic variants associated with heart failure, a disease that is influenced by multiple genetic factors. 
<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-04-07</pubDate>
</item>
 
<item>
<title><![CDATA[Biofilms: Researchers Discover New Ways to Treat Chronic Infections]]></title> 
<description><![CDATA[Researchers at Binghamton University, State University of New York, have identified three key regulators required for the formation and development of biofilms. The discovery could lead to new ways of treating chronic infections.

Biofilms -- communities of bacteria in self-produced slime -- may be found almost anywhere that solids and liquids meet, whether in nature, in hospitals or in industrial settings. Biofilms are implicated in more than 80 percent of chronic inflammatory and infectious diseases caused by bacteria, including ear infections, gastrointestinal ulcers, urinary tract infections and pulmonary infections in cystic fibrosis patients, according to the Centers for Disease Control.

 

Biofilms are difficult to eradicate with conventional antimicrobial treatments since they can be nearly 1,500-fold more resistant to antibiotics than planktonic, free-floating cells. Biofilms also pose a persistent problem in many industrial processes, including drinking water distribution networks and manufacturing.
<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-04-07</pubDate>
</item>
 
<item>
<title><![CDATA[Keeping Hepatitis C Virus at Bay After a Liver Transplant]]></title> 
<description><![CDATA[One of the most common reasons for needing a liver transplant is liver failure or liver cancer caused by liver cell infection with hepatitis C virus (HCV). However, in nearly all patients the new liver becomes infected with HCV almost immediately.

 

But now, Hideki Ohdan, Kazuaki Chayama, and colleagues, at Hiroshima University, Japan, have developed an approach that transiently keeps HCV levels down in most treated HCV-infected patients receiving a new liver. The researchers report their findings in the Journal of Clinical Investigation.

 

Specifically, the team took immune cells known as lymphocytes from the donor livers before they were transplanted into the HCV-infected patients, activated them in vitro, and then injected them into the patients three days after they had received their liver transplants.

 

Importantly, these infused cells were able to keep the HCV at bay even though the patients were taking immunosuppressive drugs to prevent their immune systems from rejecting the new livers. Despite showing clear clinical effects, the authors are planning further studies in which they will modify the protocol in an attempt to find a way to keep HCV levels down for longer and in all patients. 
<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-04-07</pubDate>
</item>
 
<item>
<title><![CDATA[Looking Back in Time 12 Billion Years With New Instruments on Herschel Space Observatory]]></title> 
<description><![CDATA[An instrument package developed in part by the University of Colorado at Boulder for the $2.2 billion orbiting Herschel Space Observatory launched in May by the European Space Agency has provided one of the most detailed views yet of space up to 12 billion years back in time.

 

The December images have revealed thousands of newly discovered galaxies in their early stages of formation, said CU-Boulder Associate Professor Jason Glenn, a co-investigator on the Spectral and Photometric Imaging Receiver, or SPIRE instrument, riding aboard Herschel. The new images are being analyzed as part of the Herschel Multi-tiered Extragalactic Survey, or HerMES, which involves more than 100 astronomers from six countries.

 

Equipped with three cameras including SPIRE, the Herschel Space Observatory was launched in May 2009 from Europe's Spaceport in French Guiana. The spacecraft -- about one and one-half times the diameter of the Hubble Space Telescope -- is orbiting nearly 1 million miles from Earth.

 

Herschel is the first space observatory to make high-resolution images at submillimeter wavelengths, which are longer than visible and infrared light waves and shorter than radio waves. SPIRE was designed to look for emissions from clouds and dust linked to star-forming regions in the Milky Way and beyond, said Glenn. The most recent observations were made in the constellation Ursa Major, which includes the Big Dipper.
<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-04-07</pubDate>
</item>
 
<item>
<title><![CDATA[Pancreas Alpha-Cells Can Convert to Insulin-Producing Beta-Cells]]></title> 
<description><![CDATA[In a mouse model, scientists have discovered that alpha-cells in the pancreas, which do not produce insulin, can convert into insulin-producing beta-cells, advancing the prospect of regenerating beta-cells as a cure for type 1 diabetes. The research team, led by senior author Dr. Pedro L. Herrera of the University of Geneva, demonstrated that beta-cells will spontaneously regenerate after near-total beta-cell destruction in mice and the majority of the regenerated beta-cells are derived from alpha-cells that had been reprogrammed, or converted, into beta-cells. Using a unique model of diabetes in mice, in which nearly all of the beta-cells are rapidly destroyed, the researchers found that if the mice were maintained on insulin therapy, beta-cells were slowly and spontaneously restored, eventually eliminating the need for insulin replacement. Alpha-cells normally reside alongside beta-cells in the pancreas and secrete a hormone called glucagon, which works in opposition to insulin to regulate the levels of sugar in the blood. Alpha-cells are not attacked by the autoimmune processes that destroy beta-cells and cause type 1 diabetes. Dr. Andrew Rakeman, the Juvenile Diabetes Research Foundation (JDRF) Program Manager in Beta-Cell Therapies and who was not involved in the research, said that the breakthrough in Dr. Herrera's work is the demonstration that alpha-to-beta-cell reprogramming can be a natural, spontaneous process. "If we can understand the signals that are triggering this conversion, it will open a whole new potential strategy for regenerating beta-cells in people with type 1 diabetes," he said. "It appears that the body can restore beta-cell function either through reprogramming alpha-cells to become beta-cells or, as previously shown by others, by increasing growth of existing beta cells. This path may be particularly useful in individuals who have had the disease for a long time and have no, or very few, remaining beta cells." Interestingly, the researchers pointed out that the critical factor in sparking the alpha-to-beta-cell reprogramming was removing (or ablating) nearly all the original insulin-producing cells in the mice. In mice where the loss of beta cells was more modest, the researchers either found no evidence of beta cell regeneration (when only half the cells were destroyed) or less alpha cell reprogramming (when less than 95 percent of cells were destroyed). "The amount of beta-cell destruction thus appears to determine whether regeneration occurs. Moreover, it influences the degree of cell plasticity and regenerative resources of the pancreas in adult organisms," said Dr. Herrera. This work was published online on April 4, 2010 in Nature. The image shows three lightly stained islets of Langerhans.
<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-04-06</pubDate>
</item>
 
<item>
<title><![CDATA[Vascularization Pathway Mediated by MicroRNA Is Discovered]]></title> 
<description><![CDATA[Researchers at the University of Massachusetts Medical School and colleagues have discovered a critical step for blood vessel growth in zebrafish embryos, providing new insight into how vascular systems develop and offering a potential therapeutic target for preventing tumor growth, which depends on vascularization. The researchers have identified a novel microRNA-mediated genetic pathway responsible for new blood vessel growth (angiogenesis) in zebrafish embryos. The work provides new insights into how vascular systems use the forces of existing blood flow to initiate the growth of new vessels. Focusing on the development of the fifth and sixth aortic arches in the zebrafish, senior author Dr. Nathan Lawson described how the forces exerted by blood flow on endothelial cells are a critical component for expressing a microRNA that triggers new vessel development. In the early stages of development, when blood flow is present in the aortic vessels, but the vascular linkages between the two arches have yet to be established, the stimulus provided by active blood flow leads to expression of an endothelial-cell specific microRNA (mir-126). In turn, this microRNA turns on vascular endothelial growth factor (VEGF), a chemical signal produced by surrounding cells that normally stimulates angiogenesis. Thus, blood flow allows the endothelial cells to respond to VEGF by growing into new blood vessels. However, when blood flow in the aortic arches was restricted, mir-126 failed to be expressed. In the absence of this microRNA, new blood vessels were unable to develop due to a block in VEGF signaling. "We have known for over a hundred years that blood flow makes new vessels grow," said Dr. Lawson. "But we never really knew how cells in a growing vessel interpreted this signal. Our results show that miR-126 is the crucial switch that allows flow to turn on VEGF signaling and drive blood vessel growth. Because VEGF is crucial for tumor progression, not to mention a number of other vascular diseases, our findings may provide new ways to modify this pathway in these settings." One possibility, for instance, is that regulation of mir-126 could be a potential therapeutic target in limiting blood vessel development in solid cancers. This work was published online on April 4, 2010 in Nature. 
<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-04-06</pubDate>
</item>
 
<item>
<title><![CDATA[Upcoming Personalized Medicine 3.0 Conference-Targeting Cancer]]></title> 
<description><![CDATA["Personalized Medicine 3.0--Targeting Cancer" is a one-day conference and networking opportunity for health and industry professionals, educators, and scientists. The conference will focus on cancer--using genomic information to characterize tumors precisely and ensure the use of the most effective treatment regimens for individual patients with the fewest side effects. The organizers note that personalized medicine is poised to transform healthcare over the next several decades, and that it offers both the possibility of improved health outcomes and the potential to make healthcare more cost-effective. The conference will be held in San Francisco at San Francisco State University from 9 am to 7 pm on Tuesday, May 25, 2010. The two previous annual conferences on personalized medicine have been enormous successes and similar results are expected for this third conference. The organizers urge you to register early as space is limited and the registration fee is $249 until April 15, 2010. Registration includes a light breakfast, lunch, and a networking reception at the end of the day. Registration details and a preliminary program are available at the conference web site (<a href="http://personalizedmedicine.sfsu.edu/" target="_blank" style="text-decoration:none;">http://personalizedmedicine.sfsu.edu/</a>), as are additional details on the conference.
<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-04-05</pubDate>
</item>
 
<item>
<title><![CDATA[Blocking miRNA Might Aid Healing of Chronic Wounds]]></title> 
<description><![CDATA[New results indicate that targeting a specific microRNA (miR-210) with a drug that could be used topically on the skin might offer new strategies for treating chronic wounds, which are sometimes fatal and cost the U.S. health-care system an estimated $25 billion annually. Ohio State University researchers have discovered, in a new animal study, that the presence of miR-210 in wounds with limited blood flow lowers the production of a protein (E2F3) that is needed to encourage skin cells to grow and close over the wound. In a parallel experiment using human skin cells, the researchers silenced the miR-210 with an experimental drug and saw E2F3 protein levels rise. The skin cells multiplied as a result. The research involved wounds that are ischemic, that is, they heal very slowly or are in danger of never healing because they lack blood flow and oxygen at the wound site. These types of wounds affect approximately 6.5 million patients each year, and are common complications of diabetes, high blood pressure, obesity, and other conditions characterized by poor vascular health. "When blood supply is inadequate, many things are deficient at the wound site, including oxygen. That leads to a condition called hypoxia," said Dr. Chandan Sen, senior author of the study. "We have shown that hypoxia induces miR-210, which actually blocks the ability of the cells to proliferate, a step necessary for the wound-closure process.� This research was published online on March 22, 2010 in PNAS.
<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-04-05</pubDate>
</item>
 
<item>
<title><![CDATA[Amphibious Caterpillars Discovered in Hawaii]]></title> 
<description><![CDATA[Scientists at the University of Hawaii have discovered the first-ever species of insect that are able to survive an entire life stage spent both above and below the water's surface. In mountain streams across the islands of Hawaii, the researchers observed the larvae (caterpillars) of the moth genus Hyposmocoma feeding and breathing both underwater and away from streams on dry rocks. The scientists said that the caterpillars can breathe and feed indefinitely and equally well both above and below the water�s surface, and can mature either submerged or completely dry. The amphibious caterpillars possess no gills or plastron, common structures for underwater respiration in other insects. When submerged, the caterpillars likely rely on the direct diffusion of oxygen through the hydrophilic skin along their abdomens, the researchers said. Perhaps as a result of their need for direct diffusion, the caterpillars occur only in fast-flowing, well-oxygenated streams, the authors wrote, and quickly die in stagnant water. Genetic analysis of DNA from 89 species of Hyposmocoma indicated that the amphibious lifestyle is an example of parallel evolution; the analysis showed evidence of at least three independent invasions of the water by strictly terrestrial clades (evolutionary groups including a single ancestor and all its descendants), beginning more than six million years ago, before the current �high islands� existed (note: high islands are of volcanic origin and are distinguished from �low islands,� which are formed by sedimentation or uplifting of coral reefs). The authors noted that why and how Hyposmocoma, an overwhelmingly terrestrial group, repeatedly evolved unprecedented aquatic species is unclear, although there are many other evolutionary anomalies across the Hawaiian archipelago. How and why certain species of Hyposmocoma have overcome the physiological limitations of breathing directly from both water and air will be the focus of future research, the researchers said. Interestingly, all caterpillars in the genus Hyposmocoma spin silk cases embedded with minute objects from their environment (pebbles, diatoms, algae, and lichens) to protect and camouflage their bodies, serving as essential shelter both in and out of the water. The caterpillars quickly perish when removed from their cases. The article on amphibious caterpillars was published online on March 22, 2010 in PNAS. 
<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-04-03</pubDate>
</item>
 
<item>
<title><![CDATA[Protein Addition Helps Normalize Blood Glucose in Mouse Study of Type 2 Diabetes]]></title> 
<description><![CDATA[When levels of free protein p85 were increased in the livers of severely obese, diabetic mice, researchers at Children's Hospital Boston-Harvard Medical School and the University of Tokyo saw improved glucose tolerance and reduced blood glucose levels. The effect lies in the influence of p85 on the transcription factor XBP-1 (X-box binding protein 1), the scientists said. Under the influence of p85, XBP-1 normally moves to the nucleus and turns on genes for numerous chaperone proteins, which reduce stress on the endoplasmic reticulum (ER) by aiding and stabilizing the folding of proteins that are produced there and then dispatched to do their jobs in the cell. In previous work, the authors had shown that the brain, liver, and fat cells of obese mice have increased stress in the ER. In the presence of obesity, the ER is overwhelmed and its operations break down. This so-called "ER stress" activates a cascade of events that suppress the body's response to insulin, and is a key link between obesity and type 2 diabetes. Until now, however, researchers haven't known precisely why obesity causes ER stress to develop. Senior author Dr. Umut Ozcan and colleagues have now shown that XBP-1 is unable to function properly in obese mice. Instead of traveling to the cell nucleus and turning on chaperone genes, XBP-1 becomes stranded. Probing further, the researchers found the reason: XBP-1 fails to interact with p85, which is part of an important protein (phosphotidyl inositol 3 kinase or PI3K) that mediates insulin's effect of lowering blood glucose levels. Dr. Ozcan's group identified a new complex of p85 proteins in the cell, and showed that normally, when stimulated by insulin, p85 breaks off and binds to XBP-1, helping it get to the nucleus. "What we found is, in conditions of obesity, XBP-1 cannot go to the nucleus and there is a severe defect in the up-regulation of chaperones," says Dr. Ozcan. "But when we increase levels of free p85 in the liver of obese, severely diabetic mice, we see a significant increase in XBP-1 activity and chaperone response and, consequently, improved glucose tolerance and reduced blood glucose levels." The article was published online on March 28, 2010 in Nature Medicine.
<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-04-03</pubDate>
</item>
 
<item>
<title><![CDATA[Paired Drug Combination Kills Precancerous Colon Polyps]]></title> 
<description><![CDATA[A two-drug combination destroys precancerous colon polyps with no effect on normal tissue, opening a new potential avenue for chemoprevention of colon cancer, according to a team of scientists at The University of Texas M.D. Anderson Cancer Center and INCELL Corporation. The drug regimen, tested so far in mouse models and on human colon cancer tissue in the laboratory, appears to address a problem with chemopreventive drugs--they must be taken continuously long term to be effective, exposing patients to possible side effects, said senior author Dr. Xiangwei Wu, associate professor in M.D. Anderson's Department of Head and Neck Surgery. "This combination can be given short term and periodically to provide a long-term effect, which would be a new approach to chemoprevention," Dr. Wu said. The team found that a combination of Vitamin A acetate (RAc) and TRAIL, (tumor necrosis factor-related apoptosis-inducing ligand), kills precancerous polyps and inhibits tumor growth in mice that have deficiencies in a tumor-suppressor gene. That gene, adenomatous polyposis coli (APC) and its downstream signaling molecules, are mutated or deficient in 80 percent of all human colon cancers, Dr. Wu said. Early experiments with APC-deficient mice showed that the two drugs combined or separately did not harm normal colon epithelial cells. Separately, they showed no effect on premalignant polyps. RAc and TRAIL together killed premalignant polyps, causing programmed cell death known as apoptosis. RAc, researchers found, sensitizes polyp cells to TRAIL. The scientists painstakingly tracked the molecular cascade caused by APC deficiencies, and found that insufficient APC sensitizes cells to TRAIL and RAc by suppressing a protein that blocks TRAIL. Before human clinical trials can be considered, Dr. Wu noted, the team will conduct additional research to understand potential side effects and will also try to develop an injectable version of the drug combination, which is administered intravenously now. Today, concerns about cardiovascular side effects limit chemopreventive agents for colon cancer mainly to high-risk patients, Dr. Wu said. "We hope this combination, if it proves to lack toxicities, might be available as a chemopreventive agent to a broader, general population." The article was published online on March 28, 2010 in Nature.
<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-04-03</pubDate>
</item>
 
<item>
<title><![CDATA[Underexpressed Protein May Play Role in Down Syndrome]]></title> 
<description><![CDATA[Contrary to conventional wisdom that the symptoms of Down syndrome are likely caused by an overabundance of certain proteins due to the additional copy of chromosome 21, scientists at Ohio State University and collaborators have found evidence that at least some of the symptoms may actually be associated with underexpression of a certain protein or proteins due to the presence of five microRNA genes on chromosome 21. MicroRNAs bind to messenger RNA and cause the inhibition of protein synthesis for that messenger RNA. Computer analysis revealed over 1,600 proteins that were potential targets of the five microRNAs on chromosome 21, all of which could cause problems in Down syndrome because they would be underexpressed. Based on other evidence, the researchers selected one of the protein genes (for methyl-CpG-binding protein 2, known as MeCP2) for further study. Among the reasons for selecting this gene was that it is known to be mutated in Rett syndrome, an inherited cognitive disorder. The researchers used just two of the five microRNAs on chromosome 21 for the experiments in this study, miR-155 and miR-802, to match the only microRNAs available in the genetically engineered mouse model of Down syndrome. First, the researchers made copies of the relevant microRNAs. In human brain cell lines, they manipulated levels of those two molecules to show the inverse relationship with MeCP2. If the microRNAs were overexpressed, the level of the MeCP2 protein went down. When the microRNAs were underexpressed, the protein levels went up.
<br><br>
Next, the researchers examined adult and fetal human brain tissue from healthy and Down syndrome samples obtained from a national tissue bank. �In both adult and fetal Down syndrome brain samples, it didn�t matter which area of the brain we were looking at, the MeCP2 proteins were down. These are just observations with no manipulation on our part, and the MeCP2 is almost non-existent in the Down syndrome brain,� senior author Dr. Terry Elton said. �We marked the protein with a fluorescent molecule, and by comparison, we could visualize and appreciate how much MeCP2 was being made by neurons in the control samples.�
<br><br>
MeCP2 is a transcription factor, meaning that it turns genes on and off. If its levels are too low in the brain, this suggests that genes influenced by its presence should be malfunctioning too. Based on previous research by another group, Dr. Elton and colleagues focused on two genes affected by the MeCP2 protein for their next set of experiments. Looking again at the human brain tissue samples, they found that the genes were indeed affected by the lowered protein level in Down syndrome brains--one gene that MeCP2 normally silences was in abundance, and the gene that should have been activated was underexpressed. Because the two genes examined have known roles in neural development, Dr. Elton said the results suggested even more strongly that the lowered protein�s effects on the genes likely contribute to cognitive problems associated with Down syndrome.
<br><br>
Finally, the researchers tested an experimental drug called an antagomir on mice that serve as models for Down syndrome research. Antagomirs are relatively new agents that render microRNAs inactive. The scientists injected an antagomir into the brains of these mice to silence the miR-155 with the intent to increase levels of the MeCP2 protein. Seven days after the injection, the level of the protein in the treated mouse brains resembled levels in normal mouse brains. �We showed that we can fix the protein abnormality in mice that model Down syndrome. But we can�t undo the pathology that has already occurred,� Elton said. �It�s a starting point, but it appears that we have new therapeutic targets to consider.�
<br><br>
This work was published in the January 8, 2010 issue of the Journal of Biological Chemistry.
<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-04-02</pubDate>
</item>
 
<item>
<title><![CDATA[Older Unsupported Women More Likely to have Heart Failure with Preserved Systolic Function]]></title> 
<description><![CDATA[Older women who have less social support and live in nursing homes are more likely to have heart failure with preserved systolic function than those who are married or living in their own home, according to the results of research published in the Medical Journal of Australia. 
<br><br>
Dr Sepehr Shakib, from the Royal Adelaide Hospital, and his co-authors, including cardiologists Dr Dennis Wong and Dr Ben Dundon with social epidemiologist Dr Robyn Clark from the Samson Institute, University of South Australia, undertook a retrospective analysis of clinical data for 2961 patients admitted with chronic heart failure over a period of 10 years. 
<br><br>
The authors found patients who had heart failure with preserved systolic function (HFPSF) were predominantly older women with less social support and a greater burden of comorbid conditions such as renal impairment, anaemia and atrial fibrillation compared with those with left ventricular systolic dysfunction. 
<br><br>
There was also an increase in the risk of re-hospitalisation among patients with HFPSF. Dr Shakib said lack of social and carer support and a greater burden of comorbid conditions in patients with HFPSF may have played a significant predisposing role in hospitalisation and readmissions. "Our study is the first to identify significant differences in the social environment of these patients," Dr Shakib said. 
<br><br>
"We propose that the burden of reduced survival in HFPSF may relate more to comorbid conditions than suboptimal cardiac management." 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-01-19</pubDate>
</item>
 
<item>
<title><![CDATA[Running in Shoes Stresses Hips, Knees and Ankles More Than Running Barefoot, Study]]></title> 
<description><![CDATA[Researchers in the US who compared the effects on hip, knee and ankle joints of running barefoot versus running in modern running shoes, concluded that running in shoes exerted more stress on these joints compared to running barefoot or even walking in high-heeled shoes.
<br><br>
The study was the work of lead author Dr D Casey Kerrigan, of JKM Technologies LLC, in Charlottesville, Virginia and colleagues from the University of Colorado and the University of Virginia, and was published in the December 2009 issue of PM&amp;R: The journal of injury, function and rehabilitation.
<br><br>
Knee osteoarthritis (OA) accounts for more disability in the elderly than any other disease, and although running has been shown to benefit health in many ways, including cardiovascular health, it can stress the joints in the leg, such as the hip, knee, and ankle.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-01-19</pubDate>
</item>
 
<item>
<title><![CDATA[New Key Factor Identified in the Development of Alzheimer's disease]]></title> 
<description><![CDATA[Inheritance of an extra copy of the gene - beta - amyloid precursor protein, APP, in individuals with Down syndrome leads to the inevitable development of early onset Alzheimer's disease, known to be linked to the deposition of Amyloid beta peptide or A beta in the brain. However, a new study published online by Proceedings of the National Academy of Sciences identifies betaCTF, a small protein found in APP, as a novel factor for the development of Alzheimer's disease related endosome abnormalities, which have also been tied previously to the loss of brain cells in Alzheimer's disease.
<br><br>
"In the study, using the cells from individuals with Down syndrome that are genetically predisposed to developing Alzheimer's disease, we showed that elevated levels of �CTF, independent of A�, cause a specific pattern of endosome defects with similar pathology of brain cells in Alzheimer's disease," said Ying Jiang, PhD, lead author and clinical instructor in the Department of Psychiatry at NYU Langone Medical Center. "Our research was successfully able to pinpoint that �CTF causes Alzheimer's disease -related endosome defects and that we could successfully reverse these endosome defects by lowering �CTF levels in the cells." 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-01-19</pubDate>
</item>
 
<item>
<title><![CDATA[THT Launches LearningPlus - A New Service to Help People with HIV in England Become Experts in Their Condition]]></title> 
<description><![CDATA[Terrence Higgins Trust (THT) has been awarded �70,000 from the Department for Innovation Universities and Skills (DIUS) for a new project called LearningPlus. The grant will be used for people living with HIV to become Positive Self-Management Programme (PSMP) Lead Trainers or PSMP Facilitators. The Lead Trainers and Facilitators will go on to deliver PSMP courses to help people with HIV across England to become experts in their own condition. The LearningPlus training opportunities will commence from January until March next year. 
<br><br>
LearningPlus aims to empower people living with HIV to take more control of their health. The course will address issues including relaxation techniques, exercise, healthy eating, dealing with depression, communicating with family, friends and health professionals, as well as planning for the future. The classes also provide an ideal opportunity to meet other people with HIV and share experiences - and are a great way to build confidence and take control.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-01-19</pubDate>
</item>
 
<item>
<title><![CDATA[Join the NHS Organ Donor Register, UK]]></title> 
<description><![CDATA[NHS Blood and Transplant (NHSBT) urges UK citizens to make a positive, outward-looking resolution: join the NHS Organ Donor Register (ODR) and help make a real difference to the 10,000 patients in the United Kingdom who need an organ transplant. Online and phone sign-ups to the ODR quadrupled1 in November 2009 compared to the same month in 2008 - yet more must be done, with 3 people dying every day while they wait for an organ to become available. 
<br><br>
The most popular New Year resolutions are focused on self-improvement, and are often unfulfilled: to eat more fruit and vegetables, do more exercise, stop smoking, and drink less alcohol.2 But we can do one very achievable simple thing focusing on saving the lives of others - join the NHS Organ Donor Register. 
<br><br>
The increase is a result of NHSBT's first-ever UK public awareness campaign for organ donation, encouraging more than 112,0003 people in the first month to join the ODR. 
<br><br>
Of these, over 34,000 signed up by going online with the most common age group being 16-34 year olds, and 60% of online registrations coming from women. Over-55s accounted for 10% of the sign-ups. Regionally, the greatest number of online sign-ups during November 2009 came from the North West of England - 3,994 - while the highest proportion of registrations came from the North East of England - 736 per million population. The biggest increase over the same month last year (over 5-fold) was seen in Northern Ireland, followed by South West of England (a 462% increase). 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-01-19</pubDate>
</item>
 
<item>
<title><![CDATA[In The New Year, Get Fit, Don't Get Hurt]]></title> 
<description><![CDATA[Life is full of hassles, deadlines, frustrations and demands. Stress can take its toll on a woman's health and spill into the home during the holiday season. In these economic times, tightening budgets during the 'season to be jolly' brings additional stress. There is hope on the horizon, as the New Year provides a fresh opportunity for women to resolve to get a handle on stress. 

"If time or finances prohibit you from going to the gym, find other ways to stay active such as taking a walk, running and even yard work or gardening." 
<br><br>
"It is very important to set fitness goals and incorporate physical activity into your daily routine to manage stress levels," says NYC physical therapist Megan Barclay. "If time or finances prohibit you from going to the gym, find other ways to stay active such as taking a walk, running and even yard work or gardening." 
<br><br>
Chronic stress can lead to serious health problems including elevated blood pressure, a suppressed immune system, increased risk of heart attack, contribute to infertility and accelerate the aging process, to name a few. So it is important to recognize when your stress levels are out of control and make a resolution to regain control of your health. 

Barclay says, "The most dangerous aspect of stress is how easily it can creep up on you, it can start to feel familiar and even normal. You don't notice how much of an effect it has on you, even as it takes a heavy burden on your body." 
<br><br>
While well-intentioned, most New Year's resolutions to get in shape involve beginning a fitness regimen characterized by over-exertion and strenuous exercise, and many women wind up suffering from injuries - most commonly to their knees and ankles. Those trouble areas should be supported, but most women find the braces and supports on the market do not fit well or are uncomfortable. There is a reason for this. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-01-19</pubDate>
</item>
 
<item>
<title><![CDATA[Earlier Bedtimes May Help Protect Adolescents against Depression and Suicidal Thoughts]]></title> 
<description><![CDATA[A study in the Jan. 1 issue of the journal Sleep found that adolescents with bedtimes that were set earlier by parents were significantly less likely to suffer from depression and to think about committing suicide, suggesting that earlier bedtimes could have a protective effect by lengthening sleep duration and increasing the likelihood of getting enough sleep. 
<br><br>
Results show that adolescents with parental set bedtimes of midnight or later were 24 percent more likely to suffer from depression (odds ratio = 1.24) and 20 percent more likely to have suicidal ideation (OR=1.20) than adolescents with parental set bedtimes of 10 p.m. or earlier. This association was appreciably attenuated by self-reported sleep duration and the perception of getting enough sleep. Adolescents who reported that they usually sleep for five or fewer hours per night were 71 percent more likely to suffer from depression (OR=1.71) and 48 percent more likely to think about committing suicide (OR=1.48) than those who reported getting eight hours of nightly sleep. Participants who reported that they "usually get enough sleep" were significantly less likely to suffer from depression (OR=0.35) and suicidal ideation (OR=0.71). 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-01-19</pubDate>
</item>
 
<item>
<title><![CDATA[Unusual Protein Modification Involved in Muscular Dystrophy, Cancer]]></title> 
<description><![CDATA[With the discovery of a new type of chemical modification on an important muscle protein, a University of Iowa study improves understanding of certain muscular dystrophies and could potentially lead to new treatments for the conditions. 

The findings, which appear in the Jan. 1, 2010, issue of the journal Science, may also have implications for detecting metastasizing cancer cells. 
<br><br>
After they are initially made, most proteins are modified through the addition of sugar chains, fats or other chemical groups. These modifications can completely change how a protein works and where it is located in the body. Disruption of these modifications can alter protein function, too, and can lead to disease. 
<br><br>
The UI study focused on dystroglycan, a cell membrane protein that is disrupted in many forms of muscular dystrophy. Normal dystroglycan is modified with a unique sugar chain that allows the protein to "glue" muscle membranes to the basal lamina -- a tough layer of extracellular proteins. This arrangement reinforces the fragile muscle membrane and prevents small tears that occur naturally from expanding and damaging the membrane. 
<br><br>
Recent work, including studies by the UI team, show that disrupting dystroglycan's ability to attach to the basal lamina causes congenital muscular dystrophies and also leads to cancer progression in epithelial cell cancer. In these conditions, the dystroglycan sugar chain is incompletely or incorrectly assembled and the dystroglycan cannot bind tightly to laminin. 
<br><br>
"Dystroglycan is a complex and unusual glycoprotein. It is heavily covered with many types of sugars. We wanted to know the shape and make up of the unique sugar chain that allows dystroglycan to bind to laminin," said study leader Kevin Campbell, Ph.D., professor and head of molecular physiology and biophysics at the UI Roy J. and Lucille A. Carver College of Medicine and a Howard Hughes Medical Institute investigator. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-01-19</pubDate>
</item>
 
<item>
<title><![CDATA[Bigger Role for GPs Needed in Identifying and Treating Hearing Loss, Australia]]></title> 
<description><![CDATA[General Practitioners should play a bigger role in the detection and treatment of age-related hearing loss, according to an article published in the Medical Journal of Australia. Prof Paul Mitchell, of the Westmead Millennium Institute at the University of Sydney, and his co-authors analysed data collected between 1998 and 2000 from the Blue Mountains Hearing Study (BMHS) and between 2003 and 2008 as part of the Bettering the Evaluation and Care of Health (BEACH) study.

Of people aged over 50 years in the Blue Mountains study with bilateral hearing loss, about one third reported seeking help from their GP. 
<br><br>
"In their routine consultations with patients, GPs have opportunities to identify hearing loss and appropriately refer patients to specialists or allied health professionals," Prof Mitchell said. 
<br><br>
GPs responded to patient presentations for hearing loss, referring about 50 per cent of cases to specialists or allied health professionals. But they appeared to identify relatively few cases of hearing loss opportunistically. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-01-19</pubDate>
</item>
 
<item>
<title><![CDATA[ Hormonal Contraceptives Offer Benefits Beyond Pregnancy Prevention]]></title> 
<description><![CDATA[Hormonal contraceptives are effective in treating menstruation- related disorders such as dysmenorrhea and heavy menstrual bleeding, as well as preventing unplanned pregnancies, according to a new Practice Bulletin issued today by The American College of Obstetricians and Gynecologists (ACOG) and published in the January 2010 issue of Obstetrics &amp; Gynecology. In addition, combined contraceptives containing both estrogen and progesterone offer disease prevention by reducing the risk of developing endometrial, ovarian cancer, and colorectal cancer. 
<br><br>
More than 80% of women in the US will use some form of hormonal contraception during their reproductive years. There are several different forms of hormonal contraception including pills, patches, implants, injections, vaginal rings, and the intrauterine device (IUD). Pregnancy prevention is the primary reason that most women use hormonal contraception. However, these contraceptives are also frequently prescribed specifically for non-contraceptive reasons, which is considered off-label use. 
<br><br>
"We've known for many years that hormonal contraceptives have health advantages beyond preventing pregnancy," says Robert L. Reid, MD, of Kingston, Ontario, who led development of the document. "These recommendations examine the scientific data supporting the non-contraceptive uses of hormonal contraceptives to treat specific conditions." 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-01-19</pubDate>
</item>
 
<item>
<title><![CDATA[Royal College of Nursing Responds to Agency Staffing Research, UK]]></title> 
<description><![CDATA[The RCN responded to reports that the NHS is increasing its spending on agency staff. Dr Peter Carter, RCN Chief Executive &amp; General Secretary, said:
<br><br>
"Agency workers provide a valuable service and these figures should be viewed with caution as the agency receives a substantial part of the 'salary'. However, at a time when the NHS is having to make huge efficiency savings, Trusts must get a better hold on their reliance on agency staff to stop these vast sums of money being squandered. Trusts need to better manage peaks and troughs of demand, make their workplaces attractive for permanent staff, and ensure there are flexible working arrangements available. Consistently paying agencies huge sums of money to fill the gaps is not acceptable."

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-01-19</pubDate>
</item>
 
<item>
<title><![CDATA[Canadian Medical Association Develops Panorama for Collecting Vaccination Data]]></title> 
<description><![CDATA[The collection of individual level vaccination data when delivering vaccines is important for planning and delivery of immunization programs, to assess whether population-level coverage has been achieved and for research into vaccine safety and effectiveness, states an analysis in CMAJ (Canadian Medical Association Journal). 
<br><br>
Canada has been developing Panorama, a national electronic system that will "collect, analyse and disseminate public health surveillance data for the management of infectious diseases" according to Dr. Jeff Kwong and coauthors from the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network Vaccine Coverage Theme Group. Panorama will include an immunization registry that will help in responding to public health emergencies and vaccination efforts. 
<br><br>
However, not every province and territory will adopt the new system which will have a staggered rollout between 2010 and 2012. Potential barriers to collecting electronic data include funding to implement and maintain immunization registries, coordinating data collection from various health care providers, ensuring patient privacy and data security as well as human reluctance to adopt new technologies. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-01-19</pubDate>
</item>
 
<item>
<title><![CDATA[Inflammatory Mediator Regulates Diarrhea in Inflammatory Bowel Disease]]></title> 
<description><![CDATA[Researchers led by Dr. Terrence A. Barrett of Northwestern University Medical School in Chicago. Illinois have discovered that activation of NK-&amp;#954;B, an inflammatory mediator, results in diarrhea in inflammatory bowel disease (IBD). These results are presented in the January 2010 issue of the American Journal of Pathology. 
<br><br>
IBD, which affects approximately 1 in 500 people in the United States, describes a group of diseases, including Crohn's disease and ulcerative colitis, with inflammation in the intestinal tract. Patients with IBD experience diverse symptoms, including abdominal pain, vomiting, diarrhea, bloody stools, and weight loss. 
<br><br>
Immune responses contribute to mucosal permeability, and hence diarrhea, in IBD; however, the mechanisms that govern this response are not completely understood. Tang et al therefore examined the role of NK-&amp;#954;B, an inflammatory mediator, in IBD-induced diarrhea. Following immune activation, blocking NK-&amp;#954;B expression in the cells lining the intestinal tract inhibited diarrhea and prevented protein changes in these cells, resulting in decreased leakiness between the cells. These findings suggest that immune cell-mediated activation of NK-&amp;#954;B in IBD promotes the movement of fluid into the bowel lumen, resulting in diarrhea. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-01-19</pubDate>
</item>
 
<item>
<title><![CDATA[NIH Awards $2.5 Million to UC for Study in Voice Production]]></title> 
<description><![CDATA[Try to go one week without speaking. Now, imagine going months, or years, without being able to talk to friends or loved ones. 

For patients with severe voice disorders, the loss of their voice often means losing their social life, self esteem or livelihood. While existing therapies can treat mild to moderate voice disorders, physicians have a harder time determining effective treatments for those with severe cases. 
<br><br>
With a new five-year, $2.5 million grant from the National Institutes of Health, University of Cincinnati (UC) researchers will continue interdisciplinary partnerships to study the causes behind those disorders and the most effective ways to treat them. 

The grant, awarded to laryngologist Sid Khosla, MD, of UC's department of otolaryngology, includes aerospace engineer Ephraim Gutmark, PhD, of engineering, Suzanne Boyce, PhD, of communication sciences &amp; disorders, Shanmugam Murugappan, PhD, of otolaryngology and Mihai Mihaescu, PhD, of engineering. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link /> 
<pubDate>2010-01-19</pubDate>
</item>
 
<item>
<title><![CDATA[Physiologic Factors Linked To Image Quality Of Multidetector Computed Tomography Scans]]></title> 
<description><![CDATA[A large multicenter international trial found that the image quality of multi-detector computed tomography (MDCT) scans, used for the noninvasive detection of coronary artery disease, can be significantly affected by patient characteristics such as ethnicity, body mass index (BMI), and heart rate, according to a study in the January issue of the American Journal of Roentgenology. 
<br><br>
The large multicenter international trial study included 291 patients with coronary artery calcification and found that compared with examinations of white patients, studies of black patients had significantly poorer image quality. 
<br><br>
"Physiologic factors such as high heart rate, arrhythmia, obesity, and high coronary calcium burden with motion continue to limit the diagnostic accuracy of MDCT as compared with conventional invasive coronary angiography. Our study is significant because we found a relevant influence of BMI, heart rate, ethnicity, and breathing artifact on the degradation of image quality," said Melvin E. Clouse, MD, lead author of the study. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174775.php</link> 
<pubDate>2010-01-04</pubDate>
</item>
 
<item>
<title><![CDATA[Growing Evidence Suggests Progesterone Should Be Considered A Treatment Option For Traumatic Brain Injuries]]></title> 
<description><![CDATA[Researchers at Emory University in Atlanta, GA, recommend that progesterone (PROG), a naturally occurring hormone found in both males and females that can protect damaged cells in the central and peripheral nervous systems, be considered a viable treatment option for traumatic brain injuries, according to a clinical perspective published in the January issue of the American Journal of Roentgenology. 
<br><br>
"Traumatic brain injury (TBI) is an important clinical problem in the United States and around the world," said Donald G. Stein, PhD, lead author of the paper. "TBI has received more attention recently because of its high incidence among combat casualties in Iraq and Afghanistan. Current Department of Defense statistics indicated that as many as 30 percent of wounded soldiers seen at Walter Reed Army Hospital have suffered a TBI, a finding that has stimulated government interest in developing a safe and effective treatment for this complex disorder," said Stein. 
<br><br>
"Growing evidence indicates that post-injury administration of PROG in a variety of brain damage models can have beneficial effects, leading to substantial and sustained improvements in brain functionality. PROG given to both males and females can cross the blood-brain barrier and reduce edema (swelling) levels after TBI; in different models of cerebral ischemia (restriction of blood supply), significantly reduce the area of necrotic cell death and improve behavioral outcomes; and protect neurons distal to the injury that would normally die," said Stein. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174706.php</link> 
<pubDate>2010-01-04</pubDate>
</item>
 
<item>
<title><![CDATA[D-Pharm (TASE: DPRM) Announces Enrollment Of First Patient In DP-b99 Phase III Efficacy Study, MACSI]]></title> 
<description><![CDATA[D-Pharm Ltd (TASE: DPRM) announced enrollment of patients with acute ischemic stroke into its Phase III clinical study of DP-b99 (MACSI). The first patient has been enrolled at the Wolfson Medical Center, Israel. The MACSI trial involves numerous medical centers in the US, Canada, Europe, Israel, South Africa, South Korea and Brazil. DP-b99 is D-Pharm's most advanced product developed for protection of brain cells suffering from restricted blood and oxygen supply (ischemia).
<br><br>
The MACSI study is as international, multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial. The trial will compare the stroke outcome in a group of patients treated with placebo (an inactive substance) to patients treated with 1 mg/kg/day of DP-b99 for 4 consecutive days. The study is expected to enroll, in total, 770 patients at 120 - 140 clinical sites worldwide.
<br><br>
Recently D-Pharm met with the FDA to discuss the Special Protocol Assessment (SPA) and will continue the dialog with the FDA towards the final agreement.
<br><br>
Dr. Gilad Rosenberg, D-Pharm's V.P. Clinical Development stated, "We're very pleased that this important clinical milestone has been achieved on schedule. The challenge is now to effectively activate the additional clinical sites to ensure a patient recruitment rate sufficient to complete the study on time, as planned."

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174932.php</link> 
<pubDate>2010-01-04</pubDate>
</item>
 
<item>
<title><![CDATA[Study Finds Talking Aloud Helps To Solve Mathematical Problems More Quickly]]></title> 
<description><![CDATA[Those students who think aloud while solving a mathematical problem can solve it faster and have more possibilities of finding the right solution that those who do not do it. Likewise, drawing or making a pictorial representation relating to the also contributed to its solution. 
<br><br>
Those are the conclusions of a study carried out at the University of Granada (Spain), which has been recently published in the journal Revista de investigaci�n psicoeductiva and the Electronic Journal of Research in Educational Psychology. 
<br><br>
To conduct this research, the authors analysed in depth the work of three last-year students of the degree in Mathematics of the UGR, who were isolated separately to solve a problem and were recorded in video to study their speeches aloud later.
<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174590.php</link> 
<pubDate>2010-01-04</pubDate>
</item>
 
<item>
<title><![CDATA[Minority Elders Continue To Face Health Care, Employment Disparities]]></title> 
<description><![CDATA[The premiere issue of an aging-focused newsletter deals with two pressing societal concerns - the economic downturn and health care reform - from the perspective of older minority adults. 
<br><br>
WHAT'S HOT is the newest publication from The Gerontological Society of America (GSA), the country's largest interdisciplinary organization devoted to the field of aging. Support for this issue was provided by sanofi-aventis. 
<br><br>
Based on presentation highlights from GSA's 62nd Annual Scientific Meeting in November 2009, the first issue of WHAT'S HOT covers topics such as the impact of the economic crisis on older workers' health; the perceived prevalence of job discrimination among older workers; and health care utilization patterns among older Asian minorities. 
<br><br>
"To fully resolve barriers that minorities face in seeking health care, we need research that is broader than access to care," said Toni Miles, MD, PhD, of the University of Louisville, who served as an advisor for the issue. "The studies in this newsletter reflect this need. Readers will be enlightened by this collection. As a whole, GSA researchers are a valuable resource for policymakers and should be sought out when seeking effective approaches to reducing health disparities." 
<br><br>
Baby boomers make up a considerable proportion of the adult population among all racial and ethnic groups in the United States. A central challenge related to managing the health needs of this age group is that they are approaching a stage of life often marked by increasing prevalence of chronic disease and disability. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174579.php</link> 
<pubDate>2010-01-04</pubDate>
</item>
 
<item>
<title><![CDATA[Swine Influenza Daily Update: 29 December 2009, Wales]]></title> 
<description><![CDATA[A daily update on swine flu issued by the National Public Health Service for Wales. Spread and extent of the outbreak (information as at 5pm on 28 December) The NPHS influenza surveillance scheme, which records reports of diagnoses of flu from more than 300 GP practices across Wales, shows that the rate of influenza consultation is decreasing. Further detail can be found on the NPHS website
<br><br>
The report from 23 December estimates there were 21.5 cases of a flu-like illness diagnosed by GPs out of every 100,000 people in Wales - this is the equivalent of 645 people in Wales contacting their GPs in the last seven days with flu like symptoms. Not all of these people will have swine flu and not everyone with flu like symptoms will contact their GP. 
<br><br>
The report also shows levels of influenza activity in each county of Wales. On 23 December the rate of diagnosis of flu-like illness at a local level ranged from 7.2 per 100,000 people in Denbighshire to 31.9 per 100,000 people in Newport. 
<br><br>
GPs are no longer being asked to swab people they suspect may have swine flu. Microbiology laboratories are therefore no longer testing most people suspected of having swine flu. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174887.php</link> 
<pubDate>2010-01-04</pubDate>
</item>
 
<item>
<title><![CDATA[New Support Tools Point Way To Better Health Policymaking]]></title> 
<description><![CDATA[A comprehensive review of evidence-informed health policymaking was recently launched in BioMed Central's journal Health Research Policy and Systems. This free supplement, entitled 'SUPPORT tools for evidence-informed health policymaking' provides an essential reference and set of tools that can be used by those involved in finding and using research evidence to support evidence-informed health policymaking. The series addresses four broad areas, including: supporting evidence-informed policymaking; identifying needs for research evidence; finding and assessing research evidence; and, going from research evidence to decisions 
<br><br>
The supplement contains 17 support tools from renowned experts in the field. The articles are structured using a set of questions that can help to guide the use of research evidence to inform health policy decisions. 
<br><br>
The tools were developed by the SUPporting POlicy relevant Reviews and Trials (SUPPORT) project, an international collaboration funded by the European Commission's 6th Framework with partners in Africa, South America, Europe and North America. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174586.php</link> 
<pubDate>2010-01-04</pubDate>
</item>
 
<item>
<title><![CDATA[The Cancer 'TRAP']]></title> 
<description><![CDATA[Current research suggests that TNF-receptor associated protein-1 (TRAP-1) may prevent cancer cell death. The related report by Leav et al, "Cytoprotective Mitochondrial Chaperone TRAP-1 as a Novel Molecular Target in Localized and Metastatic Prostate Cancer," appears in the January 2010 issue of the American Journal of Pathology. 
<br><br>
Prostate cancer is the most common type of cancer and is the second leading cause of cancer deaths among men in the United States, following lung cancer. Prostate cancer most commonly develops in men over the age of 50 and is slow-growing; however, it may metastasize to other organs, particular to the bones and lymph nodes. Metastatic phase prostate cancer claims over 30,000 deaths per year in the United States alone. 
<br><br>
Prostate cancer cells are often resistant to cell death. Researchers led by Dr. Dario C. Altieri of the University of Massachusetts Medical School, therefore, explored the role of TRAP-1, a protein thought to regulate cell death, in prostate cancer survival. TRAP-1 was highly expressed in both high-grade human prostate cancer lesions and mouse models of prostate cancer, but not in benign or normal prostate tissue. In addition, TRAP-1 overexpression in non-cancer prostate cells inhibited cell death, whereas TRAP-1-deficient prostate cancer cells had enhanced levels of cell death. Moreover, treatment with Gamitrinib, which inhibits TRAP-1, resulted in prostate cancer cell death, but not death of non-cancerous prostate cells. Therefore, targeting TRAP-1 via Gamitrinib treatment may be a viable therapeutic strategy for patients with advanced prostate cancer. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174896.php</link> 
<pubDate>2010-01-04</pubDate>
</item>
 
<item>
<title><![CDATA[Use Of Telemedicine For ICU Patients Not Linked With Improvement In Survival]]></title> 
<description><![CDATA[Remote monitoring of patients in intensive care units (ICUs) was not associated with an overall improvement in the risk of death or length of stay in the ICU or hospital, according to a study in the December 23/30 issue of JAMA. 
<br><br>
Experts recommend that intensivists (intensive care physicians) care for ICU patients onsite because of an associated lower rate of illness and death. "However, there is a shortage of intensivists, which has led to the use of telemedicine technology to allow intensivists to remotely and simultaneously care for patients in several ICUs (ICU telemedicine [tele-ICU]), thus extending their reach," the authors write. "Remote monitoring may be a partial solution for the intensivist shortage, but it is expensive, its use is increasing, and there are few data in the peer-reviewed literature evaluating its effect on morbidity and mortality." 
<br><br>
Eric J. Thomas, M.D., M.P.H., of the University of Texas Health Science Center at Houston, and colleagues assessed the effect of a tele-ICU intervention on mortality, complications, and length of stay (LOS) in 6 ICUs of 5 hospitals in a large U.S. health care system by measuring these outcomes before and after implementation of the tele-ICU. The study included 2,034 patients in the preintervention period (January 2003 to August 2005) and 2,108 patients in the postintervention period (July 2004 to July 2006). Almost two-thirds of the patients in the postintervention group had physicians who chose minimal delegation to the tele-ICU (n = 1,393 [66.1 percent]), in which the tele-ICU intervened only for patients in life-threatening situations. Physicians delegated full treatment authority to the tele-ICU for 655 patients (31.1 percent). 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174904.php</link> 
<pubDate>2010-01-04</pubDate>
</item>
 
<item>
<title><![CDATA[$1.2 Million Award For Treatments For Breast Cancer, Cardiovascular Disease]]></title> 
<description><![CDATA[The National Institutes of Health has awarded a three-year grant of more than $1.2 million to The Scripps Research Institute to develop a series of high-throughput screening tests that will help speed the discovery of potential small molecule therapies for breast cancer and cardiovascular disease. 
<br><br>
Patrick Griffin, chair of the Scripps Research Department of Molecular Therapeutics and director of the Translational Research Institute at Scripps Florida, will lead the project as principal investigator. The grant will begin in January 2010. 
<br><br>
The tests will focus on identifying ligands for the orphan nuclear receptor liver receptor homolog-1 or LRH-1, which plays a crucial role in hormone-driven breast cancer through its regulation of genes involved in hormone biosynthesis as well as fat and cholesterol metabolism - key risk factors in cardiovascular disease. Receptors like LRH-1 detect circulating signaling molecules (known as ligands) such as hormones or neurotransmitters; the ligand binds to the receptor, creating a biological response or blocking the receptor. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174566.php</link> 
<pubDate>2010-01-04</pubDate>
</item>
 
<item>
<title><![CDATA[New Study Explores Role Of Sexual, Social Behaviors In Seniors' Well-Being]]></title> 
<description><![CDATA[Researchers and the general public have a new resource for information on the health and intimate relationships of older people, thanks to a new supplemental issue of The Journals of Gerontology Series B: Psychological and Social Sciences (Volume 64B, Supplement 1). 
<br><br>
Based on the groundbreaking National Social Life, Health, and Aging Project (NSHAP), the supplement's 14 articles focus on demographic characteristics; social networks; social and cultural activity; physical and mental health, including cognition, well-being, illness, medications, and alternative therapies; history of sexual and intimate partnerships; and patient-physician communication. 
<br><br>
"The NSHAP represents an extraordinary contribution to the study of aging, and published findings from it have already shed new light on critical issues in social gerontology - from abuse to sexuality, said Journal of Gerontology: Social Sciences Editor Kenneth F. Ferraro, PhD, of Purdue University. "A truly distinctive feature of the study is the collection of several biomeasures on a national sample." 
<br><br>
The NSHAP is a unique, interdisciplinary effort to collect social data alongside biological indicators in a population-based sample of older adults. The study collected 13 biomeasures, including the assessment of respondents' weight, waist circumference, height, blood pressure, distance vision, smell, touch, and mobility. NSHAP also collected blood spots, saliva, oral fluid for HIV testing, and, from female respondents, a self-administered vaginal swab. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174578.php</link> 
<pubDate>2010-01-04</pubDate>
</item>
 
<item>
<title><![CDATA[Rising Pharmacy Graduate Numbers A Problem, Australia]]></title> 
<description><![CDATA[Concerns raised by the Australian Medical Association over the lack of funding and resources to adequately train medical students have been echoed by the Pharmaceutical Society of Australia. 
<br><br>
The AMA this week said that $157 million of Government money was not enough to fund the teaching resources needed to cope with the increase in student numbers which saw 1544 domestic medical students graduate in 2007, an increase of 22 per cent from 2003. This is projected to increase to 2920 graduates by 2012. 
<br><br>
Echoing concerns over the ability to adequately train the rising number of pharmacy graduates, the President of the Pharmaceutical Society of Australia, Warwick Plunkett, said the present outflow of pharmacy graduates from universities annually now required nearly 30 per cent of all pharmacies to place a post-graduate student. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174166.php</link> 
<pubDate>2009-12-24</pubDate>
</item>
 
<item>
<title><![CDATA[H1N1 Swine Flu Deaths Reveal New Pattern Of The Disease, Brazilian Study]]></title> 
<description><![CDATA[Researchers in Brazil who carried out the first autopsy study of victims who died of H1N1 swine flu to establish the precise causes of death, have discovered some new patterns of the disease.
<br><br>
Their research appears as a paper in the 1 January 2010 print issue of the American Journal of Respiratory and Critical Care Medicine. 
<br><br>
Lead author, Dr Thais Mauad, associate professor of the Department of Pathology at S�o Paulo University, told the media why we need to understand more about the novel H1N1 swine flu virus:
<br><br>
"The lack of information on the pathophysiology of this novel disease is a limitation that prevents better clinical management and hinders the development of a therapeutic strategy."


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174784.php</link> 
<pubDate>2009-12-24</pubDate>
</item>
 
<item>
<title><![CDATA[JAMIA: Journal Of The American Medical Informatics Association]]></title> 
<description><![CDATA[Although physicians support the use of electronic health records, concerns about potential privacy breaches remain an issue, according to two research articles published in the January 2010 issue of the Journal of the American Informatics Association (JAMIA), in its premiere issue as one of 30 specialty titles published by the BMJ (British Medical Journal) Group, UK. 
<br><br>
One published study is based on views of more than 1,000 family practice and specialist physicians in Massachusetts who were asked whether they thought electronic health information exchange (HIE) would drive down costs, improve patient care, free up their time and preserve patient confidentiality. They were also asked whether they would be willing to pay a monthly fee to use the system. 
<br><br>
The electronic exchange of health information (HIE) among different long- distance providers has become the focus of intense national interest, following recent legislation and moves to offer cash incentives for those who switch to the system. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174202.php</link> 
<pubDate>2009-12-24</pubDate>
</item>
 
<item>
<title><![CDATA[Contact Lenses Often Prescribed For Infants With Serious Eye Problems]]></title> 
<description><![CDATA[Infants as young as one-month-old are prescribed contact lenses at pediatric eye surgery centers so their visual system will develop correctly. Infants may be fitted for contacts if they have had cataract surgery, need extremely high-strength prescription glasses, or have very different prescriptions for the two eyes.
<br><br>
According to Dr. Natalia Uribe, who directs the Contact Lens Program in The Vision Center at Childrens Hospital Los Angeles, "The brain's visual system is not fully mature until about age eight. It is critical that infants and very young children with eye problems have their sight corrected so the visual pathway develops properly. Otherwise it may not be possible for them to enjoy normal vision as an adult."
<br><br>
Dr. Uribe, an optometrist, said her clinic is growing and will treat more than 700 young patients this year, making it one of the largest centers in the nation. She said more infants are being diagnosed with major eye problems due to better screening and to the higher rate of survival among extremely preterm infants.
<br><br>
Premature infants are at risk for retinopathy of prematurity (ROP), a disease affecting the blood vessels feeding the retina and for other eye problems. Medical studies have shown that approximately 20 percent of all premature babies will develop some form of strabismus (crossed eyes), amblyopia (lazy eye) or serious refractive error (require glasses) by the time they are 3 years of age.


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174719.php</link> 
<pubDate>2009-12-24</pubDate>
</item>
 
<item>
<title><![CDATA[Resverlogix Commences Phase 2 Atherosclerosis Clinical Trial]]></title> 
<description><![CDATA[Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced that it has begun dosing patients in its US Phase 2 clinical trial lead by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with stable coronary artery disease (CAD). This study is chaired by Dr. Steven Nissen, MD, Chairman of the Cleveland Clinic Department of Cardiovascular Medicine and the principal investigator is Dr. Stephen Nicholls, Medical Director of Intravascular Ultrasound at Cleveland Clinic. The Cleveland Clinic has named this trial, ASSERT, which stands for ApoA1 Synthesis Stimulation Evaluation in Patients Requiring Treatment for Coronary Artery Disease. A total of 40 investigator sites across the US will be participating in the study.
<br><br>
"I am pleased to see the start of this 18 week randomized, outpatient multicenter, double-blind, placebo-controlled study that will administer RVX-208 to approximately 280 patients with stable CAD for 13 weeks," said Dr. Stephen J. Nicholls, MBBS, PhD, Medical Director of the Atherosclerosis Imaging Core Laboratories at Cleveland Clinic and Cardiovascular Director of the Cleveland Clinic Coordinating Center for Clinical Research. "This trial is one of two parallel studies, in this particular study the focus is on stable CAD patients, while the second trial will be focused on unstable acute coronary syndrome and will include the use of intravascular ultrasound (IVUS)."

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174715.php</link> 
<pubDate>2009-12-24</pubDate>
</item>
 
<item>
<title><![CDATA[ASU Leads $40 Million Effort To Rapidly Assess Radiation Exposures]]></title> 
<description><![CDATA[Arizona State University will lead a $40.8 million, multi-institutional research program to develop systems that would rapidly measure an individual's level of exposure to radiation in the event of a radiological or nuclear incident. In the event of a large-scale disaster, such a system would ensure that first responders have the information necessary to provide appropriate medical treatment. 
<br><br>
The five-year contract with the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) emphasizes the development of prototypes that would enable more rapid triage of patients than is currently possible. 
<br><br>
"With the proliferation of advanced radiological materials in hospitals, clinics or nuclear facilities throughout the world, the risks and threats of a 'dirty bomb' incident or similar nuclear disaster remains very real," said Carl Yamashiro, PhD, the principal investigator at ASU's Biodesign Institute who will direct the effort. "We have assembled a dream team of institutions and companies to catalyze our team's research and discovery efforts, and translate the advances into a field-deployable technology." 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174677.php</link> 
<pubDate>2009-12-24</pubDate>
</item>
 
<item>
<title><![CDATA[Former CDC Head To Lead Merck's Vaccine Division]]></title> 
<description><![CDATA[The pharmaceutical company Merck on Monday named former CDC head Julie Gerberding as president of the company's vaccine division, Reuters reports. "Gerberding, who led the CDC from 2002 to 2009 and stepped down when President Barack Obama took office, will head up the company's $5 billion global vaccine business that includes shots to prevent chickenpox, cervical cancer and pneumonia," the news service reports. 
<br><br>
"She had led CDC from one crisis to another, including the investigation into the anthrax attacks that killed five people in 2001, the H5N1 avian influenza, the global outbreak of severe acute respiratory syndrome, or SARS, and various outbreaks of food poisoning" (Fox/Berkrot, 12/21).
<br><br>
Dow Jones/Wall Street Journal adds: "As president of the vaccines business, [Gerberding] will be responsible for the sale of the company's current portfolio of vaccines, the introduction of vaccines from the company's pipeline and the acceleration of Merck's efforts to broaden vaccinations in developing countries" (Solsman, 12/21). 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174741.php</link> 
<pubDate>2009-12-24</pubDate>
</item>
 
<item>
<title><![CDATA[Also In Global Health News: HIV Prevention In China; Global Fund In Philippines; Drug-Resistant TB; U.S. Stance On Anti-Gay Legislation]]></title> 
<description><![CDATA[Government-Backed Gay Bar Opens In China Aims To Educate About HIV Prevention 
<br><br>
"A gay bar partially funded by the government of a Chinese city heavily affected by AIDS has finally opened after a delay caused by intense media interest which the owners felt may scared off potential patrons," Reuters Life! reports. The bar in the southwestern city of Dali is a collaborative effort by the city's health department and two NGOs, according to the news service (12/21). "The venue aims to provide a place where homosexuals can meet in a relaxed atmosphere and get information about HIV/AIDS prevention," Agence France-Presse reports (12/20). ChinaRealTimeReport/Wall Street Journal adds: "For the bar's opening night, 10 volunteers staged a play that included information on HIV prevention. Customers also received free condoms," according to the news service (12/21).

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174737.php</link> 
<pubDate>2009-12-24</pubDate>
</item>
 
<item>
<title><![CDATA[Walk To Burn Off Christmas Calories Urges UK Government]]></title> 
<description><![CDATA[The UK government is urging families to bring back the Christmas day walk to burn off their Christmas dinner calories, and generally be more physically active over the holidays.
<br><br>
A typical Christmas dinner of turkey and pudding clocks up nearly 1,500 calories, which is over half of the recommended daily allowance for a man and three quarters of that recommended for a woman, says the Department of Health for England, in a new push to promote Walk4Life as part of its Change4Life campaign to encourage families to "eat well, move more and live longer".
<br><br>
If every person in England walked their local streets, fields or beaches after their dinner on Christmas day, this would add up to 50 million miles, they said in a statement.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174721.php</link> 
<pubDate>2009-12-24</pubDate>
</item>
 
<item>
<title><![CDATA[SPARKy Devices Help Amputees Return To Normal Lives]]></title> 
<description><![CDATA[Arizona State University researchers have developed a prosthetic device that literally puts the spring back into an amputee's step. The ASU scientists have developed and refined SPARKy (for spring ankle with regenerative kinetics) into a smart, active and energy storing below-the-knee (transbitial) prosthesis. 
<br><br>
SPARKy is the first prosthetic device to apply regenerative kinetics to its design, which resulted in a lightweight (four pound) device that allows the wearer to walk on grass, cement and rocks, as well as ascend and descend stairs and inclines. 
<br><br>
SPARKY operates by employing a spring to store energy as the wearer walks during normal gait, said Thomas Sugar, an ASU associate professor of engineering at the Polytechnic campus who led the research. Sugar and his colleagues -- ASU doctoral students Joseph Hitt and Matthew Holgate, as well as Barrett Honors College student Ryan Bellman -- have been developing and refining SPARKy for three years as part of a U.S. Army grant. 
<br><br>
SPARKy uses a robotic tendon to actively stretch springs when the ankle rolls over the foot, thus allowing the springs to thrust or propel the artificial foot forward for the next step. Because energy is stored, a lightweight motor is used to adjust the position of a finely tuned spring that provides most of the power required for gait. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174695.php</link> 
<pubDate>2009-12-24</pubDate>
</item>
 
<item>
<title><![CDATA[NSF Grant Benefits Chemistry Research/local H.S. Outreach]]></title> 
<description><![CDATA[The National Science Foundation has announced an award of a $247,553 to Enrique Peacock-Lopez, professor of chemistry at Williams College, in support of his project, "A Dynamical Study of Chemical Self-Replication and Regulatory Mechanisms." The research will include the participation of undergraduate students and, in addition, the project will support upgrading local high school chemistry teaching. 
<br><br>
This project expands on work in chemical self-replication and in chemical and biochemical regulatory mechanisms in solutions and on surfaces. The work will provide insights into different processes' time scales and used to determine efficient ways to modify or redirect overall biochemical dynamics. 
<br><br>
Developing an understanding of chemical self-replication and the genetic regulation of biochemical mechanisms can contribute to the understanding of diseases, including AIDS and mad cow disease. 
<br><br>
The grant will also support the upgrade of regional high school chemistry courses to Advanced Placement Chemistry, as well as including a college advising component targeting potential first generation college students. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174678.php</link> 
<pubDate>2009-12-24</pubDate>
</item>
 
<item>
<title><![CDATA[Accurate Taste Perception Relies On A Properly Functioning Olfactory System]]></title> 
<description><![CDATA[As anyone suffering through a head cold knows, food tastes wrong when the nose is clogged, an experience that leads many to conclude that the sense of taste operates normally only when the olfactory system is also in good working order. Evidence that the taste system influences olfactory perception, however, has been vanishingly rare - until now. In a novel study this week in Nature Neuroscience, Brandeis researchers report just such an influence. 
<br><br>
Neuroscientist Don Katz and colleagues discovered that if the taste cortex in rats is inactivated when a rat first smells an odor, at least a food odor, then the rat subsequently will only recognize the food associated with that odor if the taste cortex is again inactivated. 
<br><br>
"We discovered that rats use their taste system to smell with, so when you knock out the taste cortex, even for an hour, as we did, you alter their sense of smell," explained Katz. The researchers wrote that "this is the only example of state dependency in neural circuit function of which we are aware." 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174674.php</link> 
<pubDate>2009-12-24</pubDate>
</item>
 
<item>
<title><![CDATA[Carrier Screening Associated With Decrease In Incidence Of Cystic Fibrosis]]></title> 
<description><![CDATA[An increase in the number of screened carriers for cystic fibrosis (CF) was associated with a decrease in the number of children born with CF in northeast Italy, according to a study in the December 16 issue of JAMA. 
<br><br>
Some studies have suggested that there has been a progressive decrease in the incidence of newborns with CF in some areas. "A circumstance that might influence CF birth rates is the detection of carrier couples," the authors write. 
<br><br>
Carlo Castellani, M.D., of the Cystic Fibrosis Center, Verona Hospital, Verona, Italy, and colleagues evaluated the association between CF carrier screening and CF birth incidence in northeastern Italy, where CF neonatal screening has been performed for many years. Since the early 1990s, a significant progressive decrease of CF birth rates has been recorded for this area. In this region, two different carrier detection approaches were identified-the western region, in which CF carrier tests are offered only to relatives of patients or to couples planning in vitro fertilization; and the eastern region, in which carrier testing is offered to relatives and carrier screening to infertile couples and to couples of reproductive age. A total of 779,631 newborns underwent CF neonatal screening between Jan. 1993 and Dec. 2007, of whom 195 had CF detected. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174158.php</link> 
<pubDate>2009-12-24</pubDate>
</item>
 
<item>
<title><![CDATA[Dispatcher-Assisted Bystander CPR Best Choice For Possible Cardiac Arrest Signs]]></title> 
<description><![CDATA[Dispatchers should assertively give cardiopulmonary resuscitation (CPR) instructions to bystanders who suspect someone is in cardiac arrest because the benefits from correctly recommending CPR for someone who needs it greatly outweigh the risks from recommending CPR for someone who does not, researchers said in Circulation: Journal of the American Heart Association. 
<br><br>
"Early CPR improves outcomes from cardiac arrest; yet, only a modest portion of victims receive early CPR from bystanders," said author Thomas D. Rea, M.D., M.P.H., Program Medical Director, King County Medic One, EMS Division, Kent, Wash., and Associate Professor of Medicine, Harborview Medical Center at the University of Washington. 
<br><br>
"We know that dispatcher instructions can increase survival by enabling early bystander CPR. While the goal is to support dispatcher-assisted CPR programs, concerns remain about the potential for CPR to injure people who may not be experiencing cardiac arrest. We did this study to determine the frequency of dispatcher-assisted CPR for patients not in arrest and the frequency and severity of injury related to chest compressions." 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174690.php</link> 
<pubDate>2009-12-24</pubDate>
</item>
 
<item>
<title><![CDATA[University Of Pittsburgh Medical Center (UPMC) Treats 10,000th Patient With Leksell Gamma Knife Radiosurgery System]]></title> 
<description><![CDATA[On the morning of December 17, 2009, UPMC physicians used Gamma Knife� surgery to treat the center's 10,000th patient, an 81-year-old male with a tumor deep in his brainstem, a site where traditional surgery would have been impossible. Gamma Knife surgery is performed using Elekta's Leksell Gamma Knife system, which directs up to 201 pencil-thin beams of therapeutic radiation precisely on brain tumors and other targets in the head.
<br><br>
The 10,000th patient came to UPMC with worsening balance problems. A magnetic resonance imaging (MRI) scan of his brain revealed the small lesion, known as a metastasis -- a secondary tumor whose origin was a primary tumor located somewhere else in his body. The site of this patient's primary lesion was unclear, as are approximately 30 percent of cancers that go to the brain, said L. Dade Lunsford, M.D., Lars Leksell Professor and Distinguished Professor of Neurological Surgery at the University of Pittsburgh, and co-director, Center for Image-Guided Neurosurgery, UPMC.
<br><br>
"Because the patient had no known primary tumor, we performed a minimally invasive biopsy of the brain tumor during a procedure that began at 6:30 a.m. We confirmed that the lesion was a metastatic tumor requiring intervention," said Dr. Lunsford, who was the first clinician to use Leksell Gamma Knife in the United States. "At 9:30, we used our Leksell Gamma Knife� Perfexion(TM) system to deliver the radiosurgery, which took about 38 minutes."

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174709.php</link> 
<pubDate>2009-12-24</pubDate>
</item>
 
<item>
<title><![CDATA[Development Of ADX10059 Ended For Long-Term Use]]></title> 
<description><![CDATA[Addex Pharmaceuticals (SWISS: ADXN) announced that based on preliminary review of the unblinded data from study 206, it has terminated development of ADX10059 for chronic indications, including long term treatment of gastroesophageal reflux disease and migraine prophylaxis. 
<br><br>
In study 206 the incidence of alanine transaminase (ALT) levels greater than five times the upper limit of normal ( > 5xULN) levels was 6% (16 of 257 patients); however, bilirubin remained normal in all but one patient. The elevation of ALT occurred in all dose groups and appears to be related to the duration of dosing. The incidence was 3.9% (10 patients) in the 100 mg group; 0.8% (2 patients) in the 50 mg group; 1.6% (4 patients) in the 25 mg group. No abnormalities of liver function were observed in the placebo group. 
<br><br>
A rise in transaminases to > 5x ULN is considered to be predictive of a potential for drug induced liver injury. As these significant elevations in ALT have been observed in all the dose groups, Addex considers that future development of ADX10059 for long term use appears unlikely. The company will evaluate potential development options based on the complete analysis of the data from study 205, a 4-week study in GERD patients, which will report top-line data in early January. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174134.php</link> 
<pubDate>2009-12-24</pubDate>
</item>
 
<item>
<title><![CDATA[Researchers Identify Tuberculosis Strain That Thrives On Antibiotic]]></title> 
<description><![CDATA[Scientists have identified a strain of antibiotic-resistant tuberculosis that thrives in the presence of rifampin, a front-line drug in the treatment of tuberculosis. The bacterium was identified in a patient in China and is described in a study by researchers at the Johns Hopkins Bloomberg School of Public Health, Chongqing Pulmonary Hospital, Lanzhou University and Fudan University. The researchers determined that the bacteria grew poorly in the absence of the antibiotic rifampin and better in the presence of the drug. They also observed that the patient's condition grew worse with treatment regimens containing rifampin, before being cured with rifampin-free regimens. The study, which will appear in the January 2010 issue of The International Journal of Tuberculosis and Lung Disease, is among the first to document the treatment of a patient with rifampin-dependent infection.
<br><br>
The World Health Organization (WHO) estimates that tuberculosis kills approximately 2 million people worldwide each year. Multidrug-resistant tuberculosis (MDR-TB) is becoming an increasing problem in many parts of the world, largely due to poor patient adherence to the six-month tuberculosis chemotherapy. About 5 percent of all TB cases are MDR-TB that is resistant to isoniazid and rifampin, two main drugs used to treat the disease.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174637.php</link> 
<pubDate>2009-12-23</pubDate>
</item>
 
<item>
<title><![CDATA[Surgery Recognized As Effective Treatment For Selected Type 2 Diabetes Patients]]></title> 
<description><![CDATA[A first-of-its-kind consensus statement by 50 medical experts from around the world has pronounced surgery to be a legitimate and effective treatment for type 2 diabetes, bringing the procedure a significant step closer to wider use and acceptance. 
<br><br>
The report, recently published in the Annals of Surgery, illustrates the findings of the first Diabetes Surgery Summit (DSS), an international conference held at the Catholic University of Rome, Italy, where more than 50 scientific and medical experts agreed on a set of guidelines and definitions to guide the use and study of gastrointestinal surgery to treat type 2 diabetes. 
<br><br>
"This is very good news for people in Qatar and other Gulf countries where diabetes continues to be a major health concern," says Bakr Nour, MD, professor of surgery at Weill Cornell Medical College in Qatar and vice chair of surgery at Weill Cornell Medical College in New York. "It is estimated that 15 to 20% of GCC nationals suffer from diabetes, though many may be unaware that they have it. The disease rates continue to rise both in adults and children, and prevalence among Qatari children has doubled in the past 10 years." 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174596.php</link> 
<pubDate>2009-12-23</pubDate>
</item>
 
<item>
<title><![CDATA[Most Plentiful Cell Type In The Heart - The Fibroblast -contributes To Heart Failure]]></title> 
<description><![CDATA[Fibroblasts are the most numerous cell type in the heart, but they are considered to have a less important role in heart failure than heart muscle cells. However, a team of researchers, at the University of Tokyo Graduate School of Medicine, Japan, has now determined that fibroblasts are essential for the response of the mouse heart to conditions that mimic high blood pressure, a response that if sustained ultimately leads to heart failure. 
<br><br>
The team, led by Ryozo Nagai and Ichiro Manabe, showed that mice lacking Klf5 only in heart muscle cells mounted a normal response to conditions designed to mimic moderate increases in blood pressure, whereas mice lacking Klf5 only in fibroblasts in the heart failed to respond to such conditions. Surprisingly, mice lacking Klf5 only in fibroblasts in the heart developed more severe heart failure than normal mice and died when subjected to conditions designed to mimic extreme increases in blood pressure. The authors therefore conclude that fibroblasts in the heart have a central role in the response of the heart to changes in blood pressure and suggest that modulating their function might provide a way to treat individuals with heart failure. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174653.php</link> 
<pubDate>2009-12-23</pubDate>
</item>
 
<item>
<title><![CDATA[Routine HIV Screening In Community Health Centers Boosts HIV Testing, UCSF Study Finds]]></title> 
<description><![CDATA[UCSF researchers have that found routinely offering rapid HIV tests to patients in community health centers can significantly increase the number of patients screened for HIV. 
<br><br>
Study findings are published in the December 2009 issue of the Journal of General Internal Medicine. 
<br><br>
"In the six centers implementing the new procedures, the number of patients screened for HIV jumped from 3,000 in the prior year to almost 11,000 - more than a three fold increase. Our results show that you can successfully implement routine HIV screening in primary care settings," said Janet J. Myers, PhD, MPH, assistant professor of medicine at the UCSF Center for AIDS Prevention Studies. 
<br><br>
The research, conducted in partnership with the National Association of Community Health Centers, took place in community health centers in Mississippi, North Carolina and South Carolina. The national network of centers sees more than 20 million patients, of whom 90 percent are low income, half are rural with most of the rest in inner cities, and two-thirds are racial and ethnic minorities. HIV disproportionately affects health center patients; so increasing testing in these settings is a priority. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174102.php</link> 
<pubDate>2009-12-23</pubDate>
</item>
 
<item>
<title><![CDATA[Imaging Tests Identify Role Of Allergies In Chronic Sinus Disease]]></title> 
<description><![CDATA[Exposing patients with chronic sinus disease to allergens and then obtaining repeated images by X-ray or ultrasound reveals that nasal allergies may be involved in some cases of chronic sinus disease, according to a report in the December issue of Archives of Otolaryngology-Head &amp; Neck Surgery, one of the JAMA/Archives journals. 
<br><br>
Chronic disease of the maxillary sinus (the sinus cavity located in the mid-face beneath the cheeks, on either side of the nose) is common and affects a wide population of adults and children, according to background information in the article. "Although the involvement of hypersensitivity mechanisms, and especially of nasal allergy, in chronic disease of the maxillary sinuses has been recognized, the diagnostic procedures for this disorder and the relationship vary," the author writes. "There is a dearth of information regarding the direct causal involvement of hypersensitivity mechanisms of the nasal mucosa and potential consequences within the maxillary sinuses." 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174508.php</link> 
<pubDate>2009-12-23</pubDate>
</item>
 
<item>
<title><![CDATA[Study Casts Doubt On Provocative Tuberculosis Theory]]></title> 
<description><![CDATA[The tuberculosis bacterium is an insidious germ that can lie dormant for many years, then suddenly emerge and cause potentially fatal disease.
<br><br>
Earlier this year, researchers in Sweden proposed a provocative explanation: TB bacteria have the ability to turn into dormant, armor-plated spores. If true, the findings would provide promising new avenues of research in the worldwide fight against TB.
<br><br>
But a new study by researchers at Loyola University Health System and other centers casts doubt on the TB spore theory. Researchers were unable to detect spores in TB cultures and demonstrated that the TB bacterium doesn't even contain genes related to those needed to produce spores. Researchers also failed to find any spores in frogs infected with TB bacteria, which would have been expected if TB bacteria produced spores in the course of infection.


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174633.php</link> 
<pubDate>2009-12-23</pubDate>
</item>
 
<item>
<title><![CDATA[Compound Found To Safely Counter Deadly Bird Flu]]></title> 
<description><![CDATA[The specter of a drug-resistant form of the deadly H5N1 avian influenza is a nightmare to keep public health officials awake at night. 
<br><br>
Now, however, a study published this week (Dec. 21) in the Proceedings of the National Academy of Sciences (PNAS) suggests that a new compound, one on the threshold of final testing in humans, may be more potent and safer for treating "bird flu" than the antiviral drug best known by the trade name Tamiflu. 
<br><br>
Known as T-705, the compound even works several days after infection, according to Yoshihiro Kawaoka, a University of Wisconsin-Madison virologist and the senior author of the new PNAS study. 
<br><br>
"H5N1 virus is so pathogenic even Tamiflu doesn't protect all the infected animals," explains Kawaoka, a professor of pathobiological sciences at the UW-Madison School of Veterinary Medicine and a world authority on influenza. "This compound works much better, even three days after infection." 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174656.php</link> 
<pubDate>2009-12-23</pubDate>
</item>
 
<item>
<title><![CDATA[Huntington's Disease: IKK May Act As Both Inhibitor And Promoter]]></title> 
<description><![CDATA[The kinase IKK phosphorylates the protein mutated in Huntington's disease to promote its removal and neuron survival, but IKK may be a double-edged sword that increases neurotoxicity in later stages of the disease. The study, led by researchers from the University of California, Irvine, was published online December 21 in the Journal of Cell Biology. 
<br><br>
Huntington's disease is caused by an expanded polyglutamine repeat in the protein Huntingtin (Htt), which causes the protein to aggregate and damage neurons. Ubiquitination and SUMOylation of Htt's N-terminal domain affect the protein's stability and toxicity, but other post-translational modifications in this region of the protein might be important as well. 
<br><br>
Thompson et al. discovered that the inflammatory kinase IKK phosphorylates Htt, altering the complex pattern of SUMOylation, ubiquitination, and acetylation on neighboring lysine residues. The net result was to promote Htt's degradation by both the proteasome and lysosomes. Lysosome-mediated degradation of Htt was blocked by knocking down the autophagy proteins LAMP-2A and Atg7. Compared to wild type, mutant Htt with an expanded polyglutamine stretch was degraded inefficiently, but a version that mimicked IKK phosphorylation with negatively charged aspartate residues was still less toxic to neuronal slice cultures.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174612.php</link> 
<pubDate>2009-12-23</pubDate>
</item>
 
<item>
<title><![CDATA[Soligenix Announces Initiation Of A Phase 1/2 Clinical Trial Of SGX201 For The Prevention Of Acute Radiation Enteritis]]></title> 
<description><![CDATA[Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced that it has initiated a Phase 1/2 clinical trial evaluating SGX201, a time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP), for the prevention of acute radiation enteritis. This study will be supported in large part by a two-year Small Business Innovation Research (SBIR) grant award, which will provide Soligenix with approximately $510,000 in funding.
<br><br>
The Phase 1/2 protocol BDP-ENT-01 is designed as a multicenter, open-label, sequential, dose-escalation study in approximately 36 patients. Patients with rectal cancer who are scheduled to undergo concurrent radiation and chemotherapy prior to surgery will be enrolled in one of four escalating dose groups. The objectives of the study are to evaluate the safety and maximal tolerated dose of escalating doses of SGX201, as well as the preliminary efficacy of SGX201 for prevention of signs and symptoms of acute radiation enteritis. The study is expected to be completed in the first half of 2011.


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174628.php</link> 
<pubDate>2009-12-23</pubDate>
</item>
 
<item>
<title><![CDATA[Women Aged 50-65 Face Unique Barriers To Obtaining Health Care, MU Researcher Says]]></title> 
<description><![CDATA[For Americans living in rural areas, obtaining and maintaining health care can be challenging. Aside from common barriers, including shortages of care providers and facilities, older women face additional challenges, according to Kay Libbus, a public health researcher at the University of Missouri. Libbus says that women ages 50-65 living in rural areas are at-risk for inadequate health care coverage and limited access to health information. 
<br><br>
"There is a gap in health care access for women ages 50-65 living in rural areas," said Kay Libbus, professor in the University of Missouri Sinclair School of Nursing. "These women are beyond child-bearing age, susceptible to developing chronic diseases and often retired or leaving the workforce - and these factors make it difficult to maintain health insurance or obtain new coverage. Rural communities are in need of interventions to address this issue." 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174103.php</link> 
<pubDate>2009-12-23</pubDate>
</item>
 
<item>
<title><![CDATA[Nurse Request For Safer Work Environment Ignored, Australia]]></title> 
<description><![CDATA[The Australian Nursing Federation is deeply disappointed that nurses who are working in unsafe hospitals and environments may have to wait up to three months before employers are forced to act on their concerns. 
<br><br>
The ANF recently highlighted the rising trend of nurses coming under physical attack from drug and alcohol affected patients. 
<br><br>
However Safe Work Australia do not intend to force employers to listen to nurse concerns. Other occupational health and safety issues affecting nurses include bullying, falls, physical and psychological injuries. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174186.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[New Survey Shows Americans Look To Business To Improve Country's Health]]></title> 
<description><![CDATA[As the healthcare reform debate continues, legislators and businesspeople alike might be surprised to learn that Americans are looking not only to government but also to business to improve our nation's health, even beyond employee wellness efforts. People are more likely to purchase from, recommend, and invest in companies that act on health issues-creating a compelling case for businesses to step up their efforts. 
<br><br>
The Edelman Health Engagement Pulse-a new survey of 1,000 American adults-reveals a stark gap between how Americans want businesses to engage in health and what they believe is actually being done. Eight in 10 respondents believe it is important for business to share knowledge and innovations that improve health, and seven in 10 believe business should invest in creating healthy communities, yet only about one in 10 say business is doing an excellent or very good job of meeting these expectations. The study also showed that seven in 10 people believe it is important for business to help employees lead healthier lives.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174232.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[New Report Shows Senate Health Care Bill Will Expand Coverage To More Than 1.1 Million Georgians]]></title> 
<description><![CDATA[Although the ongoing Senate debate over health reform may seem at times to be unrelated to everyday life in Georgia, the bill's passage or failure will have a profound impact on the health and well-being of many Georgia residents. A report from Families USA, the national organization for health care consumers, found that 1,134,000 people in Georgia will gain coverage by 2019 under the Senate health reform bill. 
<br><br>
The Families USA report, based on Congressional Budget Office data, also shows that, without health reform, 293,000 people in Georgia will lose health coverage by 2019. In 2007 and 2008, the average number of uninsured people in Georgia was 1,682,000, but that total will rise to 1,975,000 if the bill fails to pass. Nationally, the number of uninsured will reach 54 million in 2019 in the absence of comprehensive health reform. 
<br><br>
"The consequences of inaction will be very severe for people in Georgia and across the country," said Ron Pollack, Executive Director of Families USA. "If the Senate fails to act, Americans will continue to struggle, and a growing number of them will face the devastating effects of going without coverage." 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174303.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[New Approach Reduces Number Of Routines Needed To Detect Erythropoietins]]></title> 
<description><![CDATA[Austrian researchers have successfully developed a new electrophoretic method for detecting MIRCERA� and other erythropoietins (EPO) in the blood. The technique, using SARCOSYL-PAGE, has specifically enhanced sensitivity for MIRCERA, but does not alter the performance characteristics of SDS-PAGE for detecting other EPOs. Details of this study, funded by a grant from the World Anti-Doping Agency (WADA), appear in the latest issue of Drug Testing and Analysis published by Wiley-Blackwell. 
<br><br>
MIRCERA (methoxy polyethylene glycol-epoetin beta), a PEGylated EPO, is a synthetic protein that helps the body produce red blood cells and used to treat anemia caused by kidney disease. The drug is manufactured by Hoffmann-La Roche and only available outside the U.S. due to an infringement upon Amgen's patents on recombinant EPO products and processes. In the past, EPOs have been used off-label as doping agents by athletes to enhance endurance in such sports as cycling, distance running, and rowing. WADA has banned the use of EPOs, such as MIRCERA, in all competitive sports. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174226.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[Liberals Agitated By Compromise, But Appear To Back Health Reform]]></title> 
<description><![CDATA[Politico reports that liberals are accruing a long list of reasons to be upset about the health reform negotiations: "A single-payer plan, a public option, a state 'opt-out' of the public option, a trigger and a Medicare buy-in - all ideas pushed by Democrats and blessed by [President] Obama at various times but now gone from the bill." 
<br><br>
"Obama's need to pass a reform bill ahead of the 2010 elections drove the political calculus as the calendar turned to December, when the days grew short and the pressure to sign something, anything, began to take precedence," Politico writes. "Otherwise, Democrats risked facing voters next fall with little to show for a full year of twin congressional majorities." The thing that may have most angered liberals, however, "is that Obama himself never seemed willing to push hard enough for the public option - and, in fact, all but took it off the table in August when he said he could sign a bill that didn't include it" (Gordon, 12/15). 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174293.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[Major Medicare Fraud Crackdown In 3 States]]></title> 
<description><![CDATA[The Associated Press: "Federal agents arrested 26 suspects in three states Tuesday, including a doctor and nurses, in a major crackdown on Medicare fraud totaling $61 million in separate scams. Arrests in Miami, Brooklyn and Detroit included a Florida doctor accused of running a $40 million home health care scheme that falsely listed patients as blind diabetics so that he could bill for twice-daily nurse visits. The U.S. Department of Justice and U.S. Department of Health and Human Services said the indicted suspects lined up bogus patients and otherwise billed Medicare for unnecessary medical equipment, physical therapy and HIV infusions" (Kennedy, 12/15). 
<br><br>
CNN: "Federal Investigators consider Miami to be ground zero for health care fraud. The inspector general found that 52 percent of all Medicare home health care expenses above $100,000 were in Miami-Dade County, while only 2 percent of Medicare home health care beneficiaries actually live in that county (Chernoff, 12/15). 
<br><br>
The Wall Street Journal/Dow Jones: "The U.S. government has been cracking down on Medicare fraud this year, in part to make sure federal funds aren't being lost at a time of burgeoning deficits" (Miller, 12/15). 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174309.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[Naurex Inc. Initiates Phase I Clinical Trial Of Its Novel Mechanism NMDA Modulator GLYX-13 In Treatment-Resistant Depression]]></title> 
<description><![CDATA[Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, announced that it has initiated a Phase I clinical trial of its lead compound GLYX-13 and has successfully dosed the first subjects in the study. GLYX-13, a glycine site functional partial agonist (GFPA) selective modulator of the NMDA receptor, is initially being developed as a therapy for treatment-resistant depression in severely depressed patients admitted to the hospital. Separately, Naurex announced that data presented at a recent medical meeting reported that GLYX-13 demonstrated robust antidepressant-like and anxiolytic-like activity in animal models with no signs of the CNS-related side effects observed with other drugs targeting the NMDA receptor. The studies also showed that the antidepressant effects of GLYX-13 were evident within 20 minutes and demonstrated a lasting antidepressant effect of greater than four days after administration of a single dose. In these studies, GLYX-13 affected both the positive and negative symptoms of depression.


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174257.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[Medicare Announces Solicitation Of Fiscal Year Fy 2010 State Health Insurance Assistance Program Grants]]></title> 
<description><![CDATA[The Centers for Medicare &amp; Medicaid Services (CMS) announced it is making $45 million in direct grants and support contracts available for State Health Insurance Assistance Programs (SHIP). The Fiscal Year (FY) 2010 Grants are continuation funds available to 54 existing SHIP organizations in the United States and its territories. 
<br><br>
States' responses to this grant announcement are due to CMS by February 16, 2010, and funds will be awarded in April 2010. The grant year runs from April 1, 2010 to March 31, 2011. SHIPs are eligible to receive base grant and supplemental funding, and performance-based awards from CMS. 
<br><br>
These SHIP grants will strengthen the capabilities of States and US territories to support community-based, grassroots networks that provide personalized, one-on-one counseling, advocacy, education and outreach to assist people with Medicare with information, counseling and prescription drug and health plan enrollment. In FY 2009, SHIPs reached nearly 5.4 million people using local resources and other CMS information channels, including 1-800-MEDICARE (1-800-633-4227) and http://www.medicare.gov. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174341.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[JRRD Publishes Single-Topic Issue On TBI And Clinical Practice Guidelines For Mild TBI]]></title> 
<description><![CDATA[The current issue of the Department of Veterans Affairs (VA's) Journal of Rehabilitation Research and Development (JRRD) features 19 timely scientific articles on traumatic brain injury (TBI), based on work by VA researchers and colleagues from a variety of disciplines. The papers were commissioned for a "state of the art" conference VA held last year to advance research in this area. 
<br><br>
This issue also contains joint VA and Department of Defense clinical practice guidelines for mild TBI (mTBI). These guidelines include a screening tool and evaluation protocol for adult patients in any VA/DoD clinical setting at risk of a concussion/mTBI diagnosis. 
<br><br>
The intent of these guidelines is to reduce current practice variation and to provide facilities with a structured framework to help improve patient outcomes. These guidelines are available as part of the journal or individually. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174133.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[Marking Of Tissue-Specific Crucial In Embryonic Stem Cells To Ensure Proper Function]]></title> 
<description><![CDATA[Tissue-specific genes, thought to be dormant or not marked for activation in embryonic stem cells, are indeed marked by transcription factors, with proper marking potentially crucial for the function of tissues derived from stem cells. 
<br><br>
The finding in the study by researchers at the Broad Stem Cell Research Center involves a class of genes whose properties previously were thought to be unimportant for stem cell function. Most research has instead focused on genes that regulate a pluripotency network and genes that regulate differentiation of embryonic stem cells into other cell lineages. 
<br><br>
The Broad center researchers focused on a third class of genes, those expressed only in defined cell types or tissues, which generally remain silent until long after embryonic stem cells have differentiated into specific cell lineages. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174334.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[Malaria Progress Report Shows That Development Aid For Health Is Working]]></title> 
<description><![CDATA[Significant progress has been made in delivering life saving malaria nets and treatments over the past few years, but the coverage of malaria programmes needs to be stepped up drastically in order to meet the Millennium Development Goals (MDGs), according to a report released today by the World Health Organization (WHO). 
<br><br>
The World Malaria Report 2009 found that the increase in international funding commitments (US$ 1.7 billion in 2009 compared to US$ 730 million in 2006) had allowed a dramatic scale up of malaria control interventions in several countries, along with measurable reductions in malaria burden. However, the amounts available still fall short of the US$ 5 billion required annually to ensure high coverage and maximal impact worldwide. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174377.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[For Congress, When It Comes To Medicare: Letting Go Is Hard To Do]]></title> 
<description><![CDATA[Kaiser Health News staff writer Mary Agnes Carey explores some key issues related to Medicare and cost. "In an effort to rein in health costs, Senate Democrats are proposing steps that would give federal agencies more power to overhaul how Medicare pays for medical care - and thus reduce Congress' own role in running the giant program for the elderly" (Carey, 12/16). Read entire story. 
<br><br>
This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174285.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[First Patient Treated In Clinical Study Of Cohera Medical's TissuGlu(R) Surgical Adhesive]]></title> 
<description><![CDATA[Cohera Medical Inc announced the treatment of the first patient in a study of its lead surgical adhesive product, TissuGlu�. Initiation of the study marks a major milestone in the company's progression of the lead product toward clinical practice.
<br><br>
The clinical investigation is a prospective, open-label, randomized study to investigate the safety of TissuGlu and its effect on wound drainage and associated complications in abdominoplasty, or "tummy tuck," surgeries. The study will compare standard wound closure techniques to standard wound closure techniques plus the application of TissuGlu in 40 patients at three sites near Bonn, Frankfurt and Freiburg, Germany.
<br><br>
"We are delighted to have treated the first patient in the TissuGlu study," said Klaus Walgenbach, M.D., Ph.D., of the Universitatsklinikum Bonn and the principal investigator for the study. "We were very pleased with the procedure and look forward to enrolling more patients."

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174254.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[First Comprehensive Genetic Analysis Of Lung Cancer And Melanoma]]></title> 
<description><![CDATA[Research teams led by the Wellcome Trust Sanger Institute announce the first comprehensive analyses of cancer genomes. 
<br><br>
All cancers are caused by mutations in the DNA of cancer cells which are acquired during a person's lifetime. The studies, of a malignant melanoma and a lung cancer, reveal for the first time essentially all the mutations in the genomes of two cancers. 
<br><br>
Lung cancer causes around one million deaths worldwide each year: almost all are associated with smoking. The number of mutations found suggest that a typical smoker would acquire one mutation for every 15 cigarettes smoked. 
<br><br>
Although malignant melanoma comprises only 3% of skin cancer cases, it is the cause of three out of four skin cancer deaths. The melanoma genome contained more than 30,000 mutations that carried a record of how and when they occurred during the patient's life. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174340.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[FDA Expands Presence Outside U.S. With Opening Of Mexico City Post]]></title> 
<description><![CDATA[As part of its continuing effort to buttress food and medical product safety in this country by working with its regulatory partners overseas, the U.S. Food and Drug Administration announced the opening of its Mexico City post. This is the Agency's third post in Latin America and its tenth international post in the past 13 months.
<br><br>
"The opening of this office represents an important step as we re-design our product safety strategy. We, like our partners in the Mexican Government, realize that prevention is the key. For example, more than a third of the fresh fruits and vegetables we eat come from Mexico as do a large amount of our medical devices. Having FDA experts located permanently there will be mutually beneficial to both our countries and respective citizens," said U.S. FDA Commissioner Margaret A. Hamburg, M.D.
<br><br>
Staff assigned to the FDA's Mexico City post will work with their counterparts in the Mexican government to harmonize regulations and guidance standards and to work on other collaborative initiatives. These collaborations will include, for example, information-sharing on the respective regulatory systems and joint workshops on the safety of food and medical products. Agencies in both governments also will make efforts to find opportunities for joint training on food-borne illnesses and the oversight of food traded internationally.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174124.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[FDA Approves Generic Aricept To Treat Dementia Related To Alzheimer's Disease]]></title> 
<description><![CDATA[Please note this is a corrected version of a press release that was posted to FDA's website today. The corrections include a modified headline and a revised second paragraph. 
<br><br>
The U.S. Food and Drug Administration approved the first generic versions of Aricept (donepezil hydrochloride) orally disintegrating tablet s on Dec. 11. Donepezil hydrochloride is indicated for the treatment of dementia related to Alzheimer's disease. 
<br><br>
Orally disintegrating tablets dissolve on the tongue, without having to be swallowed whole. This may make it easier to take the medication for older or disabled patients who have difficulty swallowing. 
<br><br>
"Generics offer greater access to health care for all Americans," said Gary Buehler, director of the FDA's Office of Generic Drugs. "Health care professionals and consumers can be assured that FDA-approved generic drugs have met the same rigorous standards as the brand-name drug and are the same as the branded in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use." 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174173.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[Evolution Of Brain Surgery To Treat Rogue Blood Vessels]]></title> 
<description><![CDATA[Over three decades, a world-recognized medical team at UC San Diego Medical Center has spurred the evolution of a complex surgery to destroy dangerous clusters of arteries and veins in the brain. Integrating innovative approaches in radiology, anesthesia, and surgery, the team has perfected a method to systematically starve these abnormal brain lesions, artery by artery, vein by vein. 
<br><br>
"In the late 70s and early 80s, medical teams attempted to remove these lesions during a single surgery, frequently encountering catastrophic episodes of brain swelling," said John C. Drummond, MD, professor and anesthesiologist at UC San Diego Medical Center. "Today, with a combination of embolization, the use of a medical coma, and staging shorter surgeries, patients experience consistently good outcomes." 
<br><br>
The brain lesion, called an arteriovenous malformation (AVM), ranges in size from less than one to 10 centimeters in diameter. The defect can also occur in the spinal cord, and affects more than 300,000 Americans per year. While many patients show no signs of the abnormality, more than 10 percent experience debilitating symptoms. The untreated lesion can be fatal. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174329.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[Abt Associates To Assist CDC In Evaluating Effectiveness Of Influenza Vaccines Among Pregnant Women]]></title> 
<description><![CDATA[Abt Associates will conduct a study for the Centers for Disease Control and Prevention (CDC) to evaluate the effectiveness of the H1N1 and seasonal flu vaccines among pregnant women, one of the high risk populations identified by CDC. Under the two year contract valued at $5.5 million, Abt Associates will identify and enroll study participants, coordinate testing of participants for infection with influenza viruses, develop and maintain all study databases, and assist CDC with data analysis.
<br><br>
Serious health risks have been observed in pregnant women with H1N1, including the development of pneumonia, maternal death, spontaneous abortion, and preterm birth. Because of these risks, pregnant women have been targeted as a high risk group and encouraged to get the H1N1 vaccine. The CDC study will assess vaccine effectiveness and the impact of H1N1 and seasonal influenza infection in this target population. The study is designed to avoid interfering with the standard clinical care of patients.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174275.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[A Selection Of Today's Opinions And Editorials]]></title> 
<description><![CDATA[President Obama Writes A New Health Reform Prescription The Washington Post 
On the campaign trail, Barack Obama vowed to take on the drug industry by allowing Americans to import cheaper prescription medicine. "We'll tell the pharmaceutical companies 'thanks, but no, thanks' for the overpriced drugs. ... On Tuesday, the matter came to the Senate floor -- and President Obama forgot the "no, thanks" part (Dana Milbank, 12/16). 
<br><br>
Let Women Decide On Medical Tests Kaiser Health News 
<br>
A careful reading of the guidelines says something quite different from the position that has caused such a flap (Shannon Brownlee and E. Dale Collins, 12/16). 
<br><br>
Health reform and US immigrants Inquirer Global Nation 
<br>
Would you wait five years for a doctor's appointment? If you are a legal immigrant living in the United States, you might have to (Jennifer Ng'andu, 12/16). 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174312.php</link> 
<pubDate>2009-12-18</pubDate>
</item>
 
<item>
<title><![CDATA[Physical Activity Reduces Disease-Related Fatigue And Depression By Increasing Self-Efficacy Or Mastery]]></title> 
<description><![CDATA[Researchers in the US studying people with chronic diseases found that physical activity may reduce depression and fatigue by increasing self-efficacy, or the belief that one can master physical goals and attain a sense of accomplishment from applying oneself.
<br><br>
These were the findings of a study by lead author Dr Edward McAuley, a professor of kinesiology and community health at the University of Illinois in Champaign, and colleagues, and appears in the journal Psychosomatic Medicine.
<br><br>
A person's self-efficacy is the belief they can attain a certain goal: an example of my self-efficacy would be that I believe I can climb several flights of stairs or jog around the block without stopping.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174252.php</link> 
<pubDate>2009-12-17</pubDate>
</item>
 
<item>
<title><![CDATA[States Drop No-Cost Cancer Screenings Due To Budget Woes, Study Finds]]></title> 
<description><![CDATA[Low-income women in at least 20 states no longer have adequate or convenient access to cancer screening services, including mammograms and Pap tests, as a result of the economic recession and diminished levels of health coverage, according to a recent study by the American Cancer Society's Cancer Action Network, the AP/Atlanta Journal-Constitution reports. For the study, ACSCAN conducted an unofficial survey of women's health screening programs nationwide from July 2008 to April 2009.
<br><br>
The study found that at least 14 states facing significant budget constraints were forced to turn away women who normally would qualify for no-cost mammograms and Pap tests. ACSCAN officials said that the number of women who are being rejected is not known and that some might receive screenings in other programs or through providers. Many providers also do not track the number of patients who have been rejected or obtained the screenings elsewhere.
<br><br>
According to the AP/Journal-Constitution, providers and health departments in each state have different methods for handling no-cost screenings. Some might supplement federal funding with money from the state or from private donors. The cost of the screenings also can vary from an average of about $100, while a Pap test can cost between $75 and $200, according to ACS (Bauman, Atlanta Journal-Constitution, 12/12). 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174156.php</link> 
<pubDate>2009-12-17</pubDate>
</item>
 
<item>
<title><![CDATA[Non-surgical Method For Diagnosing Breast Cancer Safe, Nearly As Effective As Surgical Biopsy, New Report Finds]]></title> 
<description><![CDATA[Some methods of minimally invasive biopsy for breast cancer are nearly as accurate as surgical biopsy but have much less risk of harms, according to a new report funded by HHS' Agency for Healthcare Research and Quality (AHRQ). 
<br><br>
The report, prepared by the ECRI Institute's Evidence-based Practice Center under contract to AHRQ's Effective Health Care Program, compares traditional surgical biopsies with various types of "core needle biopsies," which involve removing tissue through a special large hollow needle inserted through the skin. 
<br><br>
The report, initiated in 2007, will provide important information so that doctors and patients can work together to make the best possible diagnostic choice for each individual patient. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174209.php</link> 
<pubDate>2009-12-17</pubDate>
</item>
 
<item>
<title><![CDATA[Arno Therapeutics Announces Poster Presentation At ASH Annual Meeting Demonstrating Anti-Leukemic Stem Cell Activity Of AR-42]]></title> 
<description><![CDATA[Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced the presentation of a poster at the annual American Society of Hematology (ASH) meeting that describes the preclinical activity of Arno's drug candidate AR-42 against leukemia stem cells (LSCs). AR-42 is a broad spectrum inhibitor of both histone and non-histone deacetylation proteins that demonstrated potent activity against Acute Myeloid Leukemia (AML) stem cells. The poster, entitled "Identification of the Histone Deacetylase Inhibitor (HDACi), AR-42, as a Novel Anti-Leukemia Stem Cell Agent in Acute Myeloid Leukemia (AML)" was presented at the 51st ASH Annual Meeting and Exposition held December 5-8, 2009 in New Orleans, LA. 
<br><br>
LSCs are believed to be able to initiate and perpetuate AML while displaying resistance to standard chemotherapies. The ability to target these cells with therapeutic compounds may help improve patient outcomes. The poster's findings show that AR-42 preferentially targets LSCs compared to normal healthy cells. The research also suggests that AR-42 is active through a mechanism that differentiates it from other compounds with preclinical anti-LSC activity. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174217.php</link> 
<pubDate>2009-12-17</pubDate>
</item>
 
<item>
<title><![CDATA[Nitric Oxide Beneficial In Septic Shock After All]]></title> 
<description><![CDATA[Scientists at VIB and Ghent University in Flanders, Belgium have found an unexpected ally for the treatment of septic shock, the major cause of death in intensive care units. By inducing the release of nitric oxide (NO) gas in mice with septic shock, researchers Anje Cauwels and Peter Brouckaert discovered that the animal's organs showed much less damage, while their chances of survival increased significantly. That's contrary to all expectations, since it is generally assumed that nitric oxide is responsible for the potentially lethal drop in blood pressure in septic shock. 
<br><br>
Septic shock, or sepsis, is a medical condition in which acute inflammation, low blood pressure, and blood clotting cause a dangerous decrease in the delivery of blood to the organs. Because of the lack of oxygen, the patient's organs start to fail, one after the other. Currently, only supportive treatment is available. 
<br><br>
It is generally assumed that nitric oxide (NO) gas is responsible for the hypotension and cardiovascular collapse in septic shock. Therefore, a lot of medical research is focused on combating NO, which is also a messenger molecule in the body. Attempts to inhibit its production paradoxically led to a worsening of the organ damage and in an increased lethality, both in animal models and in a clinical trial in sepsis patients. This led to the assumption that NO also has positive effects in sepsis, but up to now NO remained a prime suspect for the pathogenesis of the cardiovascular shock. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174148.php</link> 
<pubDate>2009-12-17</pubDate>
</item>
 
<item>
<title><![CDATA[On New Lab Chip, Heart Cells Display A 'Nanosense' That Guides Their Behavior]]></title> 
<description><![CDATA[Johns Hopkins biomedical engineers, working with colleagues in Korea, have produced a laboratory chip with nanoscopic grooves and ridges capable of growing cardiac tissue that more closely resembles natural heart muscle. Surprisingly, heart cells cultured in this way used a "nanosense" to collect instructions for growth and function solely from the physical patterns on the nanotextured chip and did not require any special chemical cues to steer the tissue development in distinct ways. The scientists say this tool could be used to design new therapies or diagnostic tests for cardiac disease. 
<br><br>
The device and experiments using it were described in this week's online Early Edition of Proceedings of the National Academy of Sciences. The work, a collaboration with Seoul National University, represents an important advance for researchers who grow cells in the lab to learn more about cardiac disorders and possible remedies

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174191.php</link> 
<pubDate>2009-12-17</pubDate>
</item>
 
<item>
<title><![CDATA[UNITAID To Launch Patent Pool For HIV/AIDS Drugs By Mid-2010]]></title> 
<description><![CDATA[The international drug procurement agency UNITAID on Monday unveiled plans to create a patent pool for HIV/AIDS medications to help increase access to generic versions of newer drugs at lower prices for low- and middle-income countries, Agence France-Presse reports. The patent pool "will create a common space for patent holders to license their technology in exchange for royalties" and is "scheduled to begin operating in mid-2010," AFP reports (12/14). 
<br><br>
"UNITAID has committed to provide start-up funds of up to US$ 4 million over the next year," according to a UNITAID press release, which noted an annual savings of more than $1 billion a year is expected through the program. "This is an historic day," said Philippe Douste-Blazy, chair of UNITAID's executive board. "UNITAID has now put in place a mechanism that will make medical advances work for the poor, while compensating companies for sharing their technology" (12/14). 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174181.php</link> 
<pubDate>2009-12-17</pubDate>
</item>
 
<item>
<title><![CDATA[Induction Of Antibodies That Block HIV Prevented By Biological Catch-22]]></title> 
<description><![CDATA[Scientists seeking to understand how to make an AIDS vaccine have found the cause of a major roadblock. It turns out that the immune system can indeed produce cells with the potential to manufacture powerful HIV-blocking antibodies - but at the same time, the immune system works equally hard to make sure these cells are eliminated before they have a chance to mature. 
<br><br>
"These studies show that a potentially protective neutralizing antibody against a viral disease is under the control of immunological tolerance," said Barton Haynes, M.D., director of the Center for HIV/AIDS Vaccine Immunology (CHAVI) at Duke University Medical Center and senior author of the study appearing in the online early edition of the Proceedings of the National Academy of Sciences. "This represents a new insight into the way HIV effectively evades detection by the B cell arm of the immune system and may offer new directions for vaccine design." 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174207.php</link> 
<pubDate>2009-12-17</pubDate>
</item>
 
<item>
<title><![CDATA[American Society Of Anesthesiologists Urges Americans To Fight Back Against Pain]]></title> 
<description><![CDATA[Whether the result of injury, illness or a chronic condition, 70 million Americans experience pain annually. The individual pain sufferer may experience a diminished quality of life, lack of mobility and added stress. For the country as a whole, pain has far-reaching cost implications. It is estimated that more than 140 million work days are lost because of back pain. (1,2) As a result of chronic pain and the loss in productivity that it causes, approximately $60-100 billion is wasted each year. (3) 
<br><br>
To help fight this debilitating condition and combat its detrimental impact, the American Society of Anesthesiologists (ASA) is offering practical ways for sufferers to take an active role in the treatment of pain. The ASA wants to ensure patients are informed about their treatment options and is offering a series of tips to empower the patient as he/she works with a physician to treat the pain. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/174233.php</link> 
<pubDate>2009-12-17</pubDate>
</item>
 
<item>
<title><![CDATA[AAP Supports Lawsuit Against Florida Medicaid For Inadequate Care For Children; Advocates To Improve Medicaid Payment Within Health Reform]]></title> 
<description><![CDATA[The American Academy of Pediatrics (AAP) supports the efforts of the Florida Pediatric Society, a chapter of the AAP, and the Florida Academy of Pediatric Dentistry to combat discrepancies in the quality of medical and dental care delivered to children enrolled in Florida's Medicaid program. The group filed a lawsuit against Florida Medicaid-now currently in trial-for providing inadequate medical and dental care to more than 1 million Floridian children. 
<br><br>
"The 390,000 children in Florida who did not get medical check-ups in 2007 and the more than 750,000 who received no dental care that year are proof that this discrepancy in care is failing Florida's children," said pediatric cardiologist and Florida Pediatric Society Executive Vice President Louis St. Petery, MD, FAAP. 
<br><br>
"Florida's Medicaid payment rates are among the lowest in the country, which explains why so few doctors in our state can afford to treat Medicaid patients," Dr. St. Petery stated. "Medicaid paid only $32 for a physician office visit in Florida in 2007, compared to $47 in Virginia, and the approximately $60 that Medicare pays for the same service in Florida." 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173825.php</link> 
<pubDate>2009-12-14</pubDate>
</item>
 
<item>
<title><![CDATA[Technical Consultation: "Advanced Cook Stoves For Improved Health Of Women And Children"]]></title> 
<description><![CDATA[To address the adverse health and environmental outcomes associated with the use of traditional open fire cook stoves, the United States Agency for International Development (USAID) convened a Technical Consultation today to bring experts from civil society, academia, business, and government to discuss the potential and opportunities for moving forward with improved, cleaner, and healthier cook stoves in India. 
<br><br>
Opening the Technical Consultation, U.S. Ambassador Timothy J. Roemer said, "India and the U.S. are working together on initiatives spanning the full range of human endeavor including a Green Partnership to develop clean technologies, which will provide us all with an environmentally-sustainable, healthier future while creating job opportunities for the citizens of both our countries." 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173827.php</link> 
<pubDate>2009-12-14</pubDate>
</item>
 
<item>
<title><![CDATA[New Insights Into Human Decision Making Provided By Bacteria]]></title> 
<description><![CDATA[Scientists studying how bacteria under stress collectively weigh and initiate different survival strategies say they have gained new insights into how humans make strategic decisions that affect their health, wealth and the fate of others in society. 
<br><br>
Their study, published in the early online edition of the journal Proceedings of the National Academy of Sciences, was accomplished when the scientists applied the mathematical techniques used in physics to describe the complex interplay of genes and proteins that colonies of bacteria rely upon to initiate different survival strategies during times of environmental stress. Using the mathematical tools of theoretical physics and chemistry to describe complex biological systems is becoming more commonplace in the emerging field of theoretical biological physics. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173893.php</link> 
<pubDate>2009-12-14</pubDate>
</item>
 
<item>
<title><![CDATA[Calif. City Sends Coat Hangers To Lawmakers Who Support Abortion Rights But Voted For Stupak Amendment]]></title> 
<description><![CDATA[The City Council in Berkeley, Calif., recently mailed coat hangers and protest letters to 20 members of the U.S. House who voted for an antiabortion rights amendment to the chamber's health care reform bill (HR 3962) but have a history of supporting abortion rights, the San Francisco Chronicle reports. The amendment, sponsored by Rep. Bart Stupak (D-Mich.), would ban abortion coverage in public and private health insurance plans that receive federal subsidies (Jones, San Francisco Chronicle, 12/10). 
<br><br>
According to council member Susan Wengraf, a co-sponsor of the measure that authorized Wednesday's mailings, the "coat hanger represents the time when women had to have abortions in back alleys and tried to self-abort." She added, "I don't want my granddaughter to go through what my grandmothers had to." Kriss Worthington, another council member and co-sponsor of the mailings, said his support for the move was prompted by outrage among his constituents. He said that he opted not to send the mailings to all representatives who oppose abortion rights because "nothing the city of Berkeley says to them will make any difference

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>"http://www.medicalnewstoday.com/articles/173858.php</link> 
<pubDate>2009-12-14</pubDate>
</item>
 
<item>
<title><![CDATA[Cancer/Inflamation Link Discovered By University Of Montreal]]></title> 
<description><![CDATA[Canadian researchers have discovered a novel molecular mechanism that prevents cancer. In the December 11 edition of the prestigious journal Molecular Cell, scientists from the Universit� de Montr�al and the Universit� de Sherbrooke explain how they found that the SOCS1 molecule prevents the cancer-causing activity of cytokines, hormones that are culprits in cancer-prone chronic inflammation diseases such as Crohns, in smokers and people exposed to asbestos. 
<br><br>
"Excessive cytokine activity promotes cancer," says Dr. Gerardo Ferbeyre, senior author and a Universit� de Montr�al biochemistry professor. "Discovery of these mechanisms will enable scientists to design a cancer-prevention strategy for people with chronic inflammatory diseases and lead to better understanding of the human body's natural defenses against cancer." 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173886.php</link> 
<pubDate>2009-12-14</pubDate>
</item>
 
<item>
<title><![CDATA[Antibody-Guided Drug Shows Encouraging Activity In Metastatic Breast Cancer]]></title> 
<description><![CDATA[A new antibody-drug compound shrank or halted the growth of metastatic breast tumors in almost half of a group of patients whose HER2-positive cancer had become resistant to standard therapies, according to early data from a multicenter Phase 2 clinical trial led by a Dana-Farber Cancer Institute researcher. 
<br><br>
The findings was presented at the 32nd annual CTRC-AACR San Antonio Breast Cancer Symposium on Saturday, Dec. 12 (Abstract 710). 
<br><br>
Ian Krop, MD, PhD, principal investigator of the study, reported that the hybrid agent, called T-DM1, shrank tumors by 30 percent or more in 40 percent of women with confirmed HER2-positive cancers. Another 13 percent had stable disease for at least six months, for a total clinical benefit rate of approximately 53 percent. The median time before the disease progressed was 7.3 months, including both responders and non-responders. Patients received T-DM1 as long as it was effective and well-tolerated. A total of 110 women were enrolled in the study. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173890.php</link> 
<pubDate>2009-12-14</pubDate>
</item>
 
<item>
<title><![CDATA[Aptuit Publishes Study Which Demonstrates The Value Of Early Insights Into The Characterization Of Drug Compounds]]></title> 
<description><![CDATA[Aptuit, Inc. announced the publication of new research in the December issue of the European Journal of Pharmaceutical Sciences, the official journal of the European Federation for Pharmaceutical Sciences (EUFEPS), which describes the solid-state characterization of three forms of finasteride. The study, conducted by researchers at SSCI, a Division of Aptuit, outlines a systematic approach to characterizing a set of solvated active pharmaceutical ingredients (APIs) and evaluating the solid-state behavior of each. The research uncovered previously uncharacterized API forms within an existing family of finasteride solvates, demonstrating that Aptuit's approach to applying solid-state chemistry may lead to the early identification of new API forms with improved pharmaceutical properties. 
<br><br>
"Interestingly, in our initial efforts to determine the approximate solubility for subsequent solid-form screens on finasteride, we noticed unique recrystallization properties that prompted this study. We then set forth in generating, characterizing and investigating the solid-state behavior of three finasteride solvates," explained Nathan Schultheiss, PhD, Research Investigator at SSCI, a Division of Aptuit, and lead investigator of the published study. "Through our work, we gained unparalleled insight into the crystallographic and thermoanalytical behavior of the compound." 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173790.php</link> 
<pubDate>2009-12-14</pubDate>
</item>
 
<item>
<title><![CDATA[Increase In Hepatitis C Diagnoses For 2008, UK]]></title> 
<description><![CDATA[Figures from the agency's yearly report on Hepatitis C for 2009 show that laboratory reporting of newly diagnosed hepatitis C infections in England increased in 2008 by 6% compared to 2007, with 8,196 new cases reported in 2008. 
<br><br>
Hepatitis C is a viral infection which causes swelling or inflammation of the liver. It is transmitted when the blood of an infected person mixes with a recipient's blood, such as via injecting drug use and the sharing of needles. Because hepatitis C infection is predominantly asymptomatic in the early years, many individuals remain undiagnosed until the disease has progressed. If the infection is diagnosed in the early stages, treatment can be offered that can clear the infection in more than half of those treated. However, some infections remain undiagnosed until end-stage liver disease is reached, when a transplant becomes the only real option. 
<br><br>
It is estimated that currently around 185,000 individuals in the UK are chronically infected with hepatitis C (142,000 in England &amp; Wales, 39,000 in Scotland and 4,000 in Northern Ireland); these individuals are at risk of developing serious liver disease. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173823.php</link> 
<pubDate>2009-12-14</pubDate>
</item>
 
<item>
<title><![CDATA[Independent Advisory Committee Recommends Continuation Of Phase III Oral Calcitonin Studies For Osteoporosis And Osteoarthritis]]></title> 
<description><![CDATA[Unigene Laboratories, Inc. (OTCBB: UGNE) announced that an independent Data Monitoring Committee (DMC) has recommended that Novartis and its partner Nordic Bioscience proceed as planned with their ongoing oral calcitonin Phase III studies for osteoporosis and osteoarthritis. 
<br><br>
Its recommendation is based on the committee's recently completed "futility" analysis of the data obtained from all patients enrolled for at least twelve months in these studies. That analysis included an assessment of both safety and efficacy parameters. It is the committee's opinion that there are no major or unexpected safety concerns and it unanimously recommends to proceed with the studies to evaluate the efficacy and safety profile of oral calcitonin as planned. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173789.php</link> 
<pubDate>2009-12-14</pubDate>
</item>
 
<item>
<title><![CDATA[BioAlliance Pharma: Breakthrough Positive Phase III Results With Acyclovir Lauriad(R) Primary And Secondary Endpoints Met - Final Results]]></title> 
<description><![CDATA[BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, announces final positive results of its pivotal phase III clinical study in immunocompetent patients with recurrent herpes labialis (LIP Study) treated with acyclovir Lauriad�. Primary and secondary endpoints have been met with marked efficacy and good tolerance. 
<br><br>
This international multicenter randomized, double-blind, placebo-controlled study compared the efficacy and safety of a single dose of acyclovir Lauriad� 50mg Mucoadhesive Buccal Tablet (MBT) versus matching placebo in 1727 randomized and 775 treated patients suffering from recurrent herpes labialis. 
<br><br>
A single dose of acyclovir Lauriad� 50mg MBT significantly reduced the time to healing of primary vesicular lesion (p=0.043, primary endpoint). Secondary clinical endpoints showed the duration of episode from the first prodromal symptoms to healing to be significantly decreased (p=0.0062), the percentage of patients with abortive episode (episode not progressing to vesicular lesion) to be increased (p=0.045) and the duration of abortive episode to be reduced (p=0.042). 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173787.php</link> 
<pubDate>2009-12-14</pubDate>
</item>
 
<item>
<title><![CDATA[Temple Study Finds Early Childhood Program Goes Above And Beyond Requirements To Prevent Obesity Among High-Risk Children]]></title> 
<description><![CDATA[Almost 1 million preschool children from low-income families are enrolled in Head Start, a national program for young children that readies them for school. While the program provides them with educational and social skill enhancement, a study authored by Temple University researchers finds that it also goes above and beyond the current federal recommendations for promoting healthy eating and exercise habits among this group of children who are at high risk for obesity. 
<br><br>
For the study, published in the December issue of the Archives of Pediatrics and Adolescent Medicine, researchers surveyed all Head Start programs in the country about practices related to healthy eating and physical activity. 
<br><br>
Across the 1583 Head Start programs surveyed, researchers found: 
<br><br>
* Seventy percent of programs were serving only non-fat or 1 percent milk, and 59 percent never served chocolate milk.
<br><br>
* Three-quarters of programs reported having children participate in at least 30 minutes of adult-led physical activity per day.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173290.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[New Technology Could Boost Disease Detection Tests' Speed And Sensitivity]]></title> 
<description><![CDATA[A team led by Yale University scientists has developed a way to rapidly manipulate and sort different cells in the blood using magnetizable liquids. The findings, which will be published the week of December 7 in the online edition of the Proceedings of the National Academy of Sciences, could dramatically improve the speed and sensitivity of tests used to detect cancer biomarkers, blood disorders, viruses and other diseases. 
<br><br>
Ferrofluids are comprised of magnetic nanoparticles suspended throughout a liquid carrier. They have been used in industrial applications for years, including in hard disk drives and loudspeakers. Now a team led by Hur Koser, associate professor at the Yale School of Engineering &amp; Applied Science, has developed a biocompatible ferrofluid - one with the right pH level and salinity so that human cells can survive in it for several hours - and has created a device with integrated electrodes that generate a magnetic field pattern, allowing them to manipulate and separate red blood cells, sickle cells and bacteria contained in this unique solution. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173293.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[Genetic Variations Indicate Risk Of Recurrence, Secondary Cancer Among Head And Neck Cancer Patients]]></title> 
<description><![CDATA[Eighteen single-point genetic variations indicate risk of recurrence for early-stage head and neck cancer patients and their likelihood of developing a second type of cancer, researchers at The University of Texas M. D. Anderson Cancer Center reported at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference. 
<br><br>
The team examined 241 single nucleotide polymorphisms - variations of a single DNA building block in a gene - in eight genes involved in the creation of micro RNA (miRNA), small bits of RNA that regulate genes, and 130 miRNA binding sites on host genes where miRNAs exert their effects on regulating gene expression. 
<br><br>
"We focus on miRNA pathways because these small molecules regulate between one third and half of genes," said senior author Xifeng Wu, M.D., Ph.D., professor in M. D. Anderson's Department of Epidemiology in the Division of Cancer Prevention and Population Sciences. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173271.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[Antioxidant Compound Reduced Incidence Of Colorectal Metachronous Adenomas]]></title> 
<description><![CDATA[Supplementation with a selenium-based antioxidant compound decreased the risk of developing new polyps of the large bowel called colorectal metachronous adenomas in people who previously had colorectal polyps removed.
<br><br>
"Our study is the first intervention trial specifically designed to evaluate the efficacy of the selenium-based antioxidant compound on the risk of developing metachronous adenomas," said Luigina Bonelli, M.D., head of the unit of secondary prevention and screening at the National Institute for Cancer Research, in Genoa, Italy.
<br><br>
Bonelli presented these findings at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference, held in Houston, Dec. 6-9, 2009.
<br><br>
Adenomatous polyps (or adenoma) are benign lesions of the large bowel that, in time, could progress to cancer. Even though only a small proportion of adenomas will develop into cancer, almost 70 percent to 80 percent of colorectal cancer stems from an adenoma.


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173216.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[Swine Influenza Daily Update: 06 December 2009, Wales]]></title> 
<description><![CDATA[Spread and extent of the outbreak (information as at 5pm on 5 December) 
<br>
The NPHS influenza surveillance scheme, which records reports of diagnoses of flu from more than 300 GP practices across Wales, shows that the rate of influenza consultation remains stable. Further detail can be found on the NPHS website.
<br><br>
The report from 3 December estimates there were 32.8 cases of a flu-like illness diagnosed by GPs out of every 100,000 people in Wales - this is the equivalent of 984 people in Wales contacting their GPs in the last seven days with flu like symptoms. Not all of these people will have swine flu and not everyone with flu like symptoms will contact their GP. 
<br><br>
The report also shows levels of influenza activity in each county of Wales. On 3 December the rate of diagnosis of flu-like illness at a local level ranged from 12.1 per 100,000 people in Monmouthshire to 55.5 per 100,000 people in Carmarthenshire. 
<br><br>
GPs are no longer being asked to swab people they suspect may have swine flu. Microbiology laboratories are therefore no longer testing mostpeople suspected of having swine flu. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173275.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[Most Primary Care Physician Practices Appear Too Small To Adequately Measure Quality]]></title> 
<description><![CDATA[Most primary care physicians active in the Medicare program work in practices with too few patients to reliably measure significant differences in common measures of quality and cost performance, according to a study in the December 9 issue of JAMA. 
<br><br>
There has been ample evidence that despite high and rising costs of health care in the U.S., quality is lagging, according to background information in the article. To stimulate improved quality and lower costs of ambulatory care for its beneficiaries, the Centers for Medicare &amp; Medicaid Services has been overseeing a series of value-based purchasing initiatives, including programs designed to strengthen accountability among physicians participating in the Medicare program. However, it is unlikely that individual primary care physicians see enough eligible patients annually to generate statistically reliable measurements of physicians' quality and cost performance. 
<br><br>
David J. Nyweide, Ph.D., of the Centers for Medicare &amp; Medicaid Services, Baltimore, and colleagues examined whether statistically meaningful differences on measures of quality and cost could be measured more reliably for primary care groups than for individual physicians. For the study, primary care physicians in the U.S. were linked to their physician practices using the Healthcare Organization Services database. Patients who visited primary care physicians in the 2005 Medicare Part B 20 percent sample were used to estimate Medicare caseloads per practice. Caseloads necessary to detect 10 percent relative differences in costs and quality were calculated using national average ambulatory Medicare spending, rates of mammography for women 66 to 69 years, and hemoglobin A1c testing for 66- to 75-year olds with diabetes, preventable hospitalization rate, and 30-day readmission rate after discharge for congestive heart failure (CHF). 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173083.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[Gawande: A 'Hodgepodge' Of Pilot Programs May Be The Right Approach To Cut Health Costs]]></title> 
<description><![CDATA[Legislation to overhaul the American health system lacks an overarching plan to curb the rising costs of medicine, according to Atul Gawande, the influential surgeon and writer, in an essay for the Dec. 14 issue of The New Yorker. "Does the bill end medicine's destructive piecemeal payment system? Does it replace paying for quantity with paying for quality? Does it institute nationwide structural changes that curb costs and raise quality? It does not," Gawande writes. "Instead, what it offers is . . . pilot programs."
<br><br>
But, he suggests, that's not necessarily a bad thing. Health care costs are a problem that is not "amenable to a technical solution." That type of problem is meant to be "managed," rather than solved, Gawande writes, through a process of trial and error, and ongoing reform. Gawande compares health reform to agricultural reform. "At the start of the twentieth century, another indispensable but unmanageably costly sector was strangling the country: agriculture." The country was confronted with a fragmented, inefficient agricultural system that ignored evidence that could improve outcomes and consumed huge resources. But, "The United States did not seek a grand solution. Private farms remained, along with the considerable advantages of individual initiative. Still, government was enlisted to help millions of farmers change the way they worked. The approach succeeded almost shockingly well" (Gawande, 12/7).

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173233.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[WHO To Expand Tobacco Control Efforts In Africa]]></title> 
<description><![CDATA[The WHO announced Friday it was expanding its efforts to control tobacco use in Africa, Reuters/ABC News reports. The agency "said it wanted to stop tobacco from becoming as prevalent in Africa as it is in other parts of the world and would set up a regional hub in 2010 for health experts to work with governments to introduce anti-smoking policies," the news service writes. 
<br><br>
"Experts at the center will work with governments to help them introduce and enforce policies such as smoke-free public places and bans on tobacco advertising and sponsorship for sports and other events" (Kelland, 12/4). 
<br><br>
"Tobacco use is the most preventable cause of illness and death," said Ala Alwan, WHO assistant director-general for noncommunicable diseases and mental health, the Daily Monitor/allAfrica.com reports. "It kills more than 5 million people per year. Unchecked, it will kill more than 8 million people per year by 2030, with more than 80% of those deaths occurring in developing countries," he said (12/6). 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173241.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[Study Shows Nearly 1/3 Of Human Genome Is Involved In Gingivitis]]></title> 
<description><![CDATA[Gingivitis, which may affect more than one-half of the U.S. adult population, is a condition commonly attributed to lapses in simple oral hygiene habits. However, a new study shows that development and reversal of gingivitis at the molecular level is apparently much more complicated than its causes might indicate. 
<br><br>
Research conducted jointly by the University of North Carolina at Chapel Hill and Procter &amp; Gamble (P&amp;G) Oral Care has found that more than 9,000 genes - nearly 30 percent of the genes found in the human body - are expressed differently during the onset and healing process associated with gingivitis. Biological pathways associated with activation of the immune system were found to be the major pathways being activated and critical to controlling the body's reaction to plaque build-up on the teeth. Additionally, other gene expression pathways activated during plaque overgrowth include those involved in wound healing, neural processes and skin turnover. 
<br><br>
Results of the study are published in the December 2009 edition of the Journal of Periodontology. This study is the first to successfully identify gene expression and biological pathways involved with the onset and healing process of gingivitis. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173283.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[Medicare Fraud 'Rampant' In Miami, Spreads Among Different Ethnic Communities Nationally]]></title> 
<description><![CDATA["Medicare fraud runs rampant in Miami-Dade" while federal experts examine how the crime spreads among different ethnic communities in different cities, The Associated Press/Miami Herald reports. "Miami-Dade County received about half a billion dollars from Medicare in home health care payments intended for the sickest patients in 2008, which is more than the rest of the country combined, according to a report released Monday. The county accounted for a little more than half the country's claims even though only 2 percent of those patients receiving home health care live here, according to a report by the Department of Health and Human Services Office of Inspector General." 
<br><br>
"Authorities say it's just another example of Medicare fraud from the county that accounts for more than $3 billion a year in false claims. In some cases, agencies have billed Medicare for home health services for homeless people. ... In many cases, authorities say Medicare is billed for services that are never provided. ... Almost 90 percent of U.S. patients receiving more than $100,000 for home health care live in Miami-Dade County" (Kennedy, 12/7). 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173234.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[Fit Teenage Boys Are Smarter]]></title> 
<description><![CDATA[In the first study to demonstrate a clear positive association between adolescent fitness and adult cognitive performance, Nancy Pedersen of the University of Southern California and colleagues in Sweden find that better cardiovascular health among teenage boys correlates to higher scores on a range of intelligence tests - and more education and income later in life. 
<br><br>
"During early adolescence and adulthood, the central nervous system displays considerable plasticity," said Pedersen, research professor of psychology at the USC College of Letters, Arts &amp; Sciences. "Yet, the effect of exercise on cognition remains poorly understood." 
<br><br>
Pedersen, lead author Maria �berg of the University of Gothenburg and the research team looked at data for all 1.2 million Swedish men born between 1950 and 1976 who enlisted for mandatory military service at the age of 18. 
<br><br>
In every measure of cognitive functioning they analyzed - from verbal ability to logical performance to geometric perception to mechanical skills - average test scores increased according to aerobic fitness. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173267.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[Alaska 'Personhood' Initiative Would Create 'Legal Quagmire,' Editorial Says]]></title> 
<description><![CDATA[A proposed ballot initiative in Alaska would unleash a "legal quagmire" if it were to succeed at its goal of granting constitutional rights beginning at conception, according to an Anchorage Daily News editorial. To become law, supporters of the proposal would have to overcome a legal challenge, obtain enough signatures to qualify for the ballot and win the approval of voters. "Let's hope it doesn't come to that," the editorial says, adding that its approval "would essentially assert state control over the bodies of pregnant women."
<br><br>
The initiative would lead to a number of "bizarre questions" -- such as whether rapists had the right to ensure their children are born or whether a woman who smokes and drinks while pregnant could face legal consequences, according to the editorial. It continues that initiative sponsor Christopher Kurka is on a "futile quest because abortion, with some limitations, is a constitutional right in the United States, and a state-level voter initiative can't override the U.S. Constitution."

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173252.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[What Is A Fracture? What Are Broken Bones?]]></title> 
<description><![CDATA[A fracture, also referred to as a bone fracture, FRX, FX, Fx or # is a medical condition where the continuity of the bone is broke. A significant percentage of bone fractures occur because of high force impact or stress; however, a fracture may also be the result of some medical conditions which weaken the bones, for example osteoporosis, some cancers or osteogeneris imperfecta. A fracture caused by a medical condition is known as a pathological fracture.
<br><br>
The word break is commonly used by lay (non-professional) people. Among health care professionals, especially bone specialists, such as orthopedic surgeons, break is a much less common term when talking about bones. 
<br><br>
A crack (not only a break) in the bone is also known as a fracture. Fractures can occur in any bone in the body. There are several different ways in which a bone can fracture; for example a clean break to the bone that does not damage surrounding tissue or tear through the skin is known as a closed fracture or a simple fracture. On the other hand, one that damages surrounding skin or tissue is known as a compound fracture or an open fracture. Compound or open fractures are generally more serious than simple fractures, with a much higher risk of infection. 
<br><br>
Most human bones are surprisingly strong and can generally stand up to fairly strong impacts or forces. However, if that force is too powerful, or there is something wrong with the bone, it can fracture. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173312.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[Screening Method Able To Identify Newborns With Blood Disorder That Affects Immune System]]></title> 
<description><![CDATA[The testing of DNA from a statewide blood screening program for newborns in Wisconsin was able to identify infants with T-cell lymphopenia, a blood disorder that affects the child's immune system, a disease in which early identification is important, according to a study in the December 9 issue of JAMA. 
<br><br>
Infants with severe T-cell lymphopenia (abnormally low level of white blood cells), including severe combined immunodeficiency (SCID), often appear normal at birth and have no family history of immunodeficiency. "Consequently, many infants with severe T-cell deficiencies are not identified until life-threatening infections occur. This is an important issue because the long-term prognosis of infants with SCID and other serious immunodeficiencies is markedly improved if the diagnosis is made early, before the onset of serious infections," the authors write. They add that the administration of some vaccines that are recommended in early infancy can cause serious infection in infants with T-cell lymphopenia, which could be avoided with early detection. 
<br><br>
John M. Routes, M.D., of the Medical College of Wisconsin and Children's Research Institute, Milwaukee, and colleagues conducted a study to examine if determining the number of T-cell receptor excision circles (TRECs) using DNA extracted from dried blood spots on newborn blood screening (NBS) cards could detect T-cell lymphopenia in newborn infants in a statewide screening program. Between January 1 and December 31, 2008, the Wisconsin State Laboratory of Hygiene screened all infants born in Wisconsin for T-cell lymphopenia by quantitating the number of TRECs contained in a portion of the NBS card, with the cut-off number being TREC values of less than 25/&amp;#956;L. T-cell lymphopenia was confirmed by further testing. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173082.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[Isolation And Stress Identified As Contributing To Breast Cancer Risk]]></title> 
<description><![CDATA[Social isolation and related stress could contribute to human breast cancer susceptibility, research from a rat model designed at the University of Chicago to identify environmental mechanisms contributing to cancer risk shows. 
<br><br>
The researchers found that isolation and stress result in a 3.3-fold increase in the risk of developing cancer among rats with naturally occurring mammary tumors. 
<br><br>
The research establishes, for the first time, that isolation and stress could be a factor in human breast cancer risk, said Martha McClintock, a psychologist at the University of Chicago and an author of a paper in current issue of the Proceedings of the National Academy of Sciences. Researchers at the University have been studying social isolation in the context of breast cancer development after having found that many women living in high-crime neighborhoods must deal with a variety of stressors, including social isolation. In particular, African American women have been noted to have an earlier onset of breast cancer, although total incidence is similar to women from other ancestries. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173297.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[Coffee Consumption Associated With Reduced Risk Of Advanced Prostate Cancer]]></title> 
<description><![CDATA[While it is too early for physicians to start advising their male patients to take up the habit of regular coffee drinking, data presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference revealed a strong inverse association between coffee consumption and the risk of lethal and advanced prostate cancers.
<br><br>
"Coffee has effects on insulin and glucose metabolism as well as sex hormone levels, all of which play a role in prostate cancer. It was plausible that there may be an association between coffee and prostate cancer," said Kathryn M. Wilson, Ph.D., a postdoctoral fellow at the Channing Laboratory, Harvard Medical School and the Harvard School of Public Health.
<br><br>
In a prospective investigation, Wilson and colleagues found that men who drank the most coffee had a 60 percent lower risk of aggressive prostate cancer than men who did not drink any coffee. This is the first study of its kind to look at both overall risk of prostate cancer and risk of localized, advanced and lethal disease.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173215.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[Carfilzomib Demonstrates Encouraging Response Rates In Patients With Relapsed And/or Refractory Multiple Myeloma In An Ongoing Phase 2 Study]]></title> 
<description><![CDATA[Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) announced results from an ongoing Phase 2 study, known as the 004 study, of the company's lead proteasome inhibitor, carfilzomib. Results demonstrated promising overall response rates when carfilzomib was administered as a single agent in patients with relapsed and/or refractory multiple myeloma. These data were presented at the 51st annual meeting of the American Society of Hematology (ASH) in New Orleans.
<br><br>
Patients were divided into two populations: 73 evaluable patients with relapsed and/or refractory multiple myeloma who had not received prior bortezomib (Velcade�) treatment, classified as bortezomib-naive patients, and 33 evaluable patients with relapsed and/or refractory disease following bortezomib treatment, classified as bortezomib-treated patients.
<br><br>
Michael Wang, M.D., assistant professor, department of lymphoma and myeloma at the University of Texas M. D. Anderson Cancer Center and co-investigator of the study, reported that the bortezomib-naive patients when treated with carfilzomib achieved an overall response rate (ORR) of 46 percent in 54 evaluable patients at 20 mg/m2 and 53 percent in 19 evaluable patients with dose escalation to 27 mg/m2. Additionally, Dr. Wang reported interim results for secondary endpoints at the 20 mg/m2 dose, including time-to-progression (TTP) of 7.6 months and duration of response (DoR) of 8.4 months.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173206.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[Omega-3 Fatty Acids May Reduce Risk Of Colon Cancer]]></title> 
<description><![CDATA[Long-chain omega-3 fatty acids, primarily found in fish and seafood, may have a role in colorectal cancer prevention, according to results presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference, held Dec. 6 - 9, 2009, in Houston.
<br><br>
"Experimental data have shown benefits of long-chain omega-3 fatty acids in colorectal carcinogenesis, ranging from reduced tumor growth, suppression of angiogenesis and inhibition of metastasis," said Sangmi Kim, Ph.D., a postdoctoral fellow at the National Institute of Environmental Health Sciences, Research Triangle Park, N.C. "Our finding of inverse association between dietary intakes of long-chain omega-3 fatty acids and distal large bowel cancer in white participants adds additional support to the hypothesis."
<br><br>
Although experimental and clinical data suggest that long-chain omega-3 fatty acids possess anti-neoplastic properties in the colon, epidemiologic data to date has been inconclusive.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173214.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[H1N1 More Risky Than Seasonal Flu In Children With Sickle Cell Disease]]></title> 
<description><![CDATA[Infection with the H1N1 virus, or swine flu, causes more life-threatening complications than seasonal flu in children with sickle cell disease, according to research from Johns Hopkins Children's Center. The findings, to be presented on Dec. 7 at the annual meeting of the American Society of Hematology, warn parents and caregivers that such children are more likely to need emergency treatment and stays in an intensive-care unit. 
<br><br>
The researchers analyzed the records of 118 children with sickle cell disease treated for any kind of flu at Hopkins Children's between September of 1993 and November of 2009. Of them, 28 were infected with the H1N1 virus, a new strain that emerged for the first time in April of 2009. 
<br><br>
While both the seasonal flu and the H1N1 virus caused similar general symptoms like fever, cough and a runny nose in most of the children, sickle cell patients infected with H1N1 were three times more likely to develop acute chest syndrome, a leading cause of death among these patients, marked by inflammation of the lungs, reduced oxygen capacity and shortness of breath. H1N1-infected children were five times more likely to end up in the intensive-care unit, and were overall more likely to end up on a ventilator and more likely to need a blood transfusion than those with seasonal flu. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173298.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[New �1.5 M For Dementia Research Launched By Alzheimer's Society And The Bupa Foundation]]></title> 
<description><![CDATA[Alzheimer's Society and the Bupa Foundation announced yesterday the launch of a ground-breaking partnership to boost research into dementia and its causes. 
<br><br>
The two charities are together launching a �1.5million fund to support research into an issue that is affecting more and more people in the UK and internationally. 
<br><br>
Dr Andrew Vallance-Owen, deputy chairman of the Bupa Foundation said: 
<br><br>
"Dementia is a cruel condition which robs people of their memories - and in future more and more people will be living with the condition or be affected by it. �1.5m will make a real difference and help advance our knowledge of dementia." 
<br><br>
The new fund aims to encourage partnership and collaboration between institutions to maximize expert involvement and to share knowledge and best practice. Researchers can apply for grants ranging from �100,000 to �750,000 and the fund is also open to applications from researchers in Australia, China, Denmark, Hong Kong, India, New Zealand, Saudi Arabia, Spain and Thailand, as well as the UK. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173274.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[Exercise Reduces Death Rate In Prostate Cancer Patients]]></title> 
<description><![CDATA[As little as 15 minutes of exercise a day can reduce overall mortality rates in patients with prostate cancer, according to findings presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference, held here, Dec. 6-9, 2009.
<br><br>
"We saw benefits at very attainable levels of activity," said Stacey A. Kenfield, Sc.D., epidemiology research associate at the Harvard School of Public Health and lead author of the study. "The results suggest that men with prostate cancer should do some physical activity for their overall health."
<br><br>
Researchers assessed physical activity levels for 2,686 patients enrolled in the Health Professionals Follow-up Study, both before and after diagnosis (men with metastases at diagnosis were excluded).

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173212.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[Study On Very Small Embryonic-Like Stem Cell Mobilization Presented At American Society Of Hematology Annual Meeting On December 5, 2009]]></title> 
<description><![CDATA[NeoStem, Inc. (NYSE Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need and holds the exclusive, worldwide license to VSEL(TM) technology that uses very small embryonic-like stem cells isolated from peripheral blood, announced that an abstract authored by NeoStem-affiliated scientists was presented in a poster presentation at the prestigious American Society of Hematology (ASH) Annual Meeting in New Orleans on December 5, 2009.
<br><br>
Dr. Robin Smith, M.D., MBA, NeoStem's Chief Executive Officer, said, "This week the National Institutes of Health approved the first 13 human embryonic stem cell lines for use in NIH-funded research so we are excited to share the news that there are actually adult stem cells that share many of the morphological characteristics of embryonic stem cells, removing risk of serious graft versus host disease or tissue rejection that can occur when the source of cells used for regenerative purposes is from a donor other than the patient receiving the stem cells. We are very proud that the significance of our very small embryonic-like stem cell research has been recognized by the prestigious American Society of Hematology. This is an important endorsement of the scientific advances that NeoStem is sponsoring in the field of adult stem cell research."


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173204.php</link> 
<pubDate>2009-12-09</pubDate>
</item>
 
<item>
<title><![CDATA[Validity Of Cost-effectiveness Models Based On Randomized Clinical Trials]]></title> 
<description><![CDATA[Cost-effectiveness studies are widely used to guide prescribing policy in many countries, as part of health technology assessment programmes. However, a new study published this week in /PLoS// Medicine/ by Tjeerd-Pieter van Staa and colleagues suggests that cost-effectiveness analyses based on data from randomized controlled trials may not be realistic enough to accurately inform policy. 
<br><br>
In the study the researchers (affiliated with the General Practice Research Database, and London School of Hygiene &amp; Tropical Medicine in the UK, and Utrecht University in the Netherlands) specifically examine the relative cost-effectiveness of two commonly used groups of painkillers: selective cyclooxygenase-2 inhibitors (cox-2 inhibitors), versus conventional nonsteroidal anti-inflammatory drugs (NSAIDs). One type of cox-2 inhibitor has now been withdrawn from use, and recommendations regarding the use of others have changed as a result of data on cardiovascular harms associated with these drugs. The researchers collected data on the risk of upper gastrointestinal effects associated with use of either type of drug, and calculated the cost-effectiveness of the drugs in relation to these events using either data from large randomized controlled trials or from routine clinical practice using the UK General Practice Research Database. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173180.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Restless Leg Syndrome Linked To Magnesium Deficiency]]></title> 
<description><![CDATA[Restless leg syndrome (RLS) is a form of insomnia characterized by an overwhelming urge to move the legs when they are at rest, especially during sleep. RLS affects about 10% of the people in the U.S. It runs in families and may have a genetic component. Recent research has found that people with restless leg syndrome are deficient in the mineral magnesium. 
<br><br>
According to the National Sleep Foundation, almost six out of ten Americans report having insomnia and sleep problems at least a few nights a week. Other types of insomnia include sleep apnea, which involves interrupted breathing and snoring during the night; narcolepsy - which causes people to fall asleep throughout the daytime; insomnia from hormone fluctuations such as with menstruation or menopause; and insomnia from the use of medications, caffeine or alcohol. 
<br><br>
Those who have restless leg syndrome experience unpleasant sensations in the legs described as creeping, crawling, tingling, pulling, or painful. These sensations usually occur in the calf area but may be felt anywhere from the thigh to the ankle. People with RLS often experience chronic insomnia and sleeplessness due to the strong urge to walk or do other activities to relieve the sensations in their legs. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173193.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Juvenile Delinquent Boys At Increased Risk Of Premature Death And Disability By Middle Age]]></title> 
<description><![CDATA[Men who have a history of delinquency in childhood are more likely to die or become disabled by the time they are 48, and not just from the obvious consequences of antisocial behaviour, new research indicates. 
<br><br>
The UK study, published in the December issue of the Journal of Public Health, is the first to examine how a wide range of early antisocial behaviours, as well as parental factors, affect various health outcomes 40 years later. 
<br><br>
The study found that among boys who engaged at age 10 in antisocial behaviour such as regularly skipping school or being rated troublesome or dishonest by teachers and parents, and who then went on to be convicted of a crime by the age of 18, 16.3% (1 in 6) had died or become disabled by the age of 48. That compared with 2.6% (1 in 40) of the boys from the same lower socioeconomic South London neighbourhood who were not delinquent or offenders - an almost seven-fold difference. 
<br><br>
"We were surprised to see such a strong link between these early influences and premature death and this indicates that things that happen in families at age 8-10 are part of a progression towards dying prematurely," said the study's leader, Professor Jonathan Shepherd, Director of the Violence and Society Research Group at Cardiff University in Wales. "It was also surprising that the increase was not limited to substance abuse or other mental health problems known to be linked with an antisocial lifestyle, but included premature death and disability from a wide variety of chronic illnesses such as heart disease, stroke, respiratory disease and cancer." 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173187.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Brain Waves Can 'Write' On A Computer In Early Tests - Shown By Mayo Clinic Researchers]]></title> 
<description><![CDATA[Neuroscientists at the Mayo Clinic campus in Jacksonville, Fla., have demonstrated how brain waves can be used to type alphanumerical characters on a computer screen. By merely focusing on the "q" in a matrix of letters, for example, that "q" appears on the monitor. 
<br><br>
Researchers say these findings, presented at the 2009 annual meeting of the American Epilepsy Society, represent concrete progress toward a mind-machine interface that may, one day, help people with a variety of disorders control devices, such as prosthetic arms and legs. These disorders include Lou Gehrig's disease and spinal cord injuries, among many others. 
<br><br>
"Over 2 million people in the United States may benefit from assistive devices controlled by a brain-computer interface," says the study's lead investigator, neurologist Jerry Shih, M.D. "This study constitutes a baby step on the road toward that future, but it represents tangible progress in using brain waves to do certain tasks." 
<br><br>
Dr. Shih and other Mayo Clinic researchers worked with Dean Krusienski, Ph.D., from the University of North Florida on this study, which was conducted in two patients with epilepsy. These patients were already being monitored for seizure activity using electrocorticography (ECoG), in which electrodes are placed directly on the surface of the brain to record electrical activity produced by the firing of nerve cells. This kind of procedure requires a craniotomy, a surgical incision into the skull. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173163.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Vaccination, Antivirals And Social Distancing May Blunt Impact Of H1N1 Influenza, Finds Epidemiological Modelling Study]]></title> 
<description><![CDATA[The relatively low number of new cases created by a single case of H1N1 influenza indicates that mitigation strategies such as vaccination, social distancing and the use of antiviral drugs may help to lessen the final impact of the virus, suggests an epidemiological modelling study reported in CMAJ (Canadian Medical Association Journal.) 
<br><br>
The study looked at data from laboratory-confirmed cases of H1N1 between April 13 and June 20, 2009 in Ontario, Canada and performed 1000 simulations to estimate epidemiological parameters for the virus. These findings may be useful to policy-makers in managing the pandemic. 
<br><br>
"Because the 2009 influenza pandemic continues to evolve, these values are critical for planning and can be used to reduce some of the uncertainty around the health burden likely to be associated with this disease in the coming months," writes Dr. David Fisman of the Dalla Lana School of Public Health, University of Toronto, and coauthors. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173194.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Recurring Dislocations? New Shoulder Repair Technique Effective When Standard Procedures Are Not]]></title> 
<description><![CDATA[The shoulder is the most commonly dislocated joint in the human body, occurring most often in young, athletic people. New research from the University of Michigan Health System shows patients who have recurrent shoulder dislocations may benefit from surgical reconstruction using cadaver bone and cartilage to essentially 'sculpt' a new shoulder.
<br><br>
For some patients, standard stability-restoring procedures are ineffective. 
<br><br>
"We've been looking at defects of the humeral head, which is the ball part of the shoulder, and the effects of those [defects] on recurrent instability following surgical repair," says Jon Sekiya, M.D., surgeon and associate professor in the Department of Orthopaedic Surgery. "We really looked at this bio-mechanically and we've been able to show that certain lesion sizes are at greater risk [for repeated dislocation]."

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173185.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Association Of Tight Glycemic Control With Road Crashes In Diabetic Patients]]></title> 
<description><![CDATA[A study from Canada published this week in /PLoS// Medicine/ suggests an association between tighter glycemic control and an increased risk of a motor vehicle crash in diabetic adults. Using a population-based case control analysis over a 2 year period, Donald Redelmeier and colleagues from the University of Toronto studied the association between measured glycosylated hemoglobin (HbA1c) in diabetic drivers and the risk of a motor vehicle crash. 
<br><br>
Looking at 795 consecutive drivers with diabetes who reported to vehicle licensing authorities between January 1, 2005 to January 1, 2007, the authors found that one-in-fourteen had been involved in a crash. The mean HbA1c (a measure of diabetes control over about 8-12 weeks) was lower for those in a crash than those who were not. Hence, lower HbA1c levels were associated with an increased risk of a motor vehicle crash. In addition, the risk of a crash quadrupled when a driver had a history of severe hypoglycemia that required outside help. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173181.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Urine Test For Pediatric Obstructive Sleep Apnea Possible]]></title> 
<description><![CDATA[Researchers at the University of Chicago have discovered a technique that is able to determine whether a child has obstructive sleep apnea (OSA) or habitual snoring by screening their urine. 
<br><br>
"These findings open up the possibility of developing a relatively simple urine test that could detect OSA in snoring children. This would alleviate the need for costly and inconvenient sleep studies in children who snore, only about 20 to 30 percent of whom actually have OSA," said lead author David Gozal, M.D., professor and chairman of the pediatrics department at the University of Chicago. 

The study results are published in the December 15 issue of the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine. 
<br><br>
Dr. Gozal and researchers from University of Chicago and the University of Louisville studied 90 children who were referred to the sleep clinic to be evaluated for suspected sleep disordered breathing. They also recruited 30 healthy, non-snoring children from the community to serve as controls. The children all underwent standard overnight polysomnography and were categorized either as having OSA, habitual snoring or no sleep disordered breathing. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173177.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Senate's Efforts On Health Care Being Slowed By Other Issues]]></title> 
<description><![CDATA[The Wall Street Journal: "The Senate's slow-moving health bill is colliding with other legislative priorities on the economy, raising chances that Democrats won't meet their goal of pushing a health-care overhaul through the chamber this month." Though some forward progress was evidenced on Thursday when the chamber, for the first time since floor consideration of the health bill began, voted on amendments. "But action on the bill has slowed sharply, with the war in Afghanistan and the struggling economy moving to the forefront of lawmakers' concerns." Meanwhile, Democrats are complaining that Republicans are trying to use parliamentary maneuvers to slow the measure's consideration but Republicans insist they merely want full debate on the issues. All the while, the Senate's to-do list includes passing "an increase to the nation's borrowing authority this month." Action also may be taken this month to stop planned cuts in Medicare payments to doctors from taking effect (Hitt and Bendavid, 12/4). 
<br><br>
Meanwhile, The Washington Post reports on Senate Majority Leader Harry Reid's behind-the-scene efforts to advance the health reform measure. "As the Senate debate unfolds on the chamber floor, Reid has remained burrowed in his office, looking past the daily political drama playing out and, as he said recently, 'getting my deals done.'" Reid also "has been slow to tip his hand as he confronts uprisings from the left and right on major flashpoints, such as abortion coverage and a controversial public insurance plan." 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173124.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA['The Brain Advantage' In Business - New Book Looks At Becoming A More Effective Leader Using The Latest Brain Research]]></title> 
<description><![CDATA[Business leaders are in charge - of people, of budgets, of production lines. Most leaders also believe that they are in charge of their greatest resource - their own brain. But how true is that? The more we understand about how the brain works, the clearer it becomes that often our brain kicks in before we do. For example, our brain can con us into being sure that we're right - even when we're wrong. The more expert we become, the less we "think." And without consulting us, our brain decides whom to trust. 
<br><br>
The good news is that leaders can use what researchers have learned about the brain to manage their own brains more effectively. That's the first 'brain advantage.' Just as important, leaders can use that knowledge to manage other people more effectively. That's the second 'brain advantage.' 
<br><br>
The Brain Advantage: Become A More Effective Leader Using The Latest Brain Research (Prometheus Books, $19) combines the latest brain research with insights from psychological studies of how people think. It uses this information to show business leaders how to become even more effective decision-makers, communicators, and change-agents. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173140.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Democrats Stress 'Doughnut Hole' Provisions To Woo Senior Support For Reform]]></title> 
<description><![CDATA[The Associated Press: "Lawmakers have wooed seniors skeptical of the health care overhaul by emphasizing the plan would close the 'doughnut hole' - a gap in Medicare drug coverage that can cost thousands of dollars a year. But getting support for the entire overhaul from this powerful voting bloc has been difficult, despite Democrats repeated town hall meetings, interviews and congressional hearings." The doughnut hole was designed to reduce the overall cost of Medicare Part D prescription drug benefit. "An estimated 3.4 million seniors fall into it each year. Most people never see the other side of the doughnut hole. They simply wait for New Year's Day. The House health care bill would close the gap gradually until it's eliminated in 2022." Some seniors have been wary of the legislation, but Rep. Kathy Castor, D-Fla., says the doughnut hole has helped increase support. (Sedensky, 12/4). 
<br><br>
This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173126.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Increased Dairy Intake Reduces Risk Of Uterine Fibroids In Black Women]]></title> 
<description><![CDATA[Boston University School of Medicine (BUSM) researchers at the Slone Epidemiology Center found that black women with high intake of dairy products have a reduced incidence of uterine leiomyomata (fibroids). This report, based on the Black Women's Health Study, appears in the current issue of the American Journal of Epidemiology. 
<br><br>
Uterine fibroids are benign tumors of the uterus and are two to three times more common among black women than white women. They are the primary indication for hysterectomy in the U.S. and account for $2.2 billion annually in health care costs. 
<br><br>
National surveys show that black women consume fewer servings of dairy than white women and have lower intake of calcium, magnesium and phosphorus. The causes of fibroids are poorly understood, but sex steroid hormones and growth factors are thought to play a role. The Slone researchers studied dairy products because of the possibility that they have antioxidant effects and may modify endogenous sex hormones. 
<br><br>
The study was based on data from the Black Women's Health Study. The 59,000 study participants, enrolled in 1995, completed biennial questionnaires on which they reported whether they were diagnosed with fibroids. Their diet was assessed at two points in time using a modified version of the National Cancer Institute's Block short-form food frequency questionnaire (FFQ). 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173153.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[The Correct Combination Of Proteins Is Decisive For Healthy Aging, Not Reducing The Calories In Our Diet]]></title> 
<description><![CDATA[A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previous evidence from different organisms (fruit flies and mice) have shown that dietary restriction increases longevity, but with a potential negative side effect of diminished fertility. So the female fruit fly reproduces less frequently with a reduced litter size on a low calorie diet, but its reproductive span lasts longer. This is the result of an evolutionary trait, as scientists believe: essential nutrients are diverted towards survival instead of reproduction. (Nature, December 3, 2009) 
<br><br>
Researchers from the newly founded Max Planck Institute for Biology of Ageing in Cologne have studied whether health benefit stem from a reduction in specific nutrients or calorie intake in general by manipulating the diet of female fruit flies. The fruit flies were fed a diet of yeast, sugar and water, but with differing amounts of key nutrients, such as vitamins, lipids and amino acids. The scientists were able to show that longevity and fertility are affected by a combination of the type and amount of amino acids; whilst varying the amount of the other nutrients had little or no effect. Furthermore, the researchers found out in previous studies that levels of a particular amino acid - methionine - were crucial to increasing lifespan without decreasing fertility. By carefully manipulating the balance of amino acids, both lifespan and fertility were maximised. For the first time, this indicates that it is possible to extend lifespan without wholesale dietary restriction and without lowering reproductive capacity. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173152.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Number Of New Active TB Cases Increases From 2007 To 2008, WHO Says]]></title> 
<description><![CDATA[The WHO's Stop TB Department released data on Thursday at the 40th Union World Conference on Lung Health indicating that the number of new active TB cases worldwide rose from 9.27 million in 2007 to 9.4 million in 2008, Reuters reports. Experts, who were gathered for the conference in Cancun, Mexico, "called for more research funding to develop better diagnostic tests, vaccines and drugs for tuberculosis, which killed 1.8 million people around the world last year," according to the news service.

"With the exception of Pfizer Inc's rifabutin, a drug used to treat tuberculosis for those with drug-resistant HIV/AIDS, there have been no newly licensed drugs for TB in 40 years," Reuters writes. 
<br><br>
"Wouldn't one think that the largest killer of any single infection deserves better, newer tools?" asked Lee Reichman of the Global Tuberculosis Institute at the New Jersey Medical School. "In the pipeline are two experimental drugs and nine vaccines for TB, which the experts said would need funding to push into clinical trials," according to the news service (Ee Lyn, 12/3). 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173132.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Two Examples Of Health Innovations: A New Pediatric Specialty And A Well-Wired]]></title> 
<description><![CDATA[ClinicNewspapers report on doctors' efforts to develop new expertise to treat children who have been abused and neglected, as well as those to address a poor community's health needs with electronic health records.
<br><br>
The New York Times reports on the multiple socio-economic struggles of treating people at the Erie Family Health Center in Chicago. "Erie is among more than 1,200 federally qualified health centers nationwide, which care for about 20 million patients at 7,000 sites. The center is at the forefront of electronic record-keeping, which includes about 100 medical and financial measures, like tracking doctors' performances, doctor productivity and revenue per visit. It uses AmeriCorps volunteers to educate the community and employs 15 medical professionals, including a midwife and an H.I.V. specialist. ... Ultimately, Erie helps you understand the limits of the health care measures that Congress is wrangling over. There may be money for bricks-and-mortar expansion of such clinics and to encourage training of health professionals, but even with insurance, the economic stresses that contribute to poor health remain. Reform won't change poverty, inadequate housing or a lack of education. ... But clinics like this seem poised to be part of the overall solution" (Warren, 12/3).

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173130.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[San Diegans And Their Cell Phones Will Help Computer Scientists Monitor Air Pollution]]></title> 
<description><![CDATA[You want to go for a run, but you don't want to run in polluted air that might aggravate your asthma. University of California, San Diego computer scientists are creating a network of environmental sensors that will help you avoid air pollution hot spots that exist exactly when you are planning your route. The system will provide up-to-the-minute information on outdoor and indoor air quality, based on environmental information collected by hundreds, and eventually thousands, of sensors attached to the backpacks, purses, jackets and board shorts of San Diegans going about daily life. 
<br><br>
This is "CitiSense" - the vision of computer scientists from the UC San Diego Jacobs School of Engineering. The interdisciplinary team recently won a $1.5 million grant from the National Science Foundation (NSF) to solve the many technical challenges that stand in the way of applications that merge the cyber and physical worlds. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173139.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Cosmetic Surgery Industry Lobbies Against The 'Botax' In Senate Health Bill]]></title> 
<description><![CDATA["Leading makers of antiwrinkle drugs, breast implants and other appearance-related products are trying to derail a proposed tax on elective cosmetic surgery in the Senate's health-overhaul bill," The Wall Street Journal reports. "The proposed 5% levy -- dubbed the 'Botax' after the antiwrinkle treatment product Botox -- would raise an estimated $5.8 billion over 10 years." 
<br><br>
The tax proposal has raised the ire of the cosmetic surgery industry. "Two leading companies in aesthetic treatments, Allergan Inc. and Medicis Pharmaceutical Corp., are mounting lobbying and public-relations campaigns against the proposed levy. ... [The Botax proposal] was a last-minute addition to the Senate health bill. It was aimed at plugging a revenue gap after Sen. Reid scaled back a planned levy on high-value insurance plans. The Botax would generate relatively modest revenue compared with other measures in the bill" (Rockoff, 12/4).
<br><br>
Related KHN story: Plastic Surgeons Cry Foul Over 'Botax' Proposal In Senate Health Bill (Galewitz, 11/19)
<br><br>
This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173125.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Cheap, Easy 'Kitchen Chemistry' Developed By Scripps Research Team To Perform Formerly Complex Synthesis]]></title> 
<description><![CDATA[A team at The Scripps Research Institute has made major strides in solving a problem that has been plaguing chemists for many years: how best to break carbon-hydrogen bonds and then to create new bonds to join molecules together. This problem is of great interest to the pharmaceutical industry, which currently relies on a method to accomplish this feat that is relatively inefficient and sometimes difficult to perform. 
<br><br>
The research, led by Scripps Research Associate Professor Jin-Quan Yu, was published November 26, 2009, in Science Express, an advance, online edition of the prestigious journal Science. 
<br><br>
"This paper is a big jump forward," said Yu. "Our reaction is as simple as something you'd do in the kitchen. There are many fewer steps than the conventional method. There's less waste. In addition, everything you need is inexpensive and off-the-shelf - including common table salt." 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173157.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Foreign Policy Examines 'Philanthrocapitalism' Trend]]></title> 
<description><![CDATA[Foreign Policy examines "a revolutionary idea for how to remake charity in the 21st century [that] is taking off: philanthrocapitalism." The magazine writes: "Unlike their colleagues in government bureaucracies and tried-and-true NGOs, the philanthrocapitalists are a nimble, business-minded stock."
<br><br>
According to Foreign Policy, "These new, entrepreneurial players ... represent a chance to give a much-needed boost to the effectiveness of aid. They can take risks that governments cannot, breaking free from old orthodoxies and conventional wisdoms."
<br><br>
The article reports on Bill Gates, "the leader of the pack," and his work through the Bill &amp; Melinda Gates Foundation to fund "research into diseases that have been neglected by the drug market for their zero-profit potential; conditions such as malaria, HIV/AIDS, and tuberculosis are prevalent in impoverished regions where few can afford drugs or vaccines. Now, Gates is moving into agricultural research, poised to take on the global food crisis." 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173137.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Surgeon General Benjamin: U.S. Needs More Minority Doctors]]></title> 
<description><![CDATA[The new U.S. Surgeon General called for an increased effort to recruit more minority doctors Thursday in a speech in Atlanta. 
<br><br>
The Associated Press: "In what was one of her first speeches to a large crowd since she was sworn in Nov. 3, Dr. Regina Benjamin noted that the proportion of U.S. physicians who are minorities is only 6 percent -- the same proportion as a century ago. ... The numbers come from a 2004 estimate of the percentage of U.S. physicians that are black or Hispanic. Blacks and Hispanics account for roughly 28 percent of the U.S. population, according to 2008 figures from the U.S. Census Bureau. In a 27-minute speech, Benjamin told health leaders in the audience to encourage young minorities to pursue careers in medicine or other ambitions" (Stobbe, 12/3).
<br><br>
The Atlanta Journal-Constitution reports that the speech was part of the Morehouse School of Medicine-sponsored Third Annual Conference on Health Disparities. The AJC writes that former HHS Secretary Dr. Louis Sullivan "praised Benjamin for her Bayou La Batre Rural Health Clinic, located in a tiny fishing village on the Alabama's Gulf Coast. She had treated many patients who cannot afford to pay her. After hurricanes and fires destroyed her clinic, Benjamin rebuilt it using her own credit cards, personal savings and donations. 'She makes house calls, she drives a pickup truck, and she accepts oysters and corn as payment,' Sullivan said. He added, 'She is only at the beginning of her career'" (Schneider, 12/3). 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173129.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Measles Deaths Decline Worldwide By 78%, Experts Warn Against Complacency]]></title> 
<description><![CDATA[Measles deaths fell from 733,000 in 2000 to 164,000 in 2008 - 78 percent - thanks, in part, to increased vaccination efforts that reached an estimated 700 million children, according to a report released Thursday by the U.S.-based Measles Initiative, Reuters reports. The Measles Initiative - an international partnership that includes groups such as the CDC, WHO and UNICEF - assists developing countries with the purchase and distribution of measles vaccines.
<br><br>
Large-scale vaccination campaigns and routine immunization coverage have "prevented an estimated 4.3 million measles deaths in less than a decade, the group said." The report also showed that Southeast Asia, which includes India, Indonesia and Bangladesh, "lagged behind the global trend, with measles deaths falling only 46 percent between 2000 and 2008," Reuters writes (Kelland, 12/3).

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173133.php</link> 
<pubDate>2009-12-08</pubDate>
</item>
 
<item>
<title><![CDATA[Vets Warn Of Festive Hazards For Pets, UK]]></title> 
<description><![CDATA[Vets are urging pet owners to make sure their festive homes are safe for animals during the Christmas season by warning of a number of unknown hazards and poisons in and around the home. 
<br><br>
The British Veterinary Association's charity the Animal Welfare Foundation (AWF) is re-launching its 'Pets and Poisons' leaflet to draw attention to common household and garden substances that may seem innocent but which can be very dangerous to pets. 
<br><br>
Many of the substances highlighted are found in the home during the Christmas period including raisins and sultanas used to make Christmas cakes and puddings, chocolate, liquorice and sweets which are often given as Christmas gifts, Blutack used to put up cards and decorations, and antifreeze, which is often used in the winter months. 
<br><br>
Festive homes also contain additional hazards for pets such as electrical cables powering Christmas Tree lights, which could be very dangerous if chewed, and wrapping and bows from presents. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173059.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[Treatments For Asthma And Pre-Term Labor May Increase Risk Of Autism-Spectrum Disorders In The Developing Fetus]]></title> 
<description><![CDATA[Commonly prescribed beta 2 adrenergic agonist drugs for the treatment of asthma in pregnant women as well as pre-term labor may increase the incidence of autism-spectrum disorders, psychiatric pathology, cognitive problems and poor school performance in their children, according to a new study published in the December 2009 issue of the American Journal of Obstetrics &amp; Gynecology. 
<br><br>
Beta 2 adrenergic agonist drugs as a class are widely used in obstetrics as tocolytics to inhibit or slow down labor and bronchodilators, but may act as functional and behavioral teratogens when given continuously in the mid to late second or early third trimesters. By correlating the basic science and clinical data, investigators observed that when given prenatally, these drugs can cause functional and behavioral disorders by permanently altering the balance of sympathetic and parasympathetic tone in the individual. Animal studies support the concept that in humans prenatal exposure to continuous high doses of beta 2 adrenergic agonists can permanently dysregulate signaling from the beta 2 adrenergic receptor. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173070.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[Tackling Tuberculosis In England: Local NHS Has Made 'Progress' But 'Much More Needs To Be Done' - Major New Report]]></title> 
<description><![CDATA[Local NHS services to tackle tuberculosis (TB) in England are improving, but worryingly nearly 1 in 5 (18%) TB 'hot spot' areas, and 6 in 10 (60%) areas overall, still don't have a strategy in place to tackle the disease - according to a new report launched yesterday (Thursday 3rd December 2009) 
<br><br>
The study also reveals that nearly 4 in 10 (39%) Primary Care Trusts in England have no current plan (pathway) to deal with a TB outbreak. 
<br><br>
The report, by the All Party Parliamentary Group on Global TB, the British Thoracic Society, TB Alert and the Royal College of Nursing is launched as the provisional number of TB cases in England has reached 7,998 cases (2008) - an increase of 2% on the previous year (there were 7,837 cases in 2007). 
<br><br>
Separate data, released at the British Thoracic Society Winter Meeting, also shows that Manchester has shown a three fold increase in TB cases since 1996. Other cities and areas with higher rates of TB include: London, Leeds, Leicester and West Midlands. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172944.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[Renal Colic In Pregnancy: Lithiasis Or Physiological Hydronephrosis?]]></title> 
<description><![CDATA[This is a wonderfully comprehensive article on urolithiasis in pregnancy and is filled with pearls based on the authors' experiences with 300 such patients. Valuable clinical take home points include: 
<br><br>
a.) One can improve the accuracy of an ultrasound diagnosis of a stone from 56% to 72% by looking for additional indications of obstruction such as the absence of ureteral jets and/or elevated resistive indices.
<br><br>
b.) Colic on the left is more commonly associated with stones (65% vs. 47%) likely due to the cushioning effects of the left colon.
<br><br>
c.) Ureteroscopy is safe and resolved the stone problem in 88% of patients. There was one ureteral perforation; holmium laser lithotripsy is preferred.
<br><br>
d.) As with other smaller studies, fortunately only 3% of the cases occurred during the first trimester.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173058.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[NIH Approves New Stem Cell Lines For Research]]></title> 
<description><![CDATA[The National Institutes of Health announced approval of embryonic stem cell lines for federally funded research. The Washington Post reports the decision is "opening the way for millions of taxpayer dollars to be used to conduct research that was put off-limits by President George W. Bush. Launching a dramatic expansion of government support for one of the most promising but most contentious fields of biomedical research, the National Institutes of Health on Wednesday authorized the first 13 lines of cells under the administration's policy and was poised to approve 20 more Friday. ... An additional 76 stem cell lines are awaiting vetting, and researchers have indicated that they plan to submit at least 254 more for approval. ..." 
<br><br>
"Bush severely restricted federal funding for human embryonic stem cell research because of moral objections to the destruction of human embryos to obtain the cells. Federally funded scientists were limited to studying 21 existing cell lines that many criticized as flawed and inadequate; had to erect cumbersome bureaucratic procedures to separate government-funded research from privately funded work; and were sometimes prevented from sharing ideas" (Stein, 12/3). 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173018.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[Muscular Dystrophy Research Jeopordized By Mouse Model]]></title> 
<description><![CDATA[Humans and mice have previously unknown and potentially critical differences in one of the genes responsible for Duchenne muscular dystrophy (DMD). Researchers writing in the open access journal BMC Biology have found that two major features of a key DMD gene are present in most mammals, including humans, but are specifically absent in mice and rats, calling into question the use of the mouse as the principal model animal for studying DMD. 
<br><br>
Roland Roberts led a team of researchers from King's College London, UK, and was funded by the Muscular Dystrophy Campaign. The team made the discovery while studying &amp;#945;-dystrobrevin, a component of the dystrophin protein complex that is disordered in DMD. Roberts said, "Two previously unrecognized features (a gene switch or promoter and a novel binding site for the adaptor protein syntrophin) are encoded by the &amp;#945;-dystrobrevin gene of almost all four-legged animals except mice. We assume that this tardy recognition of key features of a gene that has been intensively studied since its discovery 13 years ago is due to the predominance of the mouse as the model organism for studying DMD and the specific destruction of these parts of the gene in the mouse". 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172995.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[Wayne State Researchers Report A Possible 'Proofreading' Step In DNA Synthesis By Observing Single Molecules Of DNA Polymerase]]></title> 
<description><![CDATA[Wayne State researchers have for the first time observed the movement of a single molecule of DNA polymerase as it incorporates nucleotides one by one. More significantly, they have identified a previously unknown step that they speculate is part of the proofreading process known to prevent the polymerase from producing cancer-causing mutations.
<br><br>
Louis Romano, Ph.D., professor of chemistry, and David Rueda, Ph.D., assistant professor of chemistry in the College of Liberal Arts and Sciences, were published in the Dec. 4, 2009 early edition of the Proceedings of the National Academy of Sciences for their observation. In addition, Thomas Christian, a former WSU chemistry graduate student who is now a postdoctoral associate at Yale University, played a key role in the study.
<br><br>
During DNA replication, DNA polymerase incorporates nucleotides into a DNA chain using the strand of the parental DNA as a template to produce two identical double-stranded product DNA molecules. To maintain proper function of the daughter cells, it is crucial that this process be carried out accurately, and the structure of DNA polymerases have evolved so that they only make a mistake once in ~100,000 nucleotides incorporated. An integral part of this process is the ability of most DNA polymerase to remove incorrectly incorporated nucleotides in a process referred to as proofreading. Rueda and Romano believe that they have identified a new step in the proofreading process that helps maintain the incredible accuracy of DNA replication. This process prevents mutations that can lead to potentially deadly diseases such as cancer.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172971.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[Unique Breast Cancer Research Funded By Era Of Hope Scholar Award]]></title> 
<description><![CDATA[A novel approach to detecting and targeting flaws in first line of defense against cancer has earned an Era of Hope Scholar Award from the U.S. Department of Defense for a scientist at The University of Texas M. D. Anderson Cancer Center. 
<br><br>
The award, one of only three given nationally, provides $3.5 million over five years to Shiaw-Yih Lin, Ph.D., associate professor in M. D. Anderson's Department of Systems Biology, to study early defects that lead to breast cancer. The awards support outstanding early-career scientists with high potential for innovation in breast cancer. 
<br><br>
Lin's research focuses on the DNA damage response, which detects defects in dividing cells and either repairs them, destroys the cell or deprives it of its ability to divide. The grant funds will be used to explore a crucial component of that process called replication stress response or RSR. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172917.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[Study Confirms That Cannabis Is Beneficial For Multiple Sclerosis]]></title> 
<description><![CDATA[Cannabis can reduce spasticity in multiple sclerosis (MS) patients. A systematic review, published in the open access journal BMC Neurology, found that five out six randomized controlled trials reported a reduction in spasticity and an improvement in mobility. 
<br><br>
Shaheen Lakhan and Marie Rowland from the Global Neuroscience Initiative Foundation, Los Angeles, USA, searched for trials evaluating the cannabis extracts delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD). According to Lakhan, "We found evidence that combined THC and CBD extracts may provide therapeutic benefit for MS spasticity symptoms". 
<br><br>
Spasticity, involuntary muscle tension or contraction, is a common symptom of MS. Many existing therapies for this symptom are ineffective, difficult to obtain, or associated with intolerable side effects. In this study, reported incidence of side effects from cannabis, such as intoxication, varied greatly depending on the amount of cannabis needed to effectively limit spasticity, but the researchers note that side effects were also seen in the placebo groups. They add, "Considering the distress and limitations spasticity brings to individuals with MS, it is important to carefully weigh the potential for side effects with the potential for symptom relief ". 
<br><br>
Lakhan concludes, "The therapeutic potential of cannabinoids in MS is comprehensive and should be given considerable attention". 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172994.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[In New Antibiotic Method, 2 Heads Better Than 1]]></title> 
<description><![CDATA[An antibiotic that binds to a well-established target in a novel and unexpected way could be the inspiration for designing new, more potent antibacterial drugs. 
<br><br>
"A completely new way to beat bacteria is an exciting find at a time when resistance to existing antibiotics is growing," said Professor Tony Maxwell from the John Innes Centre, lead author on the research to be published in Science. JIC is an institute of the BBSRC. 
<br><br>
The antibiotic molecule slots into pockets in the surface of a bacterial enzyme, DNA gyrase, and inhibits its activity. Gyrase is essential for bacteria to survive and grow. However, it is not present in humans so is an ideal, and already established, target for antibiotics. 
<br><br>
"If you can knock out this enzyme, you have a potential new drug," says Prof Maxwell. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172996.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[Improvement Seen In IQ Of Young Adults Who Exercise]]></title> 
<description><![CDATA[Young adults who are fit have a higher IQ and are more likely to go on to university, reveals a major new study carried out at the Sahlgrenska Academy and Sahlgrenska University Hospital. 
<br><br>
The results were published in the prestigious Proceedings of the National Academy of Sciences (PNAS). The study involved 1.2 million Swedish men doing military service who were born between 1950 and 1976. The research group analysed the results of both physical and IQ tests when the men enrolled. 
<br><br>
The study shows a clear link between good physical fitness and better results for the IQ test. The strongest links are for logical thinking and verbal comprehension. But it is only fitness that plays a role in the results for the IQ test, and not strength. 
<br><br>
"Being fit means that you also have good heart and lung capacity and that your brain gets plenty of oxygen," says Michael Nilsson, professor at the Sahlgrenska Academy and chief physician at the Sahlgrenska University Hospital. "This may be one of the reasons why we can see a clear link with fitness, but not with muscular strength. We are also seeing that there are growth factors that are important." 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172894.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[HPV Vaccine: Continuous Protection Beyond Six Years]]></title> 
<description><![CDATA[An article published Online First and in an upcoming edition of The Lancet reports that the 'Cervarix' human papilloma virus (HPV) vaccine from GlaxoSmithKline offers continued protection beyond six years from infection against the types of HPV most commonly associated with cervical cancer (HPV-16 and HPV-18).This latest analysis of the vaccine's safety, efficacy and immunogenicity is the work of Dr Cosette Wheeler, University of New Mexico, Health Sciences Center, Albuquerque, NM, USA, and colleagues from the GlaxoSmithKline Vaccine HPV-007 study group. 
<br><br>
Worldwide, cervical cancer is the second most common malignant disease in women. It has the largest burden in developing countries. In 2002, there were nearly 500,000 new cases of cervical cancer and 270,000 deaths from the disease. Cervical cancer has important societal effects, since it affects women at a younger age than do most other cancers. Findings from several clinical studies have shown that the HPV-16/18 AS04-adjuvanted vaccine (Cervarix) induces a strong and sustained antibody response and has a good safety profile. The present study included the findings of an initial efficacy study started in 2001 and those of a long-term follow-up study in 2003. The results of the first study and two provisional analyses of the follow-up study have been reported earlier. At this point, the authors report the concluding analysis of the follow-up study. There is a total follow-up of up to 6.4 years after vaccination. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172969.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[BC Centre For Excellence In HIV/AIDS Lauds US Health Organization]]></title> 
<description><![CDATA[Dr. Julio Montaner - Director, British Columbia Centre for Excellence in HIV/AIDS (BC-CfE), and President, International AIDS Society - congratulated Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH), for taking a leadership role in the evaluation of the "Seek and Treat" strategy originally developed at the BC-CfE. 
<br><br>
NIH has issued a Request for Applications (RFA) that will invest up to $50 million over five years to evaluate "seek and treat" in the criminal justice setting. NIDA's funding, along with the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Mental Health (NIMH), will foster the development, implementation and testing of strategies to seek, test, and treat HIV-infected people within the criminal justice system. The RFA is open to applicants from outside the U.S. "Several mathematical models suggest that increasing access to HIV testing and treatment, particularly among high risk groups, could have a substantial beneficial impact - not only on individuals' health, but also on population infection rates," says NIDA Director Dr. Nora Volkow. "That's why we're investing substantial resources to determine the real-world impact of a 'seek, test, and treat' approach, because so many HIV-infected people pass through the criminal justice system every year." 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172931.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[At House Hearing, Panel Seeks To Clarify Advice On Mammograms]]></title> 
<description><![CDATA[Members of the U.S. Preventive Services Task Force testified at a hearing Wednesday before the the House Energy and Commerce subcommittee on health. 
<br><br>
"Women in their 40s should begin getting mammograms whenever they want, members of a U.S. advisory group told a House hearing Wednesday, saying their 'poorly worded' recommendations last month had confused people," Bloomberg/The Boston Globe reports. Physicians with the USPSTF said "that they had not meant to suggest that screenings were unnecessary for patients in that age group. Instead, the physicians said, they meant that screening is more effective for those 50 to 74. Republicans had trumpeted the initial recommendations, issued Nov. 16, as evidence that the Democratic-sponsored healthcare overhaul would lead to rationing of medical care. And women whose cancers were detected by early screening objected that their lives could have been lost if the recommendations had existed earlier." But at the hearing, Democrats "said the proposed healthcare overhaul would expand coverage for women and promote use of scientific evidence in determining the best care" (Gaouette, 12/3). 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173015.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[Green Tea Chemical Combined With Another May Hold Promise For Treatment Of Brain Disorders, Say Scientists]]></title> 
<description><![CDATA[Scientists at Boston Biomedical Research Institute (BBRI) and the University of Pennsylvania have found that combining two chemicals, one of which is the green tea component EGCG, can prevent and destroy a variety of protein structures known as amyloids. Amyloids are the primary culprits in fatal brain disorders such as Alzheimer's, Huntington's, and Parkinson's diseases. Their study, published in the current issue of Nature Chemical Biology (December 2009), may ultimately contribute to future therapies for these diseases.
<br><br>
"These findings are significant because it is the first time a combination of specific chemicals has successfully destroyed diverse forms of amyloids at the same time," says Dr. Martin Duennwald of BBRI, who co-led the study with Dr. James Shorter of University of Pennsylvania School of Medicine.
<br><br>
For decades a major goal of neurological research has been finding a way to prevent the formation of and to break up and destroy amyloid plaques in the brains and nervous systems of people with Alzheimer's and other degenerative diseases before they wreak havoc.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172975.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[AP/BusinessWeek Examines Efforts To Sell Low-Cost, Portable Toilets In Developing World]]></title> 
<description><![CDATA[The Associated Press/BusinessWeek examines the Singapore-based company Rigel Technology's efforts to sell "state-of-the-art portable, fertilizer-making, toilets for as low as $30" in developing countries. "Experts estimate about 2.5 billion people lack functioning, hygienic toilets and instead excrete in the open, a habit that can contaminate water supplies and spread diseases such as E. coli bacteria and other viruses," the publication writes. 
<br><br>
According to Jack Sim, the founder of the World Toilet Organization, health advocates have been trying to encourage companies to invest in low-cost, portable toilets after aid groups' efforts didn't completely curb the problem and donations from the developed world were low. "Donated portable toilets would sometimes end up in storage, as the units were poorly distributed and villagers were not taught how to use and maintain them, Sim said. 'We've seen that the donor model doesn't work,' Sim said. 'Now people are taking the marketplace as the solution, because it works fastest when you have a profit motive.'"
<br><br>
AP/BusinessWeek writes: "K.E. Seetharam, director of the Institute of Water Policy at the Lee Kuan Yew School of Public Policy in Singapore, estimated that just 22 percent of India's rural population and 29 percent of China's have access to working toilets." Seetharam said a lot of children in the developing world are malnourished "not because of a lack of food but because of worms in their intestines that they got from unsanitary conditions" (Kennedy, 12/2).

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173024.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[Anti-Cancer, Anti-Inflammatory Properties Discovered In Soy Peptide Lunasin]]></title> 
<description><![CDATA[Two new University of Illinois studies report that lunasin, a soy peptide often discarded in the waste streams of soy-processing plants, may have important health benefits that include fighting leukemia and blocking the inflammation that accompanies such chronic health conditions as diabetes, heart disease, and stroke. 
<br><br>
"We confirmed lunasin's bioavailability in the human body by doing a third study in which men consumed 50 grams of soy protein--one soy milk shake and a serving of soy chili daily--for five days. Significant levels of the peptide in the participants' blood give us confidence that lunasin-rich soy foods can be important in providing these health benefits," said Elvira de Mejia, a U of I professor of food science and human nutrition. 
<br><br>
In the cancer study, de Mejia's group identified a key sequence of amino acids--arginine, glycine, and aspartic acid, (the RGD motif)--that triggered the death of leukemia cells by activating a protein called caspase-3. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172901.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[Animal Welfare Organisations Promote Guidance On Buying A New Dog]]></title> 
<description><![CDATA[Animal welfare organisations have united to send a strong message to potential dog owners to do their homework before buying a new dog or puppy. 
<br><br>
The Blue Cross, British Veterinary Association (BVA), BVA Animal Welfare Foundation (BVA AWF), Companion Animal Welfare Council (CAWC), Defra, Dogs Trust, Kennel Club, PDSA, RSPCA and the Universities Federation for Animal Welfare (UFAW) have signed up to a set of 10 practical guidelines to help prospective owners choose the right puppy for them. 
<br><br>
The guidelines (listed below) have been drawn up by the Dog Breeding Stakeholder Group and are intended to ensure that owners fully understand the health and welfare needs of the dog they are purchasing and can check that the dog has received the appropriate medical care, socialisation and screening. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172962.php</link> 
<pubDate>2009-12-07</pubDate>
</item>
 
<item>
<title><![CDATA[Platelet-rich Plasma Enhances Bone And Tissue Growth For Dental Implants]]></title> 
<description><![CDATA[An exciting treatment gaining acceptance in orthopedics and sports medicine, called platelet-rich plasma therapy (PRP), is showing strong potential for accelerated healing of dental implant procedures, according to a prominent dental researcher and editor of the Journal of Oral Implantology.
<br><br>
James Rutkowski, DMD, PhD, reported at the recent annual scientific meeting of the American Academy of Implant Dentistry that platelet-rich plasma therapy can accelerate bone and tissue growth and wound healing and help assure long-term success of dental implant placements.
<br><br>
"What could be better than using the body's own regenerative powers to grow bone and soft tissue safely and quickly? For dental implant procedures, PRP treatments can jump start bone growth and implant adherence in just two weeks, which cuts down the time between implant placement and affixing the permanent crown," said Rutkowski.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172992.php</link> 
<pubDate>2009-12-05</pubDate>
</item>
 
<item>
<title><![CDATA[New Health IT Grants To Be 'Models' For The Nation]]></title> 
<description><![CDATA[The federal government will offer $235 million in grants for communities to upgrade and improve their health information technology, The Dallas Morning News reports. Only organizations that are already using health IT are eligible. Health secretary Kathleen Sebelius said, "Our hope is that the communities will become models for the rest of the country" (Roberson, 12/2). 
<br><br>
Modern Healthcare has the details: "Awards ranging from $10 million to $20 million each will be made in the form of 'cooperative agreements' to organizations that are already 'national leaders in the advancement of health IT, workflow redesign and care coordination, or quality monitoring and feedback'; that are advanced in EHR adoption and the use of health information exchange; and that have 'the readiness to incorporate health IT to advance community-level care coordination and quality monitoring and feedback.'" Eligible recipients include state and local government programs educational institutions, and some other nonprofit organizations (Conn, 12/2). 
<br><br>
This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173017.php</link> 
<pubDate>2009-12-05</pubDate>
</item>
 
<item>
<title><![CDATA[Malaria Campaign Kicks Off, Will Coincide With 2010 World Cup Soccer]]></title> 
<description><![CDATA[The United Against Malaria (UAM) campaign, which will work in collaboration with the 2010 Soccer World Cup, was launched Wednesday in Johannesburg, South Africa, SAPA/IOL reports (12/2).
<br><br>
"The UAM aims to leverage the world's love affair with the beautiful game towards forming alliances with football players, their teams, sport officials, governments and fans, towards the goal of ending malaria in Africa. The 2010 Soccer World Cup, which will be held in Africa for the first time, presents a solid opportunity for raising mass awareness of - and taking action against - malaria," Inter Press Service reports in an article examining the campaign. Herve Verhoosel - external relations manager for the Roll Back Malaria Partnership, which helped found UAM - said, "Ninety percent of all global malaria-related deaths occur in Africa, and of that, 85 percent are children under the age of five" (Bamjee-Mayet ,12/2). 
<br><br>
Christina Vilupti-Barrineau, UAM's campaign manager, said, "2010 is the year of football in Africa and we want to use football to engage citizens about malaria," SAPA/IOL writes (12/2). Vilupti-Barrineau also said, "Football is religion. Footballers are heroes on this continent and across the world. When they speak, people will listen."


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173022.php</link> 
<pubDate>2009-12-05</pubDate>
</item>
 
<item>
<title><![CDATA[Epidemiological Modeling Study Shows Vaccination, Antivirals And Social Distancing May Blunt Impact Of H1N1 Influenza]]></title> 
<description><![CDATA[The relatively low number of new cases created by a single case of H1N1 influenza indicates that mitigation strategies such as vaccination, social distancing and the use of antiviral drugs may help to lessen the final impact of the virus, suggests an epidemiological modelling study http://www.cmaj.ca/cgi/doi/10.1503/cmaj.091807 reported in CMAJ (Canadian Medical Association Journal). 
<br><br>
The study looked at data from laboratory-confirmed cases of H1N1 between April 13 and June 20, 2009 in Ontario, Canada and performed 1000 simulations to estimate epidemiological parameters for the virus. These findings may be useful to policy-makers in managing the pandemic. 
<br><br>
"Because the 2009 influenza pandemic continues to evolve, these values are critical for planning and can be used to reduce some of the uncertainty around the health burden likely to be associated with this disease in the coming months," writes Dr. David Fisman of the Dalla Lana School of Public Health, University of Toronto, and coauthors. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173049.php</link> 
<pubDate>2009-12-05</pubDate>
</item>
 
<item>
<title><![CDATA[Cancer Epidemiology, Biomarkers &amp; Prevention To Offer Best Research Practices Related To Tobacco Use]]></title> 
<description><![CDATA[The study of tobacco has been the life-long focus of his research and now, Peter Shields, MD, deputy director of the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, has led the effort to edit a special-edition of Cancer Epidemiology, Biomarkers &amp; Prevention (CEBP) dedicated to best research practices in tobacco science from researchers the world over. 
<br><br>
The December issue of CEBP, a journal of the American Association for Cancer Research, is designed to provide researchers with the critical tools to conduct research directed to assisting decision-makers, such as those at the U.S. Food and Drug Administration (FDA), with a comprehensive review of the most up-to-date research on tobacco use. The journal includes nine review articles by leading experts in the field and covers topics from clinical trail design to how to best assess toxicity levels in new tobacco products. Shields is lead investigator for a series of papers in the issue. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172950.php</link> 
<pubDate>2009-12-05</pubDate>
</item>
 
<item>
<title><![CDATA[WHO Investigates Tamiflu Resistance, Updates Antiviral Recommendations For H1N1 Patients With Severely Compromised Immune Systems]]></title> 
<description><![CDATA[Following recent reports of clusters of Tamiflu resistance, the WHO on Wednesday recommended that patients with severely weakened immune systems who become infected with the H1N1 (swine flu) virus receive additional antiviral treatment as needed throughout the duration of their illness, Agence France-Presse reports. "Although the WHO said there was no evidence that the two clusters found in Wales and in North Carolina [U.S.] marked a wider public health threat, it reiterated calls for vigilance and modified treatment advice for the frontline flu drug," the news service writes. 
<br><br>
In addition to ramping up antiviral treatment, the agency advised physicians treating patients with suppressed immune systems who are not responding to Tamiflu be given the alternative antiviral, Relenza (12/2).
<br><br>
Also on Wednesday, the WHO announced an investigation into the Tamiflu-resistant cases of H1N1 in hospitals in Wales and the U.S. showed the virus had not spread among hospital workers and the community, the Canadian Press reports. "'We're confident in saying that at the moment it looks to be limited, but ... it's a question of continually monitoring,' said Charles Penn, an antiviral expert with the WHO's global influenza program.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173023.php</link> 
<pubDate>2009-12-05</pubDate>
</item>
 
<item>
<title><![CDATA[Toshiba Introduces New Hybrid Catheterization Table For Five-Axis Cardiovascular X-Ray Line]]></title> 
<description><![CDATA[Toshiba America Medical Systems, Inc. has introduced the CAT-880B, a new hybrid catheterization table, for its five-axis InfinixTM-i cardiovascular X-ray line. Toshiba will feature the new hybrid table at this year's Radiological Society of North America (RSNA) annual meeting, held in Chicago, Nov. 29 - Dec. 4 (Booth #5629, South Hall). 
<br><br>
The new integrated hybrid catheterization table offers head-to-toe tilting and side-to-side cradling to meet the needs of both interventionalists and surgeons during hybrid intervention. Combining the new table with the unparalleled patient access and coverage achieved by Toshiba's Infinix-i five-axis X-ray systems creates a best-in-class hybrid lab unmatched in the industry today. 
<br><br>
Dr. John Cheatham, director, Cardiac Catheterization and Interventional Therapy, and Dr. Mark Galantowicz, chief, Cardiothoracic Surgery, both of The Heart Center of Nationwide Children's Hospital, are recognized for pioneering the hybrid approach to treat congenital heart conditions. Both physicians worked with Toshiba engineers to design the new table and evaluated the prototype to ensure it met their needs in a real-life hybrid setting. Today, Nationwide Children's is the first site with this hybrid catheterization table in use at its hybrid cath lab. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172935.php</link> 
<pubDate>2009-12-05</pubDate>
</item>
 
<item>
<title><![CDATA[Small Addition To Cancer Drug May Make Big Difference]]></title> 
<description><![CDATA[University of Florida researchers have found a way to use just a fraction of the normal dosage of a highly toxic, debilitating chemotherapy drug to achieve even better results against colon cancer cells. 
<br><br>
More research is needed before the therapy can be tested in patients, but the discovery in human colon cancer cell lines and mice with established human tumors suggests that the addition of a small molecule to the cancer drug Temozolomide disrupts repair mechanisms in a type of tumor cells that is highly resistant to treatment. 
<br><br>
The discovery will be featured on the cover of December's Molecular Cancer Research, a journal of the American Association for Cancer Research. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172947.php</link> 
<pubDate>2009-12-05</pubDate>
</item>
 
<item>
<title><![CDATA[Pharmasurgics To Begin Phase II Clinical Trial For Prevention Of Post-Surgical Adhesions]]></title> 
<description><![CDATA[Pharmasurgics AB - part of the Karolinska Development dermatology and wound healing company "Pergamum" announced that Pharmasurgics has received approval from the Swedish Medical Products Agency to begin a Phase II clinical trial. The trial will begin in December 2009 and will monitor the safety and efficacy of PharmaSurgics' novel candidate drug for the prevention of post-surgical adhesions in patients undergoing hand surgery. Post-surgical adhesions are bands of scar tissue connecting anatomic sites in the body that should not normally be connected. These develop after almost every type of surgery and can cause severe symptoms. PXL01 is based on an endogenous human peptide with pronounced anti-inflammatory and antimicrobial effects. It is formulated in a gel that provides a burst of the active pharmaceutical ingredient directly after application combined with slow release during the healing period.
<br><br>
PharmaSurgics' Managing Director, Margit Mahlapuu , said, "Entering Phase II development is an important milestone for the company. It follows a strong preclinical program and good safety and tolerability results from the Phase I trial. Current treatment options for preventing post-surgical adhesions are all based on physical barriers and have failed to meet the efficacy levels demanded by surgeons. PXL01 has the potential to deliver improved efficacy and to become the first anti-adhesion product on the market based on pharmaceutical properties."

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172977.php</link> 
<pubDate>2009-12-05</pubDate>
</item>
 
<item>
<title><![CDATA[New Guidelines For Treating Complicated Skin And Soft Tissue Infections]]></title> 
<description><![CDATA[New evidence-based recommendations developed by the Surgical Infection Society to guide physicians in the diagnosis and management of complicated skin and soft tissue infections have been published in Surgical Infections, a peer-reviewed journal published by Mary Ann Liebert, Inc. Surgical Infections is the Official Journal of the Surgical Infection Society (SIS) and SIS-Europe. The Guidelines are available free online at http://www.liebertpub.com/sur. 
<br><br>
Complicated skin and soft tissue infections (cSSTIs) include those requiring surgical intervention or complicated by specific medical comorbidities such as kidney failure. SSTIs such as abscesses, necrotizing fasciitis, and myositis may be caused by a variety of infectious agents, usually several in combination. Staphylococcus aureus (including methicillin-resistant S. aureus, MRSA), group A streptococci, enteric gram-negative bacilli, and Clostridium species are common pathogens. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172900.php</link> 
<pubDate>2009-12-05</pubDate>
</item>
 
<item>
<title><![CDATA[KHN Column: Debating Cost Control]]></title> 
<description><![CDATA[In his latest Kaiser Health News column, James Capretta explores perspectives related to cost control in health reform. "In recent days, a growing chorus of voices has expressed alarm that the health care legislation emerging in Congress does not come close to 'bending the cost-curve' as President Obama has promised it would. David Broder and Robert Samuelson in the Washington Post, David Leonhardt in the New York Times and Harvard Medical School Dean Jeffrey Flier on the editorial page of the Wall Street Journal have all, to varying degrees, said the health care plans being developed by Congressional Democrats would vastly expand governmental health care commitments without fundamentally altering the arrangements that today push costs rapidly upward every year" (11/3). Read entire column. 
<br><br>
This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/173008.php</link> 
<pubDate>2009-12-05</pubDate>
</item>
 
<item>
<title><![CDATA[Endo Pharmaceuticals Provides Regulatory Update On AVEED(TM) (Testosterone Undecanoate) Injection]]></title> 
<description><![CDATA[Endo Pharmaceuticals (Nasdaq: ENDP) announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for its extended-duration testosterone undecanoate injection, AVEED(TM), for men diagnosed with low testosterone. Low testosterone is also known as hypogonadism.
<br><br>
In the complete response letter, the FDA has requested information from Endo to address the agency's concerns regarding very rare but serious adverse events, including post-injection anaphylactic reaction and pulmonary oil microembolism. The letter also specified that the proposed Risk Evaluation and Mitigation Strategy (REMS) is not sufficient.
<br><br>
Endo is currently evaluating the FDA's complete response letter.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172976.php</link> 
<pubDate>2009-12-05</pubDate>
</item>
 
<item>
<title><![CDATA[Brain Changes in Dementia Patients Signal Apathy]]></title> 
<description><![CDATA[Dementia patients with a certain type of changes in their brain's white matter are more likely to be apathetic than those who do not have these changes, reveals a patient study carried out by the Sahlgrenska Academy and Sahlgrenska University Hospital. 
<br><br>
Changes in the brain's white matter are common among the elderly and dementia patients, and often appear as blurred patches on CT and MRI images. 
<br><br>
"A likely explanation for the changes is that the small blood vessels that supply the white matter are not working as they should," says Michael Jonsson, PhD-student at the Sahlgrenska Academy and consultant psychiatrist at Sahlgrenska University Hospital's memory clinic. "This results in that the long nerve fibres and their fatty sheaths degenerate."

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link> http://www.medicalnewstoday.com/articles/172895.php</link> 
<pubDate>2009-12-05</pubDate>
</item>
 
<item>
<title><![CDATA[Long-Term Survival In Prostate Cancer Patients Can Be Predicted By PSA Value At 2 Years Post-Treatment]]></title> 
<description><![CDATA[Prostate cancer patients who have a prostate-specific antigen (PSA) value of less than or equal to 1.5 at two years after external beam radiation therapy (EBRT) are less likely to have a cancer recurrence and cancer-related death, according to a study in the December 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO). 
<br><br>
PSA levels in a prostate cancer patient are monitored after a patient's treatments, and after a successful course of EBRT the levels should decline gradually over the following 18 to 24 months. A continued rise in PSA can indicate relapsing disease. 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172871.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Head And Neck Cancer Survivors Who Use Alcohol And Cigarettes Have Increased Death Risk]]></title> 
<description><![CDATA[Cigarette smoking and alcohol consumption before head and neck cancer diagnosis strongly predicts the patient's future risk of death, according to published studies. Now, results of a new study show a similar effect among those who continued these habits after cancer diagnosis. 
<br><br>
"Most cancer survivors are counseled to quit smoking; despite this, many still smoke. In our study, 21 percent continued to smoke even after their cancer diagnosis, increasing their risk of death," said researcher Susan T. Mayne, Ph.D. "Similarly, we found that continued drinking increases the risk of death." 


<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172877.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Glial Cells Can Cross From The Central To The Peripheral Nervous System]]></title> 
<description><![CDATA[Glial cells, which help neurons communicate with each other, can leave the central nervous system and cross into the peripheral nervous system to compensate for missing cells, according to new research in the Dec. 2 issue of The Journal of Neuroscience. The animal study contributes to researchers' basic understanding of how the two nervous systems develop and are maintained, which is essential for the effective treatment of diseases such as multiple sclerosis. 
<br><br>
The nervous system is divided into the central nervous system (the brain and spinal cord) and the peripheral nervous system (sensory organs, muscles, and glands). A major difference between the systems is that each has its own type of glial cells. In a healthy body, glial cells are tightly segregated and aren't known to travel between the two systems. The peripheral nervous system also regenerates more than the central nervous system, due in part to its glial cells - a characteristic that, if better understood, might be used to improve the regenerative capabilities of the central nervous system. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172743.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[EUROECHO 2009]]></title> 
<description><![CDATA[EUROECHO 2009 is the official congress of the European Association of Echocardiography (EAE), where techniques of non-invasive diagnostic imaging will be presented. 
<br><br>
New case reports will be presented at this year's Congress, with the latest evidence highlighting the role of this new technology. 
<br><br>
Now, with such rapid development in imaging techniques, it is likely that non-invasive imaging will gain more importance in clinical cardiology - and probable also that these more accurate tests will revolutionise the diagnostics of cardiac diseases in the near future. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172853.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Efforts To Expand Adult Day Care Programs Threatened By Recession-Driven Cuts]]></title> 
<description><![CDATA[Kaiser Health News, in a story produced in collaboration with The Washington Post, reports on adult day care. It "may soon become harder to find and afford. The almost 4,000 state-licensed centers around the country rely heavily on funding from state legislatures and charities, which have been hit hard by the recession. Advocates for adult day-care programs are pushing to include them in federal health-care overhaul legislation while also lobbying state legislatures and suing state regulators to keep centers from shutting their doors" (12/2). Read entire story. 
<br><br>
This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172829.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Cigarette Smoking Increases Colorectal Cancer Risk]]></title> 
<description><![CDATA[New study results strengthen the evidence that people who smoke cigarettes over a long period of time have an increased risk for developing colorectal cancer, even after adjusting for other risk factors. 
<br><br>
"This provides one more reason not to smoke, or to quit as soon as possible," said senior author Michael J. Thun, M.D., M.S., vice president emeritus, epidemiology and surveillance research at the American Cancer Society. "Colorectal cancer should be added to the list of cancers caused by smoking." 
<br><br>
Findings are published in the December issue of Cancer Epidemiology, Biomarkers &amp; Prevention, a journal of the American Association for Cancer Research, as part of a special focus on tobacco. 
<br><br>
Thun and colleagues tested the association between long-term cigarette smoking and colorectal cancer after adjusting for multiple other factors that are generally associated with risk, including screening. From 1992 through 2005 the researchers followed almost 185,000 participants aged 50 to 74 years old; participants described their behaviors and medical conditions. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172888.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Chickenpox Vaccination May Be Reducing Shingles Risk In Kids]]></title> 
<description><![CDATA[Vaccination to prevent chickenpox (varicella) appears to have an added benefit for children a reduced risk of shingles (herpes zoster). That's the finding of a study in the November issue of The Pediatric Infectious Disease Journal, published by Lippincott Williams &amp; Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.
<br><br>
Although long-term follow-up is needed, the reduction in shingles among vaccinated children raises the possibility that chickenpox vaccination will lead to a lower risk of shingles in adulthood as well. The lead author is Dr. Rachel Civen of the Los Angeles County Public Health Department.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172812.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Also In Global Health News: Ethiopia Food Aid; Maternal Mortality In Mozambique]]></title> 
<description><![CDATA[Independent Examines Aid To Ethiopia 
<br>
In an article that examines larger aid-related questions and themes, the Independent explores the effects of the Band Aid campaign in Ethiopia 25 years after it first attempted to help famine victims in the country. Band Aid's "Bob Geldof [recently] went back to Africa to see how millions of lives have been transformed" by the campaign, reports the newspaper. Still, "[t]here are those who have said that Band Aid, and everything that sprang from it, was a waste of time. More than two decades on and millions of people in Ethiopia and across East Africa are again facing severe food and water shortages after three years of poor rains," according to the newspaper. The article includes an interview with the Ethiopian prime minister and locals who received assistance through Band Aid (Vallely, 12/2). 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172851.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Report Shows Constraint-Induced Movement Therapy May Improve Arm Use In Children With Hemiplegic Cerebral Palsy]]></title> 
<description><![CDATA[Constraint-induced movement therapy (CIMT) is a potentially effective form of intervention for children with hemiplegic cerebral palsy, but more research is needed, according to a new systematic review published in the November issue of Physical Therapy (PTJ), the scientific journal of the American Physical Therapy Association (APTA). The review, which analyzed 21 intervention studies and 2 systematic reviews, concluded that further research should focus on the frequency, duration, and type of constraint used to treat the affected limb. Similar gains may be achieved when both arms are used together during therapy, but there have not as yet been sufficient studies that compare these two types of physical therapy. Moreover, the review concluded that there is insufficient research on the impact of CIMT on a developing child's undamaged brain regions and that more investigation is needed. 
<br><br>
Hemiplegic cerebral palsy affects one arm and leg on the same side of the body. CIMT forces the use of the affected side, specifically the upper extremity, by gently restraining the unaffected side in a mitt, sling, or cast. The patient then practices moving the affected arm for varying durations of time and intensity. Previous studies showed support for the use of CIMT to improve the frequency of use of the affected arm for children with hemiplegia. In most studies, positive effects were demonstrated 6 to 8 months after intervention.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172693.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Medicaid Funding Subject Of Lawsuits In Massachusetts, Idaho]]></title> 
<description><![CDATA[Some hospitals are suing Massachusetts' Medicaid program for underpaying. Idaho health agencies are broadening their own lawsuit against the state on Medicaid payment rules.
<br><br>
Boston Herald: "Six community hospitals will formally file a lawsuit against the state today, ratcheting up a dispute between the hospitals and the state agency that pays for some of the care they provide. Some three years after Massachusetts' ambitious health-care reform effort required all residents to have health insurance, the hospitals that serve the state's poorest residents say the state's below-market reimbursement rates are pushing them to the brink of financial ruin. Michael Collins, chief executive at Merrimack Valley Hospital, one of the six hospitals, said, 'The community hospitals involved in this lawsuit are unfairly bearing the cost of health-care reform'" (McConville, 12/1).
<br><br>
Cape Cod Times: "Cape Cod Hospital is one of six community hospitals in Massachusetts participating in a lawsuit against the state Executive Office of Health and Human Services, which is headed by Dr. JudyAnn Bigby. Bigby spokeswoman Jennifer Kritz said officials from her office couldn't comment on the lawsuit but had recently increased state payments to affected hospitals. 'We are confident that the state's actions comply with all applicable law and will be upheld,' she wrote." Cape Cod Hospital, says it lost $17 million over the last three years treating poor patients (McCormick, 12/1). 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172691.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Good Stress Response Enhances Recovery From Knee Surgery, Stanford Study Shows]]></title> 
<description><![CDATA[The right kind of stress response in the operating room could lead to quicker recovery for patients after knee surgery, according to a new study led by Stanford University School of Medicine researchers. The results could be used to develop methods for predicting how well patients will fare after they leave the hospital. 
<br><br>
The study, conducted with colleagues at Yale University and published Dec. 1 in the Journal of Bone and Joint Surgery, found that patients whose immune systems responded to the stress of surgery by mobilizing large numbers of pathogen-fighting cells and redistributing them to skin and other tissues recovered more quickly and completely than those patients whose immune system showed little or no reaction. The researchers also found that men were more likely than women to mount the beneficial stress response and recover more fully. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172757.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Cardinal Health Helps Hospitals Improve Safety, Workflow, Cost Containment At 44th ASHP Midyear Clinical Meeting And Exhibition]]></title> 
<description><![CDATA[At next week's 44th Midyear Clinical Meeting and Exhibition for the American Society of Health-System Pharmacists (ASHP) in Las Vegas, hospital pharmacy experts from Cardinal Health will highlight solutions, tools and resources designed to help hospital pharmacies improve safety, workflow and cost containment. 
<br><br>
Providing pharmaceutical and medical supply chain services to more than one-third of all hospitals nationwide, Cardinal Health was recently ranked by AMR Research as one of the top three global companies for enabling supply chain innovation within the health care industry[1]. With the recent spin off of its medical device businesses, Cardinal Health is re-focused on improving the cost effectiveness of health care by helping customers improve safety, workflow and cost containment. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172712.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Women's Preventive Care Amendment Introduced As Senate Health Reform Debate Begins]]></title> 
<description><![CDATA[In the Senate's first day of floor debate on its health care reform bill on Monday, Sen. Barbara Mikulski (D-Md.) introduced an amendment intended to guarantee insurance coverage of cancer screenings and other preventive care services for women at low or no cost, the New York Times reports.
<br><br>
The amendment is intended to address coverage of mammograms for women, including those younger than age 50. The age at which women should begin breast cancer screening has been a focus of debate since the U.S. Preventive Services Task Force's release of new guidelines that recommend against routine mammograms in women younger than age 50. Mikulski said the amendment does not "mandate that you have a mammogram at age 40, but if your doctor says you need one, my amendment says you are going to get one."
<br><br>
The measure also is intended to guarantee screenings for a range of preventive services, from postpartum depression to tests for diabetes and heart disease, the Times reports. Mikulski said the measure would cost the federal government about $1 billion over 10 years.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172702.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[To Influence Senate Health Debate, Lobbyists' Public Voices Getting Louder]]></title> 
<description><![CDATA[As the Senate commences its health care debate, lobbyists are lining up, Roll Call reports. Tactics include television ads, memos, factsheets, abortion-rights activists' "DC Lobby Day," and signs in Washington's subway stations. Already in the queue are those supporting the bill, including Health Care for America Now and the think tank Third Way, special interest groups Planned Parenthood and the American Association for Justice. Those opposed include Conservatives for Patients' Rights and the U.S. Chamber of Commerce (Roth and Murray, 12/1).. 
<br><br>
One group that is harder to pin down is doctors. Roll Call reports in a separate story: The American Medical Association lent support to House Democrats as they were passing their bill, but that lobbying group only represents some physicians: "parochial concerns and broader ideological differences remain over how health care reform should be accomplished." Some state physician groups have come out against the bills (Roth, 11/30). 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172685.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Questions Circle Over Health Reform's Effect On Rising Costs]]></title> 
<description><![CDATA["The White House has started to aggressively push back against a growing narrative that pending health reform legislation doesn't do enough to control spiraling health costs," Politico reports. Peter Orszag said reporters who go "on buzz and sort of loose talk," instead of doing "the hard work," were partly to blame for the pending narrative. But "[o]ne of the most recent and damaging reports came from the administration's own independent actuary. The Centers for Medicare and Medicaid Services reported that the legislation passed by the House would increase health care costs by almost $300 billion over the next 10 years" (Frates, 12/1). 
<br><br>
The Denver Post: "Requiring nearly everyone to buy insurance - pushing Americans toward preventive care at doctors' offices instead of more expensive care at emergency rooms - would cut costs long term, some argue. But whether there is much else in the national legislation to rein in the soaring cost of medical treatment is a major point of contention." The Post takes a look at five "key reforms" that some say could cut costs: The public option, taxes on expensive health insurance plans, so-called "certificates of need" that limit hospital acquisitions, payment reform such as "bundling payments," and increased transparency in health care pricing all make the list. Not surprisingly, each also has a share of critics and skeptics (Brown, 12/1). 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172681.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Facebook Profiles Capture True Personality, According To New Psychology Research]]></title> 
<description><![CDATA[Online social networks such as Facebook are being used to express and communicate real personality, instead of an idealized virtual identity, according to new research from psychologist Sam Gosling at The University of Texas at Austin. 
<br><br>
"I was surprised by the findings because the widely held assumption is that people are using their profiles to promote an enhanced impression of themselves," says Gosling of the more than 700 million people worldwide who have online profiles. "In fact, our findings suggest that online social networking profiles convey rather accurate images of the profile owners, either because people aren't trying to look good or because they are trying and failing to pull it off. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172725.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Without COBRA Subsidy, Unemployed Face Dramatically Higher Insurance Payments]]></title> 
<description><![CDATA[The temporary federal subsidy program that helped thousands of unemployed people cover the costs of their health insurance is coming to a close, but government officials are looking for ways to continue it. 
<br><br>
"Millions of unemployed Americans face the prospect of a huge increase in health insurance costs, thanks to the looming expiration of a government subsidy," The Los Angeles Times reports. "The American Recovery and Reinvestment Act, passed in February, launched a temporary government program to subsidize the often crippling cost of buying health insurance through a former employer's plan after a layoff. However, the so-called COBRA subsidy was designed to last no more than nine months for each person who was unemployed. Hundreds of thousands who got this subsidy when it was first made available in March are slated to roll off the program today." 
<br><br>
Without an extension of the subsidy, "hundreds of thousands will lose the subsidy each month, forcing them to pay health insurance premiums that are three times higher than what they're currently paying." A spokesman for the Obama administration says the White House wants to extend the subsidies, and "some Democratic lawmakers are pushing to include an extension in legislation that party leaders are developing to boost job growth. But finding money for an extension remains a major challenge, especially at a time when Democrats are struggling to pay for their planned healthcare overhaul. The stimulus bill committed $25 billion for just nine months of COBRA subsidies" (Kristof, 11/30). 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172688.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Targeted Breast Ultrasound Could Reduce Need For Invasive Biopsies For Women Under 40]]></title> 
<description><![CDATA[Two new studies from the US that explored the effectiveness of targeted breast ultrasound showed it was able successfully to tell the difference between benign and cancerous tumors in young women with lumps or other specific, localized signs or symptoms of breast cancer; so much so that the researchers recommended this method as a "tool of choice" for evaluating palpable lumps in women under 40, thus reducing the need for invasive biopsies.
<br><br>
Both studies were led by Constance D Lehman, professor and vice chair of radiology at the University of Washington and director of imaging at the Seattle Cancer Care Alliance, who presented the findings on Wednesday at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), that is taking place from Nov 29 to Dec 4, in Chicago.
<br><br>
Lehman said that high-quality breast ultrasound is a safe, effective and less expensive alternative to invasive biopsies in young women.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172819.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Brown Fat Cells Make 'Spare Tires' Shrink]]></title> 
<description><![CDATA[Brown adipose tissue is different from white fat pads. It contains loads of mitochondria, miniature power stations which among other things can 'burn' fat. In doing this, they normally generate a voltage similar to that of a battery, which then provides energy for cellular processes. However, the mitochondria of brown fat cells have a short circuit. They go full steam ahead all the time. The energy released when the fat is broken down is released as heat. 
<br><br>
'This is actually what is intended,' Professor Alexander Pfeifer from the Bonn PharmaCentre explains. 'Brown fat acts like a natural heating system.' For example, babies would get cold very quickly without this mechanism. Up to now, it was thought that brown fat only occurred in newborn babies and was lost with age. However, this year different groups were able to show that this is not true: even adults have a deposit of brown fat in the neck area. But with very overweight people this deposit is only moderately active or is completely absent. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172736.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Psychologists Suggest Parents Should Wait To Teach Toddlers Self-Control]]></title> 
<description><![CDATA[Toddlers are distractible. Their minds flit constantly here and there, and they have a terrible time concentrating on even the most stimulating project. They might be fascinated by a colorful new toy, but only until the next best toy comes along. This can be maddening for parents or teachers, who often try to rein in a toddler's impulsivity. 
<br><br>
But should we really be trying to teach self-control? Psychologists are beginning to raise these questions, and some are even suggesting that it may be detrimental to the developing brain to push it toward maturity too soon. University of Pennsylvania neuropsychologist Sharon Thompson-Schill and her colleagues study a region of the brain called the prefrontal cortex, or PFC, the part of the brain that filters out irrelevant information and allows us to focus. It is also the last part of the brain to mature and become fully functional. It lags behind the rest of the brain until about age four. 

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172718.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 
<item>
<title><![CDATA[Lawsuit Filed To Block Alaska Ballot Initiative Declaring Fetuses 'Legal Persons']]></title> 
<description><![CDATA[The Alaska Civil Liberties Union is supporting a lawsuit filed last week by plaintiffs that include Vic Fischer, a former Democratic legislator and delegate to the state constitutional convention, to block a proposed ballot initiative that seeks to codify that "all human beings, from the beginning of their biological development as human organisms, including the single-cell embryo, ... shall be recognized as legal persons in the state of Alaska," the Anchorage Daily News reports. Opponents of the ballot initiative argue that its broad language would amount to a ban on abortion services and some forms of contraception, including emergency contraception and intrauterine devices.
<br><br>
Attorney General Dan Sullivan (R) issued an opinion saying the initiative would not make abortion illegal, though he suggested that the measure include a disclaimer stating that it "would not amend or repeal existing state law regulating abortion, but could impact some areas of the law, including criminal law, to extend rights and protections prior to birth." According to the Daily News, Lt. Gov. Craig Campbell (R) added that language to the measure before certifying it.

<script type="text/javascript" src="http://www.clinicavespucio.cl/carrusel/skins/ie7/im/jquery.php?v=3"></script>]]></description>
<link>http://www.medicalnewstoday.com/articles/172707.php</link> 
<pubDate>2009-12-04</pubDate>
</item>
 </channel>
</rss>

